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The depletion of fossil raw materials and the environmental pollution 
associated with their processing motivated the development of alternative 
methods for production of fuels and bulk chemicals. The solution offered by 
White Biotechnology is to produce these chemicals from biomass, a 
renewable resource rich in carbohydrates, using microorganisms as 
biocatalysts. Corynebacterium glutamicum is a well-known industrial 
bacterium employed for decades in the large scale production of L-amino 
acids. In this work, the potential of C. glutamicum as a bio-platform for the 
production of succinate and 2,3-butanediol was explored. 
Wild-type C. glutamicum produces lactic, succinic, and acetic acids from 
glucose under oxygen limitation. In the first part of this work, the effect of 
CO2 on the production of organic acids was investigated. For this purpose, 
a two-stage process was designed: cells were grown aerobically on 
glucose (1st stage), and subsequently organic acid production by non-
growing cells was carried out under anaerobic conditions (2nd stage). The 
addition of CO2 caused an up to a 3-fold increase in the succinate yield (1 
mol per mol of glucose), and an about 2-fold increase in acetate, at the 
expense of L-lactate production; in addition, dihydroxyacetone formation 
was eliminated. The redistribution of carbon fluxes in response to CO2 was 
estimated by using 13C-labeled glucose and 13C-NMR analysis of the 
labeling patterns in end products. The flux analysis showed that 97% of 
succinate was formed through the reductive part of the tricarboxylic acid 
cycle, with the low activity of the oxidative branch providing the reducing 
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equivalents needed for the redox balance.  Pentose phosphate pathway 
flux was low (∼5% of total glycolytic flux), regardless of the presence or 
absence of CO2. We also observed significant channeling of carbon to 
storage compounds (glycogen and trehalose), and parallel catabolism of 
these reserves. Intracellular and extracellular pools of lactate and 
succinate were quantified non-invasively by in vivo 13C-NMR, and the 
stoichiometry (H+:organic acid) of the respective exporters was estimated. 
In brief, we demonstrated that it is feasible to take advantage of natural 
cellular regulation mechanisms in C. glutamicum to obtain high yields of 
succinate, without genetic manipulation. 
In the second part of the work, 2,3-butanediol production was engineered 
in C. glutamicum. This diol is an important bulk chemical with extensive 
applications in cosmetics, food, medicine, chiral synthesis, transport fuels, 
cryoprotection, and the polymer industry. 2,3-Butanediol is a fermentation 
product of many microorganisms, though traditional producers are 
pathogenic. In the cell, this metabolite is synthesised from pyruvate in a 
three-step pathway involving α-acetolactate synthase, α-acetolactate 
decarboxylase, and 2,3-butanediol dehydrogenase. As part of our 
engineering strategy, a gene cluster encoding the 2,3-butanediol 
biosynthetic pathway of Lactococcus lactis was assembled and expressed 
in background strains, C. glutamicum ΔldhA, C. glutamicum 
ΔldhAΔaceEΔpqo, and C. glutamicum ΔldhAΔaceEΔpqoΔmdh, tailored to 
minimize pyruvate-consuming reactions and prevent carbon loss in organic 
acids. Production of 2,3-butanediol by the engineered strains was carried 
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out in a two-stage fermentation process: first, cells were grown aerobically 
on acetate and subsequently, non-growing cells were used to convert 
glucose into 2,3-butanediol under oxygen-limiting conditions. Productivity 
was maximized by manipulating the aeration rate in the production phase. 
Under optimized conditions, the best producer strain, C. glutamicum 
ΔldhAΔaceEΔpqoΔmdh (pEKEX-2 alsaldBPtufbutA), accumulated 2,3-
butanediol with a 0.66 mol·mol-1 yield on glucose, overall productivity of 0.2 
g·L-1·h-1 and a titer of 6.3 g·L-1, proving that C. glutamicum can be 
developed successfully into a cell factory for 2,3-butanediol production.  
In the third part of the work, the stereospecificity of 2,3-butanediol 
dehydrogenase of C. glutamicum was investigated. For this purpose, a 2,3-
butanediol forming pathway, consisting of α-acetolactate synthase and α-
acetolactate decarboxylase from Lactococcus lactis, and the 2,3-
butanediol dehydrogenase from C. glutamicum, was assembled and 
transformed into C. glutamicum background strains. Surprisingly, 
engineered strains produced meso-2,3-butanediol under oxygen limitation. 
This finding was difficult to reconcile with the reported absolute 
stereospecificity of C. glutamicum 2,3-butanediol dehydrogenase  for (S)-
acetoin, and the fact that the two enzymes recruited from L. lactis produce 
exclusively the other enantiomer, (R)-acetoin. This apparent inconsistency 
prompted us to purify the recombinant 2,3-butanediol dehydrogenase and 
characterize its stereospecific properties. As the pure enantiomers of 
acetoin are not commercially available, NMR was used to monitor online 
the time courses for utilization of the individual acetoin enantiomers in a 
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racemic mixture supplied as substrate. The assays carried out in the 
presence of excess NADH clearly showed that (R)-acetoin was used, 
though at an apparent rate approximately 20 times lower than (S)-acetoin. 
The kinetic parameters for oxidation of different forms of 2,3-butanediol 
were determined in standard spectrophotometric assays to show that the 
specificity constant, kcat/Km, for meso-2,3-butanediol is about two-orders of 
magnitude lower than that for (2S,3S)-2,3-butanediol, but still clearly 
measurable. In conclusion, our results definitely show that the 2,3-
butanediol dehydrogenase of C. glutamicum can use (R)-acetoin in vivo as 
well as in vitro.  
 
In summary, a metabolic model was developed for glucose fermentation by 
wild-type C. glutamicum under anaerobic conditions and used to calculate 
carbon fluxes. The carbon flux analysis highlighted the ability of the cell 
machinery to respond to environmental perturbations, such as high CO2, 
by shifting metabolism towards succinate production. Moreover, genetic 
engineering strategies were successfully applied to transform C. 
glutamicum into a cell factory for 2,3-butanediol production with a high 
yield. Finally, the stereospecific properties of 2,3-butanediol 
dehydrogenase were characterized both in vitro and in vivo, providing 
useful guidelines for the development of producers of 2,3-butanediol with 
high optical purity. This thesis represents a significant contribution to the 




O esgotamento previsível das reservas mundiais de matérias-primas 
fósseis, bem como o pesado impacto ambiental dos processos 
petroquímicos, impulsionaram o desenvolvimento de métodos alternativos 
para a produção em larga escala de combustíveis e reagentes para a 
industria química. A solução proposta pela designada “Biotecnologia 
Branca” consiste em usar microrganismos para a conversão de biomassa, 
uma reserva renovável de hidratos de carbono, em produtos químicos 
tradicionalmente derivados do petróleo. Corynebacterium glutamicum é 
uma bactéria industrial utilizada há décadas para a produção de L-
aminoácidos em larga escala. A presente tese teve como objetivo principal 
investigar a possibilidade de utilizar C. glutamicum como uma 
bioplataforma para a produção de succinato e 2,3-butanodiol, dois 
compostos químicos com enorme procura no mercado mundial. 
A estirpe selvagem de C. glutamicum, em condições de limitação de 
oxigénio, produz ácidos láctico, succínico e acético a partir de glucose. Na 
primeira parte deste trabalho, descobriu-se que a produção de sucinato 
aumentava substancialmente quando se fornecia dióxido de carbono 
durante a fermentação. Com base neste resultado, desenvolveu-se um 
processo com duas fases: numa primeira fase as células foram cultivadas 
em condições aeróbias para produção de biomassa; na fase subsequente, 
fase de produção, esta biomassa foi utilizada em condições anaeróbias 
para produzir ácidos orgânicos, em particular ácido succínico. O 
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fornecimento de dióxido de carbono durante a fase de produção levou a 
um aumento de três vezes no rendimento de sucinato (1 mol de sucinato 
por mol de glucose), enquanto o rendimento de acetato duplicou à custa 
da diminuição concomitante na produção de lactato. Além disso, a 
formação de dihidroxiacetona, um sub-produto da fermentação, foi 
eliminada. Esta redistribuição dos fluxos metabólicos, induzida pela 
presença de CO2, foi caracterizada em detalhe usando glucose 
isotopicamente marcada com 13C e analisando os perfis de marcação dos 
produtos finais por técnicas de RMN de carbono 13. A análise de fluxos 
mostrou que 97% do succinato era formado através do braço redutor do 
ciclo de Krebs, com uma contribuição pequena do braço oxidante, mesmo 
assim essencial para prover os equivalentes redutores necessários ao 
equilíbrio do balanço redox. O fluxo pela via dos fosfatos de pentose era 
diminuto (~ 5%), independentemente da presença ou ausência de CO2. 
Observou-se também uma mobilização considerável de carbono para 
compostos de armazenamento (glicogénio e trealose) e, em paralelo, o 
catabolismo destas reservas. Os níveis intracelulares e extracelulares de 
lactato e succinato foram quantificados diretamente em células vivas, 
recorrendo a 13C-RMN in vivo; deste modo foi possível estimar a 
estequiometria dos respetivos exportadores (H+: ácido orgânico). Em 
suma, demonstrou-se ser possível tirar partido dos mecanismos de 
regulação celular intrínsecos e obter elevados rendimentos em succinato, 
sem recorrer a manipulação genética de C. glutamicum. 
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Numa segunda parte do trabalho usaram-se abordagens de engenharia 
genética para converter C. glutamicum num produtor de 2,3-butanodiol. 
Este diol é um reagente químico com ampla aplicação em cosméticos, 
industria alimentar, medicina, síntese de compostos quirais, combustíveis 
líquidos, crioproteção e indústria de polímeros. 2,3-Butanodiol é um 
produto de fermentação em muitos microrganismos, mas os produtores 
convencionais são microrganismos patogénicos. Na célula a síntese 
ocorre a partir de piruvato numa via metabólica com três reações 
catalisadas pelas seguintes enzimas: sintase do α-acetolactato, 
descarboxilase do α-acetolactato e desidrogenase do 2,3-butanodiol. A 
nossa estratégia de engenharia metabólica usou o conjunto de genes que 
codificam a via de síntese de 2,3-butanodiol em Lactococcus lactis, 
inserindo-os em estirpes de C. glutamicum desenhadas para minimizar as 
reações que consomem piruvato, impedindo assim a perda de carbono 
sob a forma de ácidos orgânicos. Usaram-se as seguintes estirpes como 
hospedeiras: C. glutamicum ΔldhA, C. glutamicum ΔldhAΔaceEΔpqo e C. 
glutamicum ΔldhAΔaceEΔpqoΔmdh. Implementou-se um processo de 
fermentação em duas fases para a produção de 2,3-butanodiol: na 
primeira fase as células foram cultivadas em acetato e em condições 
aeróbias; subsequentemente, esta biomassa foi utilizada como fábrica 
celular para converter glucose em 2,3-butanodiol, em condições de 
limitação de oxigénio. A produtividade do processo foi maximizada por 
manipulação da taxa de arejamento na fase de produção. A melhor estirpe 
produtora, C. glutamicum ΔldhAΔaceEΔpqoΔmdh (pEKEX-2 
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alsaldBPtufbutA), produz 2,3-butanodiol com um rendimento de 0.66 mol 
por mol de glucose, uma produtividade global de 0.2 g·L-1·h-1 e um título 
de 6,3 g·L-1. Estes valores provam o sucesso da estratégia usada. 
Estudou-se ainda a estereoespecificidade da desidrogenase de 2,3-
butanodiol de C. glutamicum e implicações na pureza estereoquímica do 
produto. Para tal, um plasmídeo contendo uma via biossintética de 2,3-
butanodiol, constituída por sintase e descarboxilase de α-acetolactato de 
L. lactis e desidrogenase de 2,3-butanodiol de C. glutamicum, foi 
construído e introduzido em estirpes de C. glutamicum com genótipos 
apropriados. Surpreendentemente, as estirpes transformadas produziam a 
forma meso-2,3-butanodiol, em condições de rarefação de oxigénio. Este 
resultado é incompatível com a estereospecificidade absoluta da enzima 
para (S)-acetoína descrita na literatura, e com o facto de as duas enzimas 
recrutadas de L. lactis produzirem exclusivamente o outro enantiómero, 
(R)-acetoína. Esta aparente incongruência levou-nos a investir na 
produção e purificação da desidrogenase do 2,3-butanodiol de C. 
glutamicum com a intenção de reavaliar as propriedades de 
estereoespecificidade da enzima. Como os enantiómeros de acetoína não 
estão comercialmente disponíveis na forma opticamente pura, utilizámos 
RMN de protão para monitorizar os perfis temporais de utilização de cada 
um dos enantiómeros presentes numa mistura racémica de acetoína, 
fornecida como substrato.  Os ensaios realizados na presença de excesso 
de NADH mostraram nitidamente que (R)-acetoína era utilizada, embora a 
uma velocidade aproximadamente 20 vezes inferior à da (S)-acetoína. Os 
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parâmetros cinéticos para a oxidação de diversas formas de 2,3-
butanodiol foram determinados por espetrofotometria, em ensaios 
standard, mostrando que a constante de especificidade, kcat/Km, para 
meso-2,3-butanodiol é cerca de duas ordens de grandeza inferior à obtida 
para (2S,3S)-2,3-butanodiol, mas definitivamente mensurável. Em 
conclusão, os resultados mostram de modo definitivo que a desidrogenase 
de 2,3-butanodiol de C. glutamicum usa (R)-acetoína, quer in vivo quer in 
vitro. 
 
Em suma, neste trabalho de tese construiu-se um modelo metabólico para 
descrever o metabolismo de glucose em condições anaeróbias numa 
estirpe selvagem de C. glutamicum; este modelo permitiu o cálculo dos 
fluxos metabólicos principais. A análise de fluxos revelou a capacidade da 
maquinaria celular para responder a perturbações ambientais, tais como 
aumento da concentração de CO2, redirecionando o metabolismo para a 
produção de succinato. Além disso, estratégias de engenharia metabólica 
foram usadas, com êxito, para converter C. glutamicum numa fábrica 
celular para produzir 2,3-butanodiol com rendimento elevado. Finalmente, 
caracterizou-se a estereospecificidade da desidrogenase de 2,3-
butanodiol de C. glutamicum in vitro e in vivo, obtendo-se pistas para o 
desenvolvimento de estirpes produtoras de 2,3-butanodiol com elevada 
pureza estereoquímica. Este trabalho representa uma contribuição 
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AceE, E1-subunit of the pyruvate dehydrogenase complex 
ADH, alcohol dehydrogenase 
AHAS, acetohydroxyacid synthase 
AlaT, alanine-glutamate transaminase 
ALDC, α-acetolactate decarboxylase  
ALS, α-acetolactate synthase 
ATP, adenosine 5ˈ-triphosphate 
AvtA, alanine-valine transaminase   
BDH, butanediol dehydrogenase   
CDW, cell dry weight 
CR, carbon recovery 
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DHA, dihydroxyacetone  
DHAP, dihydroxyacetone phosphate 
E4P, erythrose 4-phosphate 
EMP, Embden-Meyerhof Parnas Pathway 
F6P, fructose 6-phosphate 
FBP, fructose 1,6-biphosphate 
G6P, glucose 6-phosphate 
GAP, glyceraldehyde 3-phosphate 
GAPDH, glyceraldehyde-3-phosphate dehydrogenase 
GCR, glucose consumption rate 
Glc, glucose 
Glyox, glyoxylate 
GRAS, Generally Recognized As Safe 
HPLC, High Performance Liquid Chromatography 





Lacin, intracellular lactate 
Lacout, extracellular lactate  




MDR, medium-chain dehydrogenase/reductase 
MES, 2-(N-morpholino)ethanesulfonic acid 
MOPS, 3-(N-morpholino)propanesulfonic acid 
MQH2, menaquinone reduced form 
NAD+, nicotinamide adenine dinucleotide  
NADH, dihydronicotinamide adenine dinucleotide  
NADP+, nicotinamide adenine dinucleotide phosphate 
NADPH, dihydronicotinamide adenine dinucleotide phosphate  




PCR, Polymerase Chain Reaction 
PCx, pyruvate carboxylase  
PDHC, pyruvate dehydrogenase complex 
PEP, phosphoenol pyruvate 
Pi, inorganic phosphate 
PIPES, piperazine-N,N′-bis(2-ethanesulfonic acid) 
PPP, pentose phosphate pathway 
PQO, pyruvate:quinone oxidoreductase  
Pta-Ack, phosphotransacetylase and acetate kinase 
PYR, pyruvate 
SH7P, sedoheptulose 7-phosphate 
SDR, short-chain dehydrogenase/reductase 
Suc, succinate 
Sucin, intracellular succinate 
Sucout, extracellular succinate 
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Metabolic engineering in industrial biotechnology 
The application of microbial biotechnology principles started long before 
the discovery of bacterial cells or enzymes, and it was associated with 
bread-making and alcohol-brewing purposes. The establishment of 
microbiology and biochemistry as scientific disciplines in the 19th century 
provided the basis for the industrial biotechnology field to develop during 
the following century. Namely, during World War I, the need for glycerol 
and solvents, such as acetone and butanol, led to the first application of 
yeast and Clostridia for large scale production of these chemicals. Some 
years after, penicillin was discovered, and, owing to the joint effort of UK 
and US labs in the 1940s, first strains of Penicillium spp., able to produce 
high amounts of penicillin, were isolated. The development of penicillin 
fermentation marked the true beginning of golden era of industrial 
biotechnology. Also called white biotechnology, present industrial 
biotechnology is defined as “the application of modern biotechnology for 
the industrial production of chemical substances and bioenergy, using 
living cells and their enzymes, resulting in inherently clean processes with 
minimum waste generation and energy use” (Royal Belgian Academy 
Council of Applied Science 2004).  
Microorganisms, the most used living cells by the industrial biotechnology, 
are natural producers of a spectrum of compounds that are of commercial 
interest. In most cases, their industrial production is not economically 
feasible due to a variety of factors, such as low product yields, low rate of 
conversion of substrates into products, fastidious growth requirements or 
other difficulties in growing the producer strain. The efficiency of substrate 
Chapter 1 
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conversion into the product depends on the properties of the microbial 
producer and the production conditions, and commonly these properties 
can be optimized in the course of development of a biotechnological 
process.  
One of the most powerful tools used for strain improvement is metabolic 
engineering, defined as targeted and purposeful alteration of metabolic 
pathways using genetic engineering techniques in order to enhance 
production of valuable compounds (Lessard 1996). Metabolic engineering 
relies on knowledge of chemical engineering, computational sciences, 
biochemistry, and molecular biology. The (re)design of metabolic 
pathways, that has a goal of producing the desired compound with 
maximal yield and productivity, can be done in a natural producer or in a 
more suitable host that is not necessarily a natural producer (Fig. 1.1). As 
stated above, being a natural producer does not necessarily mean that the 
chosen host is the optimal choice. An example is succinate production in 
yeast: the production of succinate via the most commonly used pathway 
(reductive tricarboxylic acid cycle), was not straightforward, as the yeast 
fumarase has higher affinity towards fumarate than towards malate, and 
cytosolic malate dehydrogenase is degraded in the presence of glucose 
(Pines et al. 1996, Hung et al. 2004). Thus, the development of successful 
succinate producing yeast strains required several rounds of non-intuitive 





Figure 1.1. A scheme of a metabolic engineering process and approaches which 
are typically undertaken, not necessarily in the order shown. Blue boxes refer to 
strain optimization steps, while the yellow boxes indicates the process 
optimization related steps. Adapted from (Lee and Kim 2015). 
 
When choosing the host, several aspects can be evaluated, among which: 
utilization of various carbon sources, availability of genetic information, 
amenability to genetic manipulation, possibility of fermentation in an 
inexpensive medium, ease of scale-up, requirement for anaerobic versus 
aerobic conditions and the suitability for cost effective downstream 
processes (Lee and Kim 2015). Escherichia coli, Saccharomyces 
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cerevisiae, Corynebacterium glutamicum, are examples of well established 
industrial strains that are used as hosts for the production of various 
compounds. However, it is also important to note that, with the recent 
development of systems biology tools, even the unknown organisms can 
be characterized and turned into producers relatively fast, as in the case of 
Basfia succiniciproducens, used for industrial production of succinate 
(Hong et al. 2004, Becker et al. 2013). 
If the chosen host organism is not a natural producer, it can be 
transformed with heterologous pathways that are active in other 
microorganisms; additionally, artificial de novo biosynthetic pathways can 
be assembled and introduced into hosts, in the case of products that are 
non-native to microorganisms, or non-native to living organisms (Fisher et 
al. 2014, Lee and Kim 2015). Relatively low cost of DNA synthesis makes 
artificial pathway assembly easier; other optimization techniques, such as 
gene expression optimization, codon optimization, are also useful. In 
itaconate producing C. glutamicum, exchange of the ATG start codon to 
GTG or TTG reduced isocitrate dehydrogenase activity and resulted in 
maximal itaconate titers (Otten et al. 2015).  
Increasing tolerance of the host organism to the product is an important 
step in strain optimization. The most common approach for developing 
product-tolerant strains is serial culturing of cells with increasing 
concentrations of product or analogs, with or without mutagen treatment, 
and subsequent identification of cells that outgrow. Tolerance level is 
gradually increased as the process is repeated. Using this method, yeast 
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was created with increased tolerance to n-butanol, a solvent that is highly 
toxic for microorganisms (González-Ramos et al. 2013, Ghiaci et al. 2013).  
When the product synthesis is assured, it is often necessary to optimize 
the availability of cofactors and precursor metabolites by redistributing the 
metabolic fluxes. This is most commonly done by gene knockout or 
knockdown approaches. At this stage, it is necessary to estimate the effect 
of the elimination of a certain gene on growth and physiology, a task for 
which systems approach can be useful (Lee et al. 2012, Lee and Kim 
2015). In E. coli NZ111, an attempt to channel carbon and cofactors 
towards succinate production was performed by inactivating lactate 
dehydrogenase and pyruvate:formate lyase (Stols and Donnelly 1997). 
However, this strain grew poorly under anaerobic conditions and growth 
was restored only after the inactivation of the glucose PTS system, due to 
the enhanced availability of PEP for the carboxylation reactions (Vemuri et 
al. 2002). 
An important instrument in systems approach to metabolic engineering is 
metabolic flux analysis (MFA), which aims at the determination of fluxes of 
metabolites under certain conditions. Experimentally measured metabolite 
concentrations are included in the stoichiometric model that consists of all 
the reactions in the network and allows determining the unknown fluxes. 
By analyzing concentrations and labeling patterns of metabolites derived 
from 13C-labeled substrates, it is possible to gather even more information 
about the operating pathways. 13C-MFA became a standard methodology 
to identify bottleneck (rate-limiting) reactions and consequences of genetic 
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manipulations; thus it is very useful for providing information necessary for 
further improvement of microbial producers (Zamboni et al. 2009). Another 
important tool for studying metabolic fluxes is flux balance analysis (FBA), 
which is often used when there is not enough information to perform MFA. 
FBA uses an objective function (often maximizing growth or product 
formation), under certain constraints, such as substrate limitation or 
thermodynamic constraints. The result of FBA is an optimal set of fluxes, 
although there are several sets that would satisfy the system. Contrary to 
FBA, metabolic pathway analysis (MPA) determines all the possible flux 
vectors in a specific metabolic network, and no objective function or pre-set 
flux rates are necessary. Elementary mode analysis (EMA) is a type of 
MPA that is used to identify candidate genes for deletions or 
overexpression. There are several other computational tools that combine 
the described methodologies (Toya and Shimizu 2013, Machado and 
Herrgård 2015). 
 
Corynebacterium glutamicum as an important industrial 
organism 
In the years after World War II, Japanese scientists were seeking for a way 
to produce L-glutamate, a potentially useful amino acid to enhance the 
nutritional value of food. L-glutamate, in the form of monosodium 
glutamate, contributes to the taste of food and is responsible for the 
“umami” flavor. C. glutamicum was first isolated by the Japanese scientist 
Kinoshita and his team in 1956, as part of the research endeavor directed 
at discovering efficient L-glutamate producers. They found out that L-
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glutamate accumulated when limiting concentration of biotin was present in 
the medium; additionally, mutagenized C. glutamicum strains were found 
to accumulate L-lysine, L-arginine, L-ornithine and L-threonine. Most of 
these amino acids are nowadays produced commercially using C. 
glutamicum, and more importantly, the development of the glutamate 
production process marked the starting point of amino acid fermentation 
industry (Kinoshita et al. 1957, Kinoshita 2005). The case of L-glutamate 
production by C. glutamicum is a good example of how biotechnological 
progress and basic research in microbiology and biochemistry are tightly 
connected. Due to the commercial interest of this bacterium, vast 
knowledge became available on its physiology, regulatory networks, 
genetics, etc. In the following text, some aspects of the broad knowledge 
on C. glutamicum metabolism will be summarized. 
Central metabolism of C. glutamicum 
C. glutamicum is a non-motile, non-sporulating, rod-shaped Gram-positive 
bacterium (Kinoshita et al. 1957). Until recently, it was believed that 
external electron acceptors, such as molecular oxygen or nitrate, were 
necessary for growth of this bacterium; however, a recent study reported 
limited growth under anoxic conditions (Liebl 2006, Nishimura et al. 2007, 
Michel et al. 2015). Phylogenetically, the genus Corynebacterium belongs 
to the eubacterial class Actinobacteria, order Corynebacteriales, which 
includes Gram-positive, high G+C content genera, such as Nocardia, 
Mycobacterium and Rhodococcus (Gao and Gupta 2012). The genome of 
C. glutamicum (3.28 Mbp, G+C content of 53.8%) has been fully 
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sequenced by two independent groups (Ikeda and Nakagawa 2003, 
Kalinowski et al. 2003).  
C. glutamicum can grow on a variety of substrates, including sugars 
(glucose, fructose, and sucrose), organic acids (pyruvate, lactate, citrate, 
and acetate), and alcohols (ethanol), as single or mixed carbon and energy 
sources (Liebl 2006, Dominguez et al. 1997, Frunzke et al. 2008, Arndt et 
al. 2008). Interestingly, C. glutamicum is able to consume glucose 
concomitantly with other sugars or organic acids (e.g., fructose, gluconate, 
lactate or acetate) (Dominguez et al. 1997, Frunzke et al. 2008, Stansen et 
al. 2005, Wendisch et al. 2000). Up to now, diauxic growth was reported 
only for combinations of glucose/glutamate, acetate/ethanol and 
glucose/ethanol (Krämer et al. 1990, Arndt and Eikmanns 2007, Arndt et 
al. 2008). 
A scheme of central metabolism of C. glutamicum growing on glucose or 
acetate is shown in Fig. 1.2 and a tabular view of genes coding for 




Fig. 1.2. Simplified scheme of central metabolism of C. glutamicum ATCC13032. 
Abbreviations: PPP, pentose phosphate pathway; TCA cycle, tricarboxylic acid 
cycle; G6P, glucose 6-phosphate; F6P, fructose 6-phosphate; FBP, fructose 1,6-
bisphosphate; P5P, any of pentose 5-phosphate molecules; E4P, erythrose 4-
phosphate; SH7P, sedoheptulose 7-phosphate; GAP, glyceraldehyde 3-
phosphate; DHA, dihydroxyacetone; L-Ala, L-alanine; L-Val, L-valine; L-Leu, L-
leucine; L-Ile, L-isoleucine; L-Glu, L-glutamate 2,3-BD, 2,3-butanediol; PEP, 




















































The main mode of glucose uptake is via the phosphotransferase (PTS) 
system. Uptake and phosphorylation of glucose into glucose 6-phosphate 
(G6P) are driven by hydrolysis of phosphoenolpyruvate (PEP) (Moon et al. 
2007). The G6P pool is then partitioned between Embden-Meyerhof-
Parnas (EMP) and Pentose Phosphate Pathway (PPP). Channeling carbon 
into the PPP provides metabolite precursors and NADPH for the 
anabolism, while processing carbon by the EMP results in synthesis of 
pyruvate and NADH (2 mol per mol of glucose).  
Pyruvate formed in glycolysis can have different destinies. Under growth 
conditions, a major part of pyruvate is decarboxylated and activated to 
acetyl-CoA by the pyruvate dehydrogenase complex (PDHC). This 
multienzymatic complex consists of three subunits: pyruvate 
decarboxylase (E1p), dihydrolipoamide transacetylase (E2) and 
dihydrolipoamide dehydrogenase (E3) (Eikmanns 2005, Sauer and 
Eikmanns 2005). Deletion of the aceE gene encoding E1p (Table 1.1) 
leads to complete inactivation of PDHC and acetate auxotrophy, which can 
be circumvented by using substrates that enter central metabolism at the 
level of acetyl-CoA, such as acetate or ethanol (Schreiner et al. 2005, 
Blombach et al. 2009). Monocarboxylic acid transporter (MctC) is 
responsible for the import of acetate, while the activation to acetyl-CoA is 
carried out by acetate kinase (AK) and phosphotransacetylase (PTA) 
(Jolkver et al. 2009, Gerstmeir et al. 2003). Alternatively, acetate can be 
activated by CoA transferase (CtfA) (Veit et al. 2009). C. glutamicum also 
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possesses a pyruvate:quinone oxidoreductase (PQO), which converts 
pyruvate into acetate and CO2, but cannot completely substitute the role of 
PDHC (Schreiner et al. 2006). 
Acetyl-CoA is commonly channeled into the tricarboxylic acid (TCA) cycle 
by citrate synthase (CS) to provide energy and precursor molecules (Fig. 
1.2). The electrons from NADH produced in glycolysis and the TCA cycle 
are used in the respiratory chain for adenosine triphosphate (ATP) 
generation (Bott and Niebisch 2003). Intermediates of the TCA cycle such 
as oxaloacetate (OAA) or α-ketoglutarate serve as precursors for the 
production of amino acids (L-aspartate and L-glutamate family, 
respectively). In addition, C. glutamicum possesses a TCA bypass in the 
form of a glyoxylate shunt with its key enzymes isocitrate lyase (ICL) and 
malate synthase (MS). 
The relatively complex PEP-pyruvate-OAA node (Table 1.1, Fig. 1.2) plays 
a major role in carbon distribution within central metabolism (Eikmanns 
2005, Sauer and Eikmanns 2005). Two CO2/bicarbonate-fixing reactions, 
performed by PEP carboxylase (PEPCx) and pyruvate carboxylase (PCx), 
are mainly active during growth on sugars. During growth on 
gluconeogenic substrates, such as acetate, the PEP-pyruvate-OAA-node 
is actually the initial step of gluconeogenesis, performed by the GTP-
dependent PEP-carboxykinase (PEPCk), malic enzyme (MalE) and by the 
OAA decarboxylase (ODx) (Riedel et al. 2001, Gourdon et al. 2000, Klaffl 
and Eikmanns 2010).  
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Pyruvate can be also converted directly into L-lactate under oxygen limiting 
conditions (Inui et al. 2004), or it can serve for the synthesis of amino acids 
of the pyruvate-family (L-alanine, L-leucine, and L-valine), initiated by the 
enzymes alanine aminotransferase (AlaT), valine-pyruvate 
aminotransferase (AvtA), and the key enzyme for the synthesis of 
branched-chain amino acids (BCAAs), the acetohydroxyacid synthase 
(AHAS). It is worth noting that other products from pyruvate metabolism, 
such as acetoin and 2,3-butanediol (2,3-BD), were detected in the wild-
type C. glutamicum in trace amounts, suggesting minor alternative fates of 
pyruvate (Dickschat et al. 2010). 
In addition, glycerol and dihydroxyacetone (DHA), the two “over-flow” 
metabolites, were detected in C. glutamicum under lysine production 
conditions (Kiefer et al. 2004). These metabolites come from 
dephosphorylation of glyceraldehyde-3-phosphate (GAP) or 
dihydroxyacetone phosphate (DHAP); as they represent loss of carbon, 
pathways for their synthesis were studied in detail (summarized in Table 
1.1, Jojima et al. 2012, Lindner et al. 2012, Jojima et al. 2015).  
 
Metabolic flux analysis of C. glutamicum 
The reactions in central metabolism of C. glutamicum related to substrate 
uptake, glycolysis, PPP, TCA cycle, anaplerosis, glyoxylate cycle and 
product synthesis are well established, which facilitates the development of 
approaches for quantification of operating metabolic fluxes. Amino acid 
producer strains, i.e., for L-lysine, L-glutamate and L-valine, were 
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characterized; in addition, fluxes operating in cells grown on different 
substrates (acetate, glucose, acetate plus glucose, and fructose), under 
oxygen limitation, and stresses such as osmotic, have been described 
(Marx et al. 1996, Bartek et al. 2010, Vallino and Sephanopulos 1993, 
Kiefer et al. 2004, Uy et al. 2004, Wittman and Heinzle 2001, Wendisch et 
al. 2000, Dominguez et al. 1993, Varela et al. 2003).  
Of particular interest to this work are studies on metabolic fluxes in growing 
cultures using glucose, acetate and a mixture of glucose and acetate as 
substrate (Wendisch et al. 2000). When grown on glucose, cells showed a 
high PPP flux (~89% of the total glucose uptake flux), which fueled 
glycolysis at the level of fructose-6-phosphate (F6P) and GAP. The TCA 
operated as a complete cycle in the forward direction and there was no 
activity of the glyoxylate shunt. The TCA cycle was replenished by the C3 
carboxylation reactions, and, interestingly, the shuffling between C3 and C4 
compounds in the PEP-pyruvate-OAA node was particularly high (more 
than three times higher than the net flux from C3 to the TCA cycle). As 
expected, cells grown on acetate showed a metabolic flux distribution 
different from those grown on glucose. As acetate enters metabolism at the 
level of acetyl-CoA, the activity of the TCA cycle and glyoxylate shunt 
increased drastically (TCA, four times higher on acetate than on glucose). 
C4 precursors from the TCA were directed into gluconeogenesis via the 
PEP-pyruvate-OAA node. The flux through PPP was about six times lower 
in these cells compared to cells grown on glucose. Lastly, cells grown on 
acetate/glucose mixture exhibited substrate uptake rates which were twice 
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lower than the uptake rates on each individual carbon source alone. The 
PPP flux was comparable to that in cells growing on glucose and the TCA 
cycle flux was twice as high. The net direction of the anaplerosis was 
towards C3 metabolites and particularly high metabolite shuffling occurred 
in the reductive TCA. This work showed that, unlike some other bacteria, 
such as Lactococcus lactis or E. coli (Görke and Stülke 2008), C. 
glutamicum is able to utilize the two carbon sources (acetate and glucose) 
simultaneously, indicating the lack of carbon catabolite repression. More 
importantly, MFA gives information on the redistribution of fluxes in 
different growth conditions, thus providing important insights into the 




Table 1.1: Genes encoding the enzymes of central metabolism in C. glutamicum  













 +ATP → 1,3-
Bisphosphoglycerate + NADH + ADP 
Eikmanns 1992 
Omumasaba et al. 
2004 









 + CoA→ Acetyl-CoA + CO2 
+ NADH 
 
Schreiner et al. 2006 
Hoffelder et al. 2010 





Pyruvate + NADH ↔ L-Lactate + NAD
+
 Inui et al. 2004 








Lactone + NADPH 












system (glucose)  (PTS) 
Glucoseext + PEP → G6Pint + Pyruvate 
(glucose uptake) 




mctC Monocarboxylic acid 
Transporter (MctC) 
Uptake of pyruvate, propionate and acetate Jolkver et al. 2009 




Pyruvate + MQ → Acetate + CO2 + MQH2 Schreiner 2005 
Schreiner 2006 
ackA Acetate kinase  (AK) 
 
Acetate + ATP ↔ Acetyl-P + ADP 
Propionate + ATP ↔ Propionyl-P + ADP 
Shiio et al. 1969 
pta Phosphotransacetylase 
(PTA) 
Acetyl-P + CoA ↔ Acetyl-CoA + Pi 
Propionyl-P + CoA ↔ Propionyl-CoA + Pi 
Shiio et al. 1969 
cat CoA transferase (CtfA) Acetate + CoA ↔ Acetyl-CoA Veit et al. 2009 
TCA cycle and glyoxylate shunt 
gltA Citrate synthase (CS)  OAA + Acetyl-CoA + H2O → Citrate + CoA Eikmanns et al. 1994 
acn Aconitase Citrate ↔ Isocitrate Baumgart et al. 2011 




 → 2-Oxoglutarate + CO2 + 
NADPH 








 + CoA → Succinyl-
CoA + CO2 + NADH 
Usuda et al. 1996 
Kataoka et al. 2006 












fum Fumarase (Fum) Fumarate ↔ Malate Genda et al. 2006 






Genda et al. 2003 
mdh Malate dehydrogenase (Mdh) OAA + NADH → Malate + NAD
+
 Molenaar et al. 2000 
aceA Isocitrate lyase  (ICL)  Isocitrate → Glyoxylate + Succinate Reinscheid et al. 
1994a 
aceB Malate synthase 
(MS) 
Glyoxylate + Acetyl-CoA → Malate + CoA Reinscheid et al. 
1994b 
Anaplerotic reactions (PEP-pyruvate-OAA-node) 
ppc Phosphoenolpyruvate 
carboxylase (PEPCx) 
PEP + CO2 → OAA + Pi Eikmanns et al. 1989 
pyc Pyruvate carboxylase 
(PCx) 
 







OAA + ATP → PEP + ADP + CO2 Jetten and Sinskey 
1993 
Riedel et al. 2001 
odx Oxaloacetate decarboxylase 
(ODx) 
OAA → Pyruvate + CO2 Klaffl and 
Eikmanns 2010 
malE Malic enzyme (MalE) Malate + NADP
+
 → Pyruvate + NADPH + CO2 Gourdon et al. 2000 
Amino acid production 







Glutamate + NADPH 






L-Glutamine + 2-Oxoglutarate + 2 NADH → 
2 L-Glutamate + 2 NAD
+
 
















synthase subunits (AHAS) 
2 Pyruvate → α-Acetolactate + CO2 
Pyruvate + α-Ketobutyrate →  
α-Ketohydroxybutyrate + CO2  












Dihydroxy- 3-methylvalerate + NADPH 




Dehydratase  (DHAD) 
2,3-Dihydroxyisovalerate → α-KIV 
2,3-Dihydroxy-3-methylvalerate → KMV 
Radmacher et al. 
2002 
Other 
butA Butanediol dehydrogenase 
(BDH) 
Diacetyl + NADH → S-Acetoin+NAD
+
 
S-Acetoin + NADH ↔ (2S,3S)-2,3-BD + NAD
+ 
DHA + NADH ↔ Glycerol + NAD
+
 
Takusagawa et al. 
2001 
Jojima et al. 2015 
hdpA HAD superfamily 
phosphatase (HdpA) 
GAP → Glyceraldehyde + Pi 
DHAP → DHA + Pi 
G3P → Glycerol + Pi 
Jojima et al. 2012 
Jojima et al. 2015 
gpp Glycerol-3-phosphate 
phosphatase (Gpp) 
G3P → Glycerol + Pi Lindner et al. 2012 
Abbreviations: ATP, adenosine triphosphate; ADP, adenosine diphosphate; GAP, glyceraldehyde-3-phosphate; α-
KIV, α -ketoisovalerate; KMV, 2-keto-3-methylvalerate; MQ, menaquinone oxidized; MQH2, menaquinone reduced; 
OAA, oxaloacetate; PEP, phosphoenolpyruvate; Pi, inorganic phosphate; G3P, glycerol-3-phosphate; DHA, 
dihydroxyacetone; DHAP, dihydroxyacetone phosphate. Adapted from Wieschalka 2012. 
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Biotechnological production of bulk chemicals 
One of the major issues of the modern era is the high growth rate of world 
population, concomitant increase in industrial production and, consequent 
limitation of resources, such as food, land, and energy. Industrial 
production processes are commonly associated with pollution, for example 
by accumulation of greenhouse gases, such as CO2. Moreover, the raw 
initial material that is by far mostly used for the production of chemicals 
and fuels is petrol, a finite resource whose economy is unstable. Such 
limitations present a driving force in finding alternative ways to 
manufacture petroleum-derived products, and considerable effort was 
invested in white biotechnology to produce some of petroleum-based 
chemicals from biomass. This would, at least partially, ease the 
dependence on limited amounts of petrol and, on the other hand, decrease 
the pollution associated with petrol processing practices (Werpy and 
Petersen 2004, de Jong et al. 2012, Adom et al. 2014). In 2004, the US 
Department of Energy (DOE) issued the first of two reports stressing the 
need for research in the area of biobased products (Werpy and Petersen 
2004). The first report contained a list of 15 chemicals that could be 
produced from biorefinery carbohydrates, based on multiple factors such 
as the existence of processes for the production of these chemicals, 
economics, industrial viability, size of markets, and the ability of a 
compound to serve as a platform for the production of derivatives. This list 
contained the following compounds: succinic, fumaric and malic acids, 2,5-




acid, glutamic acid, itaconic acid, levulinic acid, 3-hydroxybutyrolactone, 
glycerol, sorbitol and xylitol/arabinitol (Table 1.2). A second group of 
building blocks that was also identified as potentially viable included: 
gluconic, lactic, malonic, propionic acid, the triacids, citric and aconitic, 
xylonic acid, acetoin, furfural, levoglucosan, lysine, serine and threonine. 
In 2010, Bozell and Petersen published an updated set of potential target 
molecules using similar selection methodology (Table 1.2) (Bozell and 
Petersen 2010). The revised list excluded organic acids such as malic, 
fumaric, glucaric, itaconic, glutamic and aspartic acid, and included new 
chemicals such as ethanol, lactic acid and biohydrocarbons, such as 
isoprene. Importantly, both reports served as guides for subsequent 
research efforts and technology development in the chemical building 
blocks production sphere. 
Table 1.2. Top chemical building blocks to be produced from carbohydrates 
according to the US DOE (Werpy and Petersen 2004, Bozell and Petersen 2010). 
Building blocks from carbohydrates 
2004 2010 
3-Hydroxypropionic acid 3-Hydroxypropionic acid/aldehyde 
Glycerol Glycerol and derivatives 
3-Hydroxybutyrolactone 3-Hydroxybutyrolactone 
Aspartic acid Lactic acid 
Succinic, fumaric and malic acids Succinic acid 
Glutamic acid Ethanol 
Itaconic acid Isoprene 
Levulinic acid Levulinic acid 
Xylitol/arabinitol Xylitol 
2,5-Furan dicarboxylic acid Furans 





Biobased production of succinate 
One of the important chemical building blocks recognized by US DOE 
reports is succinic acid, a four-carbon dicarboxylic acid which can be used 
as a precursor of many industrially important chemicals. The bio-succinic 
acid market was estimated to be about US$ 240.3 million in 2011 and is 
expected to grow at a CAGR (Compound Annual Growth Rate) of 19.4% 
between 2012 and 2018 (Transparency Market Research 2012). Succinate 
is a promising molecule because it can be derivatized into other chemicals 
that are commonly petrol-derived, and that have a wide range of 
applications (Fig. 1.3) (Delhomme et al. 2009). Among potential important 
application of bio-based succinic acid could be the production of 
commodity chemical 1,4-butanediol ($3 billion market), which is a starting 
material for tetrahydrofuran (THF) and γ-butyrolactone; γ-butyrolactone 
can be used to produce n-methylpyrrolidinone (NMP) that could substitute 
petrochemical adipic acid in the production of polyester polyols to 
polyurethanes (Erickson et al. 2011). Another application of succinate is in 
the production of polybutylene succinate (PBS), a promising biodegradable 
polymer. Finally, succinate can be used in the production of detergents, 
surfactants, pigments, resins, biodegradable solvents, food, and 




Fig. 1.3. Derivatives of succinic acid and their application. Abbreviations: THF, 
tetrahydrofuran; NMP, n-methylpyrrolidinone; PBS, polybutylene succinate.  
 
With such wide range of applications and growing interest in this 
compound, it is not surprising that in the last decade, bio-based succinic 
acid production had moved from laboratory into industrial setting. Venture 
projects such as Bioamber Inc., Myriant Technologies LLC, Reverdia, and 
Succinity GmbH use organisms like Escherichia coli, Saccharomyces 
cerevisiae and Basfia succiniciproducens for the industrial scale production 
(reviewed in Litsanov et al. 2014). Importantly, production of bio-succinic 
acid has the potential to become an important component of petrol-











Polymers, resins, solvents and 
printing inks for plastics, PBS Solvents, pharmaceuticals, food, 
agrochemicals, cosmetics and 





Specific microbial succinate producers 
Tricarboxylic acid (TCA) cycle, which includes succinate as a metabolite, 
has a metabolic role in providing precursor molecules for anabolism, such 
as oxaloacetate and α-ketoglutarate, and redox equivalents for respiration. 
Under aerobic conditions, succinate is formed from succinyl-CoA via the 
succinyl-CoA synthetase (Fig. 1.4). Another pathway for succinate 
synthesis involves the reduction of oxaloacetate via malate and fumarate 
as intermediates. Oxaloacetate is a product of carboxylation of either 
phosphoenolpyruvate or pyruvate. Another carboxylation reaction that 
drains pyruvate into the TCA cycle is catalyzed by the malic enzyme, which 
forms malate that can be reduced into succinate as explained above. In 
addition, succinate can be produced from malate that comes from the 
glyoxylate shunt. As various pathways can be involved in the synthesis of 
succinate, an important tool for the optimization of production was 
metabolic flux analysis, which provided important guidelines for the design 
of efficient producer strains. In the following text, physiological aspects 
such as metabolic flux analysis and main steps in strain optimization of the 




Fig. 1.4. Schematic overview of metabolic pathways that contribute to formation 
of succinate from glucose. Abbreviations: PEP, phosphoenolpyruvate; OAA, 
oxaloacetate; IsoCit, isocitrate; Glyox, glyoxylate; α-KG, α-ketoglutarate. 
 
Actinobacillus succinogenes 
Actinobacillus succinogenes is a natural succinate producer isolated from 
bovine rumen and known to be capnophilic (grows better in the presence 
of CO2). Besides succinate, it produces formate, acetate and ethanol as 

























glucose in this bacterium, enzyme assays and metabolic flux analysis were 
performed (McKinlay et al. 2007, McKinlay and Vielle 2008). A. 
succinogenes 130Z metabolizes glucose via the Embden-Meyerhof-Parnas 
(EMP) pathway, with a negligible contribution of the Entner-Doudoroff (ED) 
and a low activity of the Pentose Phosphate Pathway (PPP, between 1 and 
4%). Succinate is formed through carboxylation of PEP into oxaloacetate 
and subsequent reduction via the reductive TCA branch. This pathway is 
crucial for succinate production, as A. succinogenes does not possess a 
complete TCA cycle (genes encoding citrate synthase and isocitrate 
dehydrogenase are missing in the genome), and the glyoxylate shunt did 
not seem to contribute to succinate formation. The model predicts a low 
back flux from C4 to C3 metabolites, via the oxaloacetate decarboxylase 
and malic enzyme (McKinlay et al. 2007, McKinlay and Vielle 2008). 
Distribution of fluxes at four key points determined the succinate 
production in A. succinogenes: oxaloacetate, malate, PEP, and pyruvate. 
When CO2 in the form of sodium bicarbonate (NaHCO3) was provided, 
carboxylation of C3 intermediates, and especially of pyruvate by the malic 
enzyme, was increased. The increased flux towards reduced compound, 
such as succinate, provoked an increase in NADH forming reactions 
(formate dehydrogenase and pyruvate dehydrogenase), and a decrease in 
NADH consuming reactions (ethanol production). Addition of H2, on the 
other hand, decreased fluxes through formate and pyruvate 
dehydrogenase in response to lower reductant demand for succinate 
production. Authors conclude that these latter fluxes should be considered 
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for minimization in order to maximize carbon channeling towards 
succinate, however the future strategies would have to take into 
consideration the role of these pathways in provision of redox equivalents 




Mannheimia succiniciproducens is a rumen bacterium closely related to A. 
succinogenes, thus they share many metabolic traits. Soon after isolation 
of the bacterium in 2002, its genome was sequenced and genome-scale in 
silico metabolic model was assembled (Hong et al. 2004, Kim et al. 2007). 
Similarly to A. succinogenes, M. succiniciproducens possesses the EMP, 
PPP and ED pathways. There are three enzymes for the inter-conversion 
of C3 and C4 metabolites: PEP carboxykinase, PEP carboxylase and malic 
enzyme, the first being the most important one for the oxaloacetate 
formation. Unlike A. succinogenes, M. succinicigenes possesses citrate 
synthase and isocitrate dehydrogenase, but lacks succinyl-CoA synthetase 
to close the oxidative TCA cycle; the glyoxylate shunt is also absent. While 
acetate producing pathways are similar, M. succiniciproducens forms 
lactate rather than ethanol. With the development of genetic tools, it was 
possible to design strains unable to produce lactate and acetate by the 
inactivation of genes encoding the respective enzymes (Lee et al. 2006). 
Additionally, an in silico analysis of the effects of H2 and CO2 on the 
metabolism of the wild-type and the deletion mutants was performed to 
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estimate the organic acid production patterns (Kim et al. 2009). The model 
predicted that addition of H2 affected positively the cell growth, CO2 uptake 
rate, and succinic acid production rate, while the fluxes towards formic and 
acetic acid decreased. All mutants showed the dependence of succinate 
production on the CO2 provided, but this trend was predicted to stand until 
the CO2 uptake rate exceeds the glucose uptake rate, after which cells 
start to accumulate pyruvate, in accordance with experimental evidence 
(Song et al. 2007). 
 
Basfia succiniciproducens 
Basfia succiniciproducens is a less known rumen bacterium isolated by the 
German company BASF. Knowledge on this organism is scarce; however, 
the metabolic network of B. succiniciproducens was deduced from the 
genetic repertoire of its relative M. succiniciproducens (Hong et al. 2004, 
Becker et al. 2013). It comprises glycolysis, PPP, ED pathway, a full TCA 
cycle, anaplerotic carboxylation and decarboxylation, fermentation 
pathways, and anabolic routes into biomass. The end product spectrum 
includes the organic acids acetate, succinate and formate as major 
products, and low amounts of lactate and ethanol. Most of glucose is 
processed through EMP (92%) and by PPP to a low extent (7-8%). PPP 
provides NADPH for anabolic needs, and anabolic precursors to a lesser 
extent, as PPP intermediates were directed into the glycolysis. TCA cycle 
functions as two separate branches rather than as a cycle. Succinate was 
by far formed via the reductive branch, and almost negligibly by the 
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oxidative branch. Accordingly to the model predictions, pyruvate:formate 
lyase was inactivated as the first step of the engineering strategy. 
However, this resulted in increased lactate and a slight (5%) increase in 
succinate. Additional inactivation of lactate dehydrogenase resulted in 45% 
increase in the succinate yield compared to the wild-type. The double 
deletion mutant was predicted to be the most promising succinate producer 
of B. succiniciproducens (Becker et al. 2013). 
 
Escherichia coli 
Escherichia coli is an important industrial bacterium and a model organism 
for studying many aspects of bacterial physiology. Thus, there is a vast 
knowledge available on different features of E. coli metabolism, as well as 
a large set of genetic tools. E. coli is able to produce succinate in addition 
to acetate, lactate, ethanol and formate, but not up to high amounts as 
shown for rumen bacteria.  
Various efforts were directed to turn succinate into the major fermentation 
product in E. coli. This bacterium has different central metabolism 
compared to the described natural producers; succinate can be formed 
from oxaloacetate (produced by two PEP carboxylating enzymes) and 
reductive TCA, oxidative TCA cycle, glyoxylate shunt and action of malic 
enzyme in carboxylation of pyruvate. Having this in mind, a stoichiometric 
metabolic model was constructed in the lab of Sang Yup Lee, with the aim 
to estimate flux operation which would secure maximal succinate yields 
(Hong et al. 2003). This model suggested that maximal succinate yield was 
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1.65 mol per mol glucose, without provision of external electron sources, 
and 2 mol per mol glucose if external electrons were provided. The uptake 
of CO2 and the source of electrons for reduction reactions are two limiting 
factors for optimal succinate formation.  
Accordingly, many metabolic engineering strategies were applied to make 
recombinant E. coli succinate producers (for a comprehensive review, see 
Thakker et al. 2012). An example of this is E. coli NZ111, a platform strain 
for succinate production in which lactate dehydrogenase and 
pyruvate:formate lyase were inactivated, leading to suppression of lactate, 
acetate and formate production and increase in succinate (Stols and 
Donnelly 1997). However, this strain grew poorly under anaerobic 
conditions and excreted pyruvate. Overproduction of the malic enzyme and 
inactivation of PTS system in NZY111 resulted in construction of E. coli 
AFP 111, a strain that exhibited restored growth and increased succinate 
formation due to the enhanced availability of PEP for the carboxylation 
(Vemuri et al. 2002). In another study, 13C-labeling tracer experiments 
were coupled to metabolic flux analysis to determine the metabolic fluxes 
in non-growing E. coli AFP 111 cells under various CO2 concentrations (Lu 
et al. 2009). Authors showed that CO2 supported succinate formation and 
that about 90% of succinate was formed by incorporation of CO2 by PEP 
carboxylase. Increase in CO2 and succinate led to an increase in PPP, 
which served as a generator of reducing power in the form of NADPH. This 
was not unexpected having in mind that E. coli possesses two 
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transhydrogenases, which can interconvert NADPH and NADH and thus 
provide NADH necessary for succinate formation.  
Another approach to produce succinate anaerobically involved engineering 
of the glyoxylate shunt since the production via this pathway requires less 
NADH (Sanchez et al. 2006). The strain with inactivated alcohol 
dehydrogenase, lactate dehydrogenase and phosphotransacetylase-
acetate kinase, and with de-repressed glyoxylate pathway through deletion 
of a repressor protein gene, produced succinate with a yield of 1.6 mol per 
mol glucose. This strain used a combination of the glyoxylate shunt and 
the reductive TCA to produce succinate, for which 1.25 mol NADH was 
required, compared to 2 mol NADH per mol succinate required when solely 
the reductive TCA branch is used. 
 
Saccharomyces cerevisiae 
Saccharomyces cerevisiae is a well-studied and robust industrial host. The 
availability of a sophisticated toolbox for genetic engineering and tolerance 
to low pH and high osmotic pressure conditions make this organism an 
interesting host for the industrial production of succinate. The metabolic 
pathways for succinate formation are in principle the same as in bacteria 
such as E. coli. One of the possible strategies is to produce succinate via 
the reductive TCA cycle, however this requires complex metabolic 
engineering interventions as the yeast fumarase has 17-fold higher affinity 
towards fumarate than towards malate (Pines et al. 1996) and cytosolic 
malate dehydrogenase is subjected to proteolytic degradation in the 
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presence of glucose (Hung et al. 2004). In addition to this, succinate 
formation via the reductive TCA results in no net ATP production for cell 
growth and maintenance. Second option to produce succinate is through 
the oxidative TCA cycle; however, this can lead to maximal yield of 1 mol 
per mol glucose (half of that expected through the reductive TCA). ATP 
formed this way can be utilized to keep intracellular pH high at the low pH 
succinate producing conditions, which are desirable for more efficient 
product purification (Yuzbashev et al. 2011). Raab and Lang constructed a 
metabolic model that suggested that optimal production of succinate would 
happen when reductive TCA was used in combination with the glyoxylate 
shunt (designed as “oxido-reductive” route). Maximal yield predicted by this 
model was 1.71 mol succinate per mol glucose and it resulted in balanced 
electron production and positive net ATP yield (Raab and Lang 2011). A 
recent study by Otero et al. (2013) showed the importance of metabolic 
models and systems biology for efficient development of yeast succinate 
producers. In a systems metabolic engineering approach (in silico guided 
metabolic engineering, strain development and transcriptome guided 
metabolic engineering), yeast strains with significantly improved succinate 
production parameters were designed. The resulting strain showed a 30-
fold improvement in succinate titer, and a 43-fold improvement in succinate 
yield on biomass, highlighting the significance of systems biology for 
identification of non-intuitive targets for metabolic engineering, such as 
serine-glycine metabolism (Otero et al. 2013). However, in the meantime 
Reverdia, a joint venture between two big biotech companies Roquette 
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Freres and DSM, developed yeast with impressive production 
characteristics (100 g/L succinate at pH 3), in a two-step approach that 
consisted of rational metabolic engineering and strain development. This 
strain had suppressed production of reduced by-products such as glycerol 
and ethanol, produced succinate via the combination of glyoxylate and 
reductive TCA branch, and transport of succinate was enhanced by 
transporter engineering (van den Tweel 2010).  
 
Biobased production of 2,3-butanediol  
2,3-Butanediol (2,3-BD) is a bulk chemical with a wide range of industrial 
applications (Fig. 1.5). It can be used as carrier for pharmaceuticals as well 
as for the production of moistening and softening agents, perfumes, 
fumigants, insecticides, explosives, plasticizers and printing inks; it is a 
promising fuel additive and a cryoprotectant (Magee and Kosaric 1987, 
Garg and Jain 1995, Ji et al. 2011).  
The derivative of 2,3-BD, butanone (methyl ethyl ketone), is an important 
fuel additive with a combustion heat value higher than ethanol, solvent for 
resins and lacquers and a catalyst (Magee and Kosaric 1987, Villet 1981). 
1,3-Butadiene, another derivative of 2,3-BD, is a building block of synthetic 
rubber (van Haveren et al. 2007, Syu 2001, Celińska and Grajek 2009). 
Diacetyl and acetoin, high-value food additives, are formed by 
dehydrogenation of 2,3-BD. Acetoin can be employed as flavoring agent 
due to its buttery taste; diacetyl is an important bacteriostatic food additive 
(Bartowsky and Henschke 2004, Macciola et al. 2008). Esterification 
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derivatives of 2,3-BD have application in cosmetic products, lotions, drugs, 
and antiperspirants (Garg and Jain 1995, Syu 2001).  
 
 
Fig. 1.5. Derivatives and applications of 2,3-butanediol. 
So far, a partnership of two companies, LanzaTech and Invista, announced 
commercial production of 2,3-BD from CO (carbon monoxide) using 
acetogenic bacteria.  2,3-BD produced this way will be dehydrogenated 
into 1,3-butadiene, a precursor of synthetic rubber. 
 
Specific microbial 2,3-butanediol producers  
2,3-BD is a four-carbon polyol produced from pyruvate in a three-step 
pathway (Fig. 1.6). Two pyruvate molecules are combined into an α-
acetolactate molecule by the catabolic acetolactate synthase (ALS) or the 
anabolic acetohydroxyacid synthase (AHAS); the following step, α-
acetolactate decarboxylation into (R)-acetoin, is catalyzed by α-
Styrene-butadiene rubber (SBR): tire 
industry and Nylon production.
Fuel additive, solvent, catalyst
Ester-derivatives












acetolactate decarboxylase (ALDC). The last step, acetoin reduction into 
2,3-BD, is performed by the butanediol dehydrogenase (BDH). An 
alternative and less efficient pathway is active in the presence of oxygen 
that causes spontaneous decarboxylation of α-acetolactate into diacetyl, 
which can be converted into (R)- or (S)-acetoin by the diacetyl reductase. 
Often it is BDH that can also catalyze reduction of diacetyl (Fig. 1.6). 
 
Figure 1.6. Scheme illustrating the pathways for the synthesis of 2,3-butanediol 
in bacteria: after it is synthesized from pyruvate, α-acetolactate can be either 
decarboxylated enzymatically into (R)-acetoin, which is reduced into 2,3-BD, or it 
can get spontaneously decarboxylated into diacetyl, which is reduced in two steps 
into 2,3-BD. The more efficient pathway via ALDC is shown in bold. 
Abbreviations: ALS, α-acetolactate synthase; ALDC, α-acetolactate 
decarboxylase; BDH, butanediol dehydrogenase; AHAS, acetohydroxyacid 
synthase, DAR, diacetyl reductase.  
 
The molecule of acetoin contains a single chiral carbon and can exist as 
one of the two enantiomeric forms: (R)-acetoin or (S)-acetoin (Fig. 1.7). 








































2,3-BD (or D-2,3-butanediol), (2S,3S)-2,3-BD (or L-2,3-butanediol), and the 
optically inactive (2R,3S)-2,3-BD (or meso-2,3-BD) (Fig. 1.7).  
 
Figure 1.7.  Molecular formulas of the two acetoin enantiomers: (R)- and (S)-
acetoin, and the three stereoforms of 2,3-butanediol: optically inactive meso-2,3-
butanediol and the two enantiomeric forms: (2S,3S)-, and (2R,3R)-2,3-butanediol. 
 
In most cases, bacteria produce a mixture of 2,3-BD stereoisomers, which 
is not considered a disadvantage if bioproduced 2,3-BD is to be used as a 
bulk chemical; however, optically active forms are particularly important in 
chiral synthesis of pharmaceuticals and other high value chemicals. Also, 
(2R,3R)-butanediol is used as antifreeze agent and solvent due to its low 
freezing point (Gao et al. 2012, Qi et al. 2014). Since the production of 
pure stereoisomers of 2,3-BD is advantageous for many applications, it is 
important to study the stereospecific properties of BDHs and the respective 







BDHs belong to the NAD(P)-dependent alcohol dehydrogenase family, 
generally divided into three large groups: i) Fe-dependent alcohol 
dehydrogenases, which belong to the smallest and the least studied group; 
ii) Zn-dependent alcohol dehydrogenases, also designated medium-chain 
dehydrogenase/reductase (MDR) family; and iii) short-chain 
dehydrogenase/reductase (SDR) family that are not metal-ion-dependent.   
The BDHs of K. pneumoniae, S. marescens, and E. cloacae fall into the 
SDR family; these enzymes introduce the new hydroxyl group in the (S)-
configuration, thus reducing (R)-acetoin to meso-2,3-BD and (S)-acetoin to 
(2S,3S)-2,3-BD (Fig. 1.7, also see Table 4.1). C. glutamicum (formerly 
Brevibacterium saccharolyticum C-1012), and Rhodococcus erythropolis 
possess BDHs that belong to the SDR family, and were found to be 
absolutely specific for (S)-acetoin and (2S,3S)-2,3-BD (Wang et al. 2013, 
Takusagawa et al. 2001). On the other hand, the BDHs of B. subtilis, P. 
polymyxa and S. cerevisiae belong to the MDR family, and generally 
introduce a hydroxyl group in the (R)-configuration; they use (R)-acetoin 
and (S)-acetoin to produce (2R,3R)-2,3-BD and meso-2,3-BD, respectively 
(Fig. 1.7; Table 4.1).  
In the following text, major achievements in the biobased production of 2,3-
BD using different organisms will be summarized, with a special focus on 





Klebsiella oxytoca and Klebsiella pneumoniae are natural 2,3-BD 
producers and among the top 2,3-BD producers. Engineering strategies 
consisted in elimination of the by-products; Klebsiella oxytoca strain with 
interrupted pathways for the production of ethanol, acetate and lactate 
achieved a particularly high yield, specific productivity, and titer (0.98 mol 
2,3-BD per mol glucose, 1.2 g·L-1·h-1, and 117 g·L-1, respectively) 
(Jantama et al. 2015). However, the potential pathogenicity of these strains 
is still considered an obstacle for industrial scale production (Ji et al. 2011). 
Both Klebsiella oxytoca and Klebsiella pneumoniae are known to produce 
meso- and (2S,3S)-2,3-BD. One BDH, belonging to the SDR group, from 
Klebsiella pneumoniae was characterized and shown to catalyze reduction 
of (S)-acetoin into (2S,3S)-2,3-BD, or (R)-acetoin into meso-2,3-BD (Ui et 
al. 1997, Zhang et al. 2012). In addition, when 2,3-BD was produced from 
glycerol, (2R,3R)-2,3-BD was detected; this led to the discovery of a 
glycerol dehydrogenase with a dual role: it formed (2R,3R)-2,3-BD from 
(R)-acetoin, and meso-2,3-BD from (S)-acetoin, in addition to glycerol 
oxidation (Chen et al. 2014, Y Wang et al. 2014). 
 
Paenibacillus polymyxa 
Paenibacillus polymyxa is one of the most promising non-pathogenic 
natural 2,3-BD producers. Particularly successful is strain DSM 365, that 
produced 111 g·L−1 2,3-BD within 54 h with high optical purity (98% 
(2R,3R)-form and 2% of meso-form) under oxygen limiting conditions, in 
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medium that contained yeast extract. 2,3-BD formation by this strain was 
lower (72 g·L−1 2,3-BD and acetoin) in the medium with decreased content 
of yeast extract, since exopolysaccharide formation occurred. Optical purity 
was also affected (79% (2R,3R)-2,3-BD) (Haßler et al. 2011).  
BDH of P. polymyxa ATCC12321 and ZJ-9 were purified and 
characterized; both enzymes belonged to the MDR group and showed 
strong preference for (2R,3R)-2,3-BD (Yu et al. 2011, Gao et al. 2013).  
Enterobacter spp. 
Enterobacter cloacae and Enterobacter aerogenes are class II natural 2,3-
BD producers. E. cloacae subsp. dissolvens SDM is able to produce 78.3 
g·L−1 of 2,3-BD in 24 h using simultaneous saccharification and 
fermentation, with a yield of 0.42 g 2,3-BD per g cassava powder (0.84 mol 
per mol) and a specific productivity of 3.3 g·L−1·h−1. The produced 2,3-BD 
was mainly the meso-form (83.1%) with 5.2% of (2R,3R)-2,3-BD, and 
11.7% of (2S,3S)-2,3-BD (Wang et al. 2012). An SDR-type BDH is 
responsible for meso- and (2S,3S)-2,3-BD formation (Carballo et al. 1991). 
E. aerogenes with inactivated lactate dehydrogenase gene produced 
118.05 g·L−1 of 2,3-BD in 54 h, and even though the produced isomer was 
not specified, it was earlier shown that this bacterium produces mainly the 




Serratia marcescens  
Serratia marcescens H30 is another class II natural 2,3-BD producer; 
formation of surface-active exolipid serrawettin W1 is characteristic for this 
strain. To avoid excessive addition of antifoam agent and microbial 
contamination, S. marcescens deficient in serrawettin W1 formation was 
constructed and employed for 2,3-BD production. The resulting strain 
produced 2,3-BD from sucrose at a concentration of 152 g·L−1 with a 
productivity of 2.67 g·L−1·h−1 and a yield of 93% (Zhang et al. 2010). This 
organism was also shown to possess an SDR-type BDH, responsible for 
the meso-2,3-BD production observed in fermentations (Zhang et al. 
2014). 
Lactococcus lactis 
Lactococcus lactis belongs to the lactic acid bacteria that produce 2,3-BD 
as a part of the strategy to cope with low pH stress. Under anaerobic 
conditions, the triple lactate dehydrogenase-deficient mutant of L. lactis 
overexpressing the endogenous ALS and BDH achieved the theoretical 
yield of meso-2,3-BD under anaerobic conditions (0.67 mol per mol 
glucose) (Gaspar et al. 2012). 
L. lactis possesses two BDH activities (Crow 1990). Curiously, Crow 
described that the two activities produce different forms of 2,3-BD (meso- 
and optically active form); Gaspar and co-workers assigned butA encoded 
activity as the meso-BDH; on the other hand, Nielsen et al. concluded that 
the butB encoded activity is the one responsible for meso-2,3-BD formation 




Bacillus spp.  
The three non-pathogenic strains from the Bacillus genus, Bacillus subtilis, 
Bacillus amyloliquefaciens and Bacillus licheniformis are known to naturally 
produce 2,3-BD. All three strains are capable of producing 2,3-BD with 
high yield (~0.9 mol 2,3-BD per mol glucose), however, B. 
amyloliquefaciens and B. licheniformis are superior in terms of productivity 
and titer (specific productivities and yields of 1.16 g·L−1·h−1 and 102.3 
g·L−1; and 2.10 g·L−1·h−1 and 74 g·L−1 achieved by the two strains, 
respectively) (Fu et al. 2014, Li et al. 2014, Yang et al. 2014). Due to the 
fact that MDR-type BDH of B. subtilis was described, this enzyme was 
employed in production of enantiopure (2R,3R)-2,3-BD by non-natural 
producers (Nicholson et al. 2008, Xu et al. 2014, Lian et al. 2014). 
Escherichia coli 
Even though E. coli lacks a functional pathway for the synthesis of 2,3-BD, 
it has been engineered for the production of this diol, due to its amenability 
for the industrial scale production and availability of information about this 
bacterium. There were several attempts to engineer E. coli to produce 2,3-
BD and, in general, they consisted of overexpression of foreign pathways 
in E. coli hosts. Importantly, Xu and co-workers (Xu et al. 2014) carried out 
a systematic approach to choose the best genetic elements for the over-
expression of the biosynthetic pathway (promoters and gene clusters), and 
optimized the fermentation conditions to obtain E. coli strains that 
produced 73.8 g·L-1 of 2,3-BD in 62 h, with an approximate yield of 0.82 
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mol per mol glucose. The most efficient production was achieved by using 
the genes from Enterobacter cloacae, a pathogenic natural 2,3-BD 
producer. The main product was meso-2,3-BD, with traces of the two 
optically active forms (Xu et al. 2014). 
 
Saccharomyces cerevisiae 
The industrial organism Saccharomyces cerevisiae possesses three 
pathways for 2,3-BD biosynthesis, but produces minimal amounts of this 
compound. Using the prediction of a genome scale model, a background 
strain was built in which alcohol dehydrogenases involved in ethanol 
production were inactivated; in addition, glycerol production was 
eliminated. In this background, heterologous pathways from Enterobacter 
aerogenes and Bacillus subtilis were introduced to produce 2,3-BD with 
increased efficiency (Ng et al. 2012).  
In another study, ethanol production was eliminated by disabling pyruvate 
decarboxylases (Lian et al. 2014). Although this strain is unable to produce 
acetyl-CoA from glucose, it was enabled to grow on glucose by the means 
of adaptive evolution. A pathway consisting of yeast ALS and BDH, in 
addition to ALDC from Bacillus subtilis was introduced into the resulting 
strain. This strain produced 0.7 mol of enantiopure (2R,3R)-2,3-BD per mol 
substrate (mixture of glucose and galactose), around 100 g·L-1 in 300 h. 
Only one BDH has been characterized in S. cerevisiae; this enzyme 
belongs to a MDR group, and produced a mixture of (2R,3R)-2,3-BD and 




Acetogenic bacteria  
The three non-pathogenic acetogenic Clostridium species, Clostridium 
autoethanogenum, C. ljungdahlii, and C. ragsdalei are able to use CO-
containing industrial waste gases or syngas as the sole carbon and energy 
source to produce 2,3-BD (Köpke et al. 2011). In these organisms, CO 
and/or CO2 enter the methyl (eastern) and carbonyl (western) branches of 
the Wood-Ljungdahl pathway, resulting in the formation of acetyl-CoA, 
which serves as the central precursor for all catabolic and anabolic 
processes. Pyruvate formed from acetyl-CoA by the pyruvate synthase, is 
a precursor for the synthesis of 2,3-BD. The major form of 2,3-BD 
produced is (2R,3R)-2,3-BD; a small contamination with meso-2,3-BD was 
observed. This corresponds to sequence analysis of the BDH genes in 
these three clostridia, which shows high similarity (60%) to the (2R,3R)-
2,3-butanediol dehydrogenase of Bacillus subtilis (Köpke et al. 2011). 
Cyanobacteria (Synechococcus elongatus PCC7942) 
Cyanobacteria have the enzymatic machinery required to fix CO2, but lack 
the 2,3-BD biosynthetic pathway. As a proof of principle for the 2,3-BD 
production from CO2, Synechococcus elongatus PCC7942 was 
systematically engineered using various combinations of genes encoding 
enzymes in the 2,3-BD pathway (Oliver et al. 2012). Final strain, with a 2,3-
BD forming pathway consisting of ALS from B. subtilis, ALDC from 
Aeromonas hydrophila and BDH from Clostridium beijerinckii, produced 2.4 
g·L-1 of 2,3-BD directly from CO2 and sunlight, in 21 days. The major 
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Summary 
Corynebacterium glutamicum wild-type produces a mixture of lactic, 
succinic and acetic acid from glucose under oxygen deprivation. We 
investigated the effect of CO2 on the production of organic acids in a two-
stage process: cells were grown aerobically in glucose and, subsequently, 
organic acid production by non-growing cells was studied under anaerobic 
conditions. The presence of CO2 caused an up to 3-fold increase in the 
succinate yield (1 mol per mol of glucose), and about 2-fold increase in 
acetate, both at the expense of L-lactate production; moreover, 
dihydroxyacetone formation was abolished. The redistribution of carbon 
fluxes in response to CO2 was estimated by using 
13C-labelled glucose and 
13C-NMR analysis of the labelling patterns in end-products. The flux 
analysis showed that 97% succinate was produced via the reductive part of 
the tricarboxylic acid cycle, the low activity of the oxidative branch being 
sufficient to provide the reducing equivalents needed for the redox 
balance. The flux via the pentose phosphate pathway was low (~5%) 
regardless of the presence or absence of CO2. Moreover, there was a 
significant channelling of carbon to storage compounds (glycogen, 
trehalose), and concomitant catabolism of these reserves. The intracellular 
and extracellular pools of lactate and succinate were measured by in vivo 
NMR and the stoichiometry (H+:organic acid) of the respective exporters 
was calculated. This study shows that it is feasible to take advantage of 
natural cellular regulation mechanisms to obtain high yields of succinate 




Corynebacterium glutamicum is a facultatively anaerobic (Nishimura et al. 
2007), Gram-positive bacterium that occupies a prominent position among 
industrial microorganisms, primarily due to its outstanding performance in 
the production of L-amino acids. In fact, over two million tons of 
L-glutamate and L-lysine are produced per year by C. glutamicum 
fermentation (Shimizu and Hirasava 2007, Becker and Wittmann 2012). In 
addition, this is a GRAS-organism (Generally Regarded as Safe), robust 
(osmotolerant and phage-resistant), extensively studied with respect to 
metabolism and regulation, and amenable to genetic manipulation for 
which a comprehensive toolbox is available (Eggeling and Reyes 2005). 
Under aerobic conditions, C. glutamicum is able to grow relatively fast to 
high cell densities in minimal medium. In contrast, in the absence of 
oxygen and nitrate, cell growth is negligible, while the ability to metabolize 
sugars is retained (Okino et al. 2005, Dominguez et al. 1993). Thus, cells 
of C. glutamicum can be grown aerobically and subsequently used for 
fermentation of desired products under anoxic conditions as demonstrated 
for L-alanine, L-valine or isobutanol (Yamamoto et al. 2012, Hasegawa et 
al. 2013, Yamamoto et al. 2013, Blombach et al. 2013).  
It is well known that C. glutamicum converts glucose into organic acids 
under oxygen deprivation, i.e., L-lactic, succinic and acetic acids (Okino et 
al. 2005, Dominguez et al. 1993, Inui et al. 2004). Lactate and succinate 
are important bulk chemicals with increasing industrial demand, hence it is 
not surprising that a considerable research effort has been made to 
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optimize their production from renewable feedstocks, such as biomass 
(Bozell and Petersen 2010). Wild type C. glutamicum is able to produce L-
lactate from glucose with high yield (1.79 mol per mol glucose) (Inui et al. 
2004); moreover, it has been successfully engineered for the production of 
D-lactate and derived polyesters (Okino et al. 2008b, Song et al. 2012). In 
contrast, succinate is a minor product of glucose metabolism by wild type 
C. glutamicum (Okino et al. 2005, Dominguez et al. 1993, Inui et al. 2004). 
Studies have shown that the presence of bicarbonate increases succinate 
production considerably (Okino et al. 2005, Inui et al. 2004), and this 
finding prompted a variety of genetic and environmental manipulations 
aiming at further production enhancement (Litsanov et al. 2012a, Okino et 
al. 2008a). In particular, a high yield of succinate (1.67 mol per mol 
glucose) was achieved by using formate as electron and CO2 donor, but 
there is still need for improvement with regard to productivity and cost-
efficiency (Litsanov et al. 2012a).  
Obviously, the maximization of organic acid production implies the 
reduction of by-products, namely by metabolic engineering strategies. As 
demonstrated for the construction of effective amino acid producers, the 
success of engineering approaches depends on detailed knowledge of 
cellular metabolism, which necessarily includes quantitative information on 
carbon flux distribution throughout the network of metabolic pathways  
(Kiefer et al. 2004, Bartek et al. 2011). Over the last two decades our team 
has taken advantage of the analytical power of Nuclear Magnetic 
Resonance (NMR) and its unique non-invasive characteristics to study 
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different aspects of metabolism directly in living cell suspensions (Neves et 
al. 1999, Neves et al. 2002a, Carvalho et al. 2013). We set out to apply this 
methodology and characterize C. glutamicum metabolism in the anaerobic 
production phase, in the presence and absence of CO2, to obtain pointers 
for the design of strains with maximal succinate production.  
Herein we report the use of 13C-NMR combined with specifically 13C-
labelled glucose to assess the impact of CO2 on the metabolic flux 
distribution in wild type C. glutamicum in the anaerobic production phase. 
Moreover, the intracellular pools of organic acids were monitored in vivo 
during the production phase. Our analysis shows that the flux through the 
pentose phosphate pathway (PPP) is small and not significantly altered by 
CO2 supply. In addition, succinate production proceeds largely via the 
reductive branch of the tricarboxylic acid (TCA) cycle, but a significant flux 
via the oxidative branch provides the reducing equivalents needed for the 
redox balance. 
 
Materials and Methods 
 
Growth conditions 
Corynebacterium glutamicum strain ATCC13032 (Kinoshita et al. 1958) 
was the only organism used in this work. Cells were grown aerobically in 
the CGXII minimal medium described by Eikmanns et al. (Eikmanns et al. 
1991a), modified as follows: 5 g·L-1 (NH4)2SO4, 21 g·L
-1 MOPS (3-[N-
morpholino] propanesulfonic acid), 0.2 mg·L-1  biotin. The medium was 
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supplemented with 4% (wt/vol) glucose. Growth experiments were 
performed at 30C with constant agitation at 140 rpm in 2-liter baffled 
shake flasks. The medium was inoculated by addition of a pre-culture to an 
initial optical density at 600 nm (OD600) of approximately 0.5; the initial pH 
value was 7.0. Pre-cultures were grown for 8 h under the same conditions 
as the main cultures, except that 250 mL baffled shake flasks were used. 
In all cases the medium volume was 1/10 of the flasks’ total capacity. 
Growth was monitored by measuring the OD600. A factor of 0.24 ± 0.01, 
determined from a CDW (mg·mL-1) versus OD600 curve, was used to 
convert OD600 into dry weight (mg biomass·mL
-1). 
Preparation of cell suspensions 
Cells were grown as described above and harvested 16 h after inoculation, 
at the beginning of the stationary phase (OD600 of 40- 45), centrifuged 
(9,924 × g, 10 min, 4C), and washed twice with an appropriate buffer 
(MES - 2-(N-morpholino)ethanesulfonic acid or PIPES - piperazine-N,N′-
bis(2-ethanesulfonic acid), 10 mM at pH 7). The resulting cell suspension 
was centrifuged (11,325 × g, 10 min, 4C) and the pellet re-suspended to 
an OD600 of 100 (dense cell suspension) or 7.5 (diluted cell suspension) in 
50 mM buffer (PIPES at pH 7 or MES at pH 5.7); SAG 5693 antifoam 
(approx. 15-20 µL per 50 mL of cell suspension) and D2O (6% vol/vol) 




In vivo NMR experiments  
The experiments were performed using the on-line system described by 
Neves et al. (Neves et al. 1999), which consists of an 80 mL-bioreactor 
coupled to the NMR tube with a circulating system that allows for non-
invasive studies of metabolism under controlled conditions of pH, gas 
atmosphere and temperature. Dense cell suspensions (OD600 of 100) were 
placed in the bioreactor and kept at 30ºC. The pH was controlled at 7.0 or 
5.7 by the automatic addition of 5 M NaOH. To achieve anaerobic 
conditions, argon, carbon dioxide (CO2) or a mixture of CO2 and nitrogen 
(20% CO2; vol/vol), was bubbled through the cell suspension in the 
bioreactor and also provided to the headspace of the NMR tube. Glucose 
specifically labelled with 13C on carbon one (20 mM) was added to the cell 
suspension at time-point zero. The time course of glucose consumption, 
product formation and changes in the pools of intracellular organic acids 
were monitored in vivo. When the substrate was exhausted, an 
NMR-sample extract was prepared as described previously (Neves et al. 
1999, Neves et al. 2002a). In brief, an aliquot of the cell suspension (6 mL) 
was passed through a French press: the resulting cell extract was 
incubated at 82C (10 min) in a stoppered tube, cooled down on ice and 
cell debris and denatured macromolecules were removed by centrifugation 
(45,696 × g, 10 min at 4C). The supernatant (NMR-sample extract) was 
used for quantification of end products and minor metabolites. Samples 
were stored at -20ºC until further analysis. 
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Quantification of end-products and intracellular organic acids 
 Lactate was quantified in the NMR-sample extract by 1H-NMR in an 
AMX300 (Bruker BioSpin GmbH) spectrometer. Formic acid (sodium salt) 
was added to the samples and used as an internal concentration standard. 
The concentration of other metabolites was determined in fully relaxed 13C 
spectra of the NMR-sample extracts as described by Neves et al. (Neves 
et al. 1999). Due to the fast pulsing conditions used for acquiring in vivo 
13C-spectra, correction factors were determined to convert peak intensities 
into concentrations. The correction factors for the resonances due to C3 of 
intracellular lactate (0.60 ± 0.04) and C2-C3 of intracellular succinate (0.60 
± 0.02) were determined from the acquisition of fully and partially relaxed 
spectra of an NMR-extract. The correction factors for C3 of extracellular 
lactate (0.55 ± 0.02) and C2-C3 of extracellular succinate (0.57 ± 0.02) 
were determined as above, except that PIPES buffer (50 mM, pH 7.0) 
containing succinate (50 mM) and lactate (60 mM) was used. The 
quantitative kinetic data for intracellular metabolites were calculated as 
described elsewhere (Neves et al. 1999, Neves et al. 2002, Carvalho et al. 
2013). Intracellular concentrations were calculated using a value of 1.4 µL 
per mg CDW-1 for the intracellular volume of C. glutamicum  (Krämer et al. 
1990). Although individual experiments are illustrated in each figure, each 
experiment was repeated at least twice. The values reported are averages 
of two experiments and the uncertainty varied from ± 2 to ± 15% for 
metabolite concentration and from ± 1% to ± 10% for maximal glucose 
consumption rate (GCR).  
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Analysis of metabolic fluxes in the anaerobic phase (non-growing 
cells) 
 Diluted cell suspensions (OD600 of 7.5) prepared as described above were 
used to estimate the fluxes through the metabolic pathways operating 
under oxygen deprivation. The cell suspensions were kept at 30ºC under 
controlled pH of 7.0 and anaerobic conditions were ensured by bubbling 
argon or CO2 through the suspension. Glucose (50 mM) specifically 
labelled with 13C on carbon one, carbon two, simultaneously labelled on C1 
and C2, or uniformly labelled, was added to the cell suspension at time-
point zero. Samples (1 mL) were withdrawn at time-point zero and 
periodically for 32 h, centrifuged (10,000 × g, 2 min at 4ºC), and the 
supernatant solutions saved at 20C until further analysis. 13C-labeled 
end-products were quantified in the supernatants by 13C-NMR using as 
concentration standard tetramethylurea (99%) contained in a capillary, or 
by 1H-NMR using sodium formate as an internal standard. The total 
quantities of end-products were determined from averages of 6 
independent experiments and have a typical standard deviation of 3%. 
13C-glucose isotopomers were selected specifically to resolve the 
contributions of different pathways (Schrader et al. 1993, Klapa et al. 
1999). The labelling pattern of end products was analyzed and a scheme 
including central metabolic pathways was constructed (Fig 2.1 and Table 
2.1). This comprised glycolysis, PPP, reductive TCA cycle down to 
succinate and oxidative TCA cycle also ending at succinate, lactate and 
acetate production from pyruvate, pyruvate (Pyr) / phosphoenolpyruvate 
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(PEP) carboxylation and oxaloacetate/malate conversion to pyruvate. The 
efflux of carbon at the level of glucose-6-phosphate towards carbon 
reserves (glycogen, trehalose, etc), and respective mobilization to 
glycolysis are also considered. PEP/Pyr carboxylation reactions are 
lumped together since the labelling patterns of PEP and pyruvate are 
indistinguishable; similarly a single flux was considered for the 
decarboxylation reactions from oxaloacetate or malate. The two possible 
acetate forming pathways from pyruvate are combined into a single one. 
All reactions in the reductive TCA were considered as reversible. The 
contribution of the glyoxylate shunt was neglected (see Discussion).  
 
 
Fig 2.1. Scheme representing the reactions in the metabolic model used to 
estimate the flux distribution in non-growing cells of C. glutamicum. For more 
































Table 2.1. The equations used to calculate respective carbon fluxes.  
Flux  Equation  
Glc 
isotopomer  



















f4  f4=f3/5   
f5  f5=DHAout   
f6  f6=Lacout   
f7  f7=Acout   
f8  f8=f7/2 + f10/4   

















f12  f12=f10/2   
f13  f13=f9/4   











Cbalance)*f1   
f16  f16=
12
Cbalance -f1-f13 +f4+f5+f6+f7+f8+f9+f12+f15   
 f2+f3=f5+f6+3*f10/2+3*f11/4+3*Acout/2   
 
12
Cbalance=(f1+f13+f16)- (f4+f5+f6+f7+f8+f9+f12+f15)   
a 13C-balance value was corrected for the loss of 13C-label from the C1 of glucose 
as CO2 in the PPP in the experiments which used [1-
13C]Glc or [1,2-13C]Glc. Glcin, 
supplied glucose; DHAout, dyhydroxyacetone; Lacout, lactate; Acout, acetate; Sucout, 
succinate. 
 
Deconvolution of overlapping intra- and extracellular organic acid 
resonances 
 Partial overlap of the resonances due to internal and external lactate 
hampered direct integration. Therefore, deconvolution of the relevant 
spectral region was performed by fitting the sum of Lorentzian and 
Gaussian functions using Matlab V7.1 (The Math Works, Natick, MA, 
USA). 
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Determination of n, number of protons exported concomitantly with 
each molecule of organic acid 
 The total amounts of internal and external organic acids were fitted to 
exponential curves which were used to calculate the n-value numerically, 
as in Carvalho et al. (Carvalho et al. 2013). The intracellular pH was 
determined by 31P-NMR and the relative concentrations of the ionised 
forms were obtained using pKa1=4.2 and pKa2=5.6 for succinic acid. 
NMR spectroscopy 
 All carbon-13 spectra were acquired at 125.77 MHz on a Bruker AVANCE 
II 500 MHz spectrometer (Bruker BioSpin GmbH) at 30ºC. In vivo 
experiments were run using a quadruple nuclei probe head, as described 
earlier (Neves et al. 1999). 13C-NMR spectra of supernatants derived from 
diluted cell suspensions (OD600 of 7.5) were recorded using a 
13C-selective 
probe head, 32 K data points, a 68° flip angle and a repetition delay of 90.5 
s. Tetramethylurea contained in a capillary was used as concentration 
standard and also as a reference for chemical shifts (δ=38.7 ppm).  
Quantification of end-products by HPLC 
End-products in supernatants derived from diluted cell suspensions or 
NMR-sample extracts (dense cell suspensions) were also quantified by 
HPLC, using an apparatus equipped with a refractive index detector 
(Shodex RI-101, Showa Denko K. K., Japan) and an HPX-87H anion 
exchange column (Bio-Rad Laboratories Inc., California, USA) at 60ºC, 





 [1-13C]glucose, [2-13C]glucose, [1,2-13C]glucose and [U-13C]glucose were 
obtained from Cambridge Isotope Laboratories, Inc. The SAG 5693 
antifoam agent was from Union Carbide Chemicals & Plastics. Formic acid 
(sodium salt) and tetramethylurea were purchased from Merck Sharp & 
Dohme and Sigma-Aldrich, respectively. All other chemicals were reagent 
grade (Sigma-Aldrich and Merck Sharp & Dohme).  
 
Results 
The effect of CO2 on succinate production 
 In vivo 13C-NMR was used to characterise the metabolism of glucose in 
C. glutamicum ATCC 13032 at OD600 = 100 and pH = 7 under anaerobic 
conditions in: i) the absence of CO2, ii) 20% (vol/vol) CO2, and iii) pure CO2 
(Fig. 2.2). In the absence of CO2, C. glutamicum produced lactate, 
succinate and acetate from glucose, with lactate accounting for 1.22 mol 
per mol of glucose consumed (i.e., 61%) (Fig. 2.2A and Table 2.2). 
Replacement of argon by 20% (vol/vol) CO2 (Fig. 2.2B), led to a decrease 
in lactate by about one third (from 24.5  3.1 mM to 14.6  0.2 mM), while 
succinate production doubled (from 5.9  0.2 to 11.8  1.0 mM) (Fig. 2.2). 
This trend was even more pronounced when the pure CO2 was bubbled 
through the cell suspension (Fig. 2.2C and Table 2.2): lactate accounted 
for 21% of the glucose consumed (0.42  0.01 mol per mol), corresponding 
to circa three times lower yield than in the absence of CO2. 
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Figure 2.2. Time courses of glucose consumption and product accumulation 
during the metabolism of 20 mM [1-13C]glucose in non-growing cell suspensions 
of C. glutamicum (OD600 = 100). The experiments were monitored by in vivo 
13C-NMR and carried out at 30 ºC, with pH controlled at 7.0 and bubbling (A) no 
CO2, (B) 20% CO2 or (C) 100% CO2. Glucose consumption rates: (A) 34.5 (B) 
22.5 (C) 21.2 nmol·min-1·mg CDW-1. Symbols: grey diamonds, glucose; open 
circles, succinate; black squares, lactate; black triangles, acetate. Each panel 
represents a single experiment from a set of at least two similar replicates. 
 
 Under pure CO2, succinate was the major end-product, reaching a 
maximal concentration of 17.5  0.3 mM. CO2 also had a positive effect on 
the acetate yield, which increased approximately two-fold in the presence 
of 100% CO2 as compared to no added CO2 (Table 2.2). Other minor 
products, including L-glutamate, L-alanine, -ketoglutarate, trehalose and 
glycogen were detected under all conditions examined. A negative 
correlation was observed between CO2 supply and the glucose 
consumption rate (GCR), which dropped from 34.5  0.7 nmol·min-1·mg 
CDW-1 to 22.5  2.1 and 21.2  0.1 nmol·min-1·mg CDW-1 when 20% 




Table 2.2. The effect of CO2 availability on the anaerobic metabolism of 
glucose by C. glutamicum ATCC13032. The initial concentration of glucose 
was 20 and 50 mM for the experiments with dense and diluted cell 
suspensions, respectively. In dense cell suspensions (OD600 =100), end-
products and glucose were determined online by in vivo NMR while in 
diluted cell suspensions (OD600 =7.5), they were measured by NMR and 
HPLC off-line in the sample supernatants. The pH of the cell suspension 

































OD600 =100      
7.0 
0 1.22  0.16 0.29  0.01 0.13  0.02 34.5  0.7 90.1  6.5 141  2 
20 0.73  0.01 0.59  0.05 0.19  0.01 22.5  2.1 83.8  0.4 163  21 
100 0.42  0.01 0.87  0.02 0.28  0.01 21.2  0.1 87.5  1.2 173 13 
        
5.7 
0 1.19  0.06 0.15  0.01 0.06  0.01 19.7  0.4 86.5  0.9 110  11 
100 0.83  0.04 0.41  0.01 0.13  0.01 18.4  0.2 77.2  3.4 111  3 




0 1.24  0.06 0.03  0.01 0.03  0.01 25.0  3.6 89.0  2.8 103  4 
100 0.56  0.12 0.91  0.11 0.26  0.02 21.3  1.4 79.7  5.2 91  6 
aProduct yields were calculated assuming that [1-13C]glucose was processed via 
the EMP pathway and produces a labelled and an unlabelled pyruvate molecule 
as follows: lactate yield = [3-13C]lactate×2/[1-13C]glucose; acetate yield = [2-
13C]acetate×2/[1-13C]glucose; succinate yield = ([2,3-13C]succinate×2 + [1,4-
13C]succinate)/ [1-13C]glucose; b  13C balance is the percentage of carbon in 
metabolized 13C-glucose that is recovered in the fermentation products; c total 
carbon balances were calculated summing up the end product concentrations. 
Abbreviations: GCR, glucose consumption rate. 
 
Carbon flux analysis of succinate production in C. glutamicum 
 63 
Carbon flux analysis in non-growing cells based on 13C-NMR 
The fundamental as well as biotechnological interest of finding that the 
succinate yield was strongly increased by CO2 motivated us to characterize 
the redistribution of carbon fluxes induced by CO2 in non-growing cells 
(production stage). To this end, we relied on isotopomeric 13C-NMR 
analysis of end-products from the anaerobic metabolism of glucose 
specifically labelled in suitable positions. The set of experiments was 
performed with diluted cell suspensions (OD600 of 7.5, as compared to 100 
used for in vivo NMR). The use of diluted cell suspensions was dictated by 
the need to reduce the contribution of unlabelled end products attributed to 
the concomitant metabolism of internal reserves, which would complicate 
the analysis of labelling patterns in end-products. Indeed, in dense cell 
suspensions the total amount of carbon recovered in end-products was up 
to 70% greater than that expected from the supplied glucose (Table 2.2). 
Curiously, in the absence of CO2, the succinate yield was around 10 times 
higher in the experiments with dense cell suspensions as compared to 
diluted cell suspensions. We speculate that this difference is related with a 
higher concentration of endogenous bicarbonate in thick suspensions 
since CO2 removal is less efficient.         
Considering the fate of 13C-label derived from the several glucose 
isotopomers led to the conclusion that [2-13C]glucose should provide 
optimal information on the activity of anaerobic pathways. Other 
isotopomers of glucose ([1-13C]glucose, [1,2-13C]glucose and [U-
13C]glucose) gave additional information: by using [1-13C]glucose and [U-
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13C]glucose we were able to track backflux from the TCA cycle 
(oxaloacetate/malate) to 3-carbon units (PEP/Pyr); [1,2-13C]glucose 
confirmed the PPP activity provided by the analysis of [2-13C]glucose 
metabolism; all experiments were used to estimate the extent of 
metabolization of internal reserves. Because we were unable to analyse 
metabolites other than end-products, namely lactate, acetate, succinate, 
dihydroxyacetone (DHA) and glycerol, the model is necessarily highly 
simplified. Nonetheless, using this model we were able to estimate and 
compare the activity of main pathways in response to CO2, including the 
split PPP/glycolysis and the proportions of the reductive and oxidative 
branches in the TCA cycle.  
NMR analysis of end-products derived from metabolism of [2-13C]glucose 
(Fig. 2.3, Table 2.3), provided a straightforward and accurate way to 
determine division between the Embden-Meyerhof-Parnas (EMP) and PPP 
using the 13C-enrichments in C2 and C3 of lactate or DHA (Schrader et al. 
1993). Our data showed that the majority of glucose was metabolized via 
the EMP pathway, in the absence of CO2, while the activity of PPP 
accounted for about 2% of the carbon taken up in glucose (Fig. 2.4A). The 
PPP flux was 5% in the presence of pure CO2 (Fig. 2.4B). Without added 
CO2, we observed a high production of DHA (21% of the total glucose 
carbon), while addition of CO2 abolished DHA formation. Moreover, the 
presence of CO2 had a strong impact on the distribution of fluxes at the 
pyruvate node, i.e., lactate production was reduced (from 65 to 25% of 
carbon input), while the remaining fluxes towards pyruvate dehydrogenase 
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and PEP/Pyr carboxylation reactions were clearly enhanced (about 6- and 
16- fold, respectively).  
 
Figure 2.3. Relevant sections of 13C-NMR spectra of end-products derived from 
the anaerobic metabolism of [2-13C]glucose by diluted cells suspensions (OD600 = 
7.5) of C. glutamicum in the absence of CO2 (A) or presence of 100% CO2 (B, C 
and D). C and D are expansions of the resonance patterns, respectively due to 
[2,3-13C]succinate and [2-13C]lactate in spectrum B. Symbols: DHA, 
dihydroxyacetone; Lac, lactate; Suc, succinate; Ac, acetate. A representative 
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Cells produced a low amount of [1,2-13C]lactate (about 1% of total lactate) 
from the metabolism of [2-13C]glucose, regardless of the CO2 content in the 
atmosphere (Fig. 2.3D). The appearance of labelling on contiguous carbon 
atoms can originate from the reversible reactions catalysed by 
transketolase and transaldolase in the PPP (Schrader et al. 1993), or from 
the decarboxylation of four-carbon dicarboxylic acids 
(oxaloacetate/malate), that are labelled in adjacent carbons (back-flux from 
oxaloacetate/malate to PEP/Pyr). To clarify the origin of [1,2-13C]lactate 
(derived from [2-13C]glucose), we performed experiments with supply of 
[1-13C]glucose and [1,2-13C]glucose: small amounts (about 0.5 mM) of 
[1-13C]lactate and [1,2,3-13C]lactate were detected, respectively (data not 
shown). This labelling pattern can be explained by a small percentage of 
fructose 6-phosphate produced through EMP that is directed to the 
reactions catalysed by transketolase and transaldolase in PPP. To confirm 
or rule out the occurrence of back-flux from oxaloacetate/malate to 
PEP/Pyr, the alternative path that would produce the same labelling, we 
looked for [2-13C]lactate in the end-products derived from [1-13C]glucose, 
and also for [2,3-13C]lactate derived from the metabolism of [U-13C]glucose, 
following an approach eloquently described by McKinley and Vieille 2008 
(McKinlay and Vieille 2008). The analysis showed only vestigial amounts of 
[2-13C]lactate or [2,3-13C]lactate (data not shown), meaning that the back-
flux to pyruvate under 100% CO2 atmosphere is insignificant.  
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Table 2.3. 13C-labelling in the end-products derived from anaerobic 
metabolism of [2-13C]glucose. Concentrations were determined by 13C-
NMR and corrected for natural abundance (1.1%). Values are average of 
three independent experiments. n.d., not detected or no greater than 
natural abundance. The total concentrations were obtained by HPLC and 
are the average of five independent experiments. 
Metabolite 
Concentration (mM) 
 0% CO2 100% CO2 
Lactate C3 0.48 0.51 
Lactate C2 27.28 11.31 
Lactate C1 0.13 0.10 
Lactate C3-C2 n.d. n.d. 
Lactate C2-C1 0.29 0.19 
Total lactate 64.88 24.73 
   
Succinate C2,3 0.56 18.92 
Succinate C1,4 n.d. 0.58 
Succinate C1-2 n.d. 0.21 
Total succinate 4.09 67.44 
   
Acetate C2 n.d. 0.27 
Acetate C1 0.64 5.51 
Acetate C1-C2 n.d. n.d. 
Total acetate 1.75 10.38 
   
DHA C1,C3 0.20 n.d. 
DHA C2 10.70 n.d. 
DHA C1-C2 0.13 n.d. 
Total DHA 21.09 n.d. 
   
Glycerol C1,C3 0.28 0.15 
Glycerol C2 1.61 0.20 
Total glycerol 3.25 0.36 







Table 2.4. Values calculated for the metabolic fluxes. 
Carbon flux 
0% CO2 100% CO2 
% of carbon per 100 carbon atoms taken up in glucose 
f1 100.00 100.00 
f2 90.04 88.40 
f3 1.92 4.81 
f4 0.38 0.96 
f5 21.09 0.00 
f6 64.88 24.73 
f7 1.76 10.38 
f8 0.84 5.65 
f9 4.10 67.44 
f10 -0.14 1.83 
f11 4.24 65.61 
f12 -0.07 0.91 
f13 1.02 16.86 
f14 0.60 0.53 
(f16-f15) -8.04 -6.79 
f15 11.97 19.30 
f16 3.94 12.51 
13
C balance 87.87 80.70 
12
C balance 91.83 102.55 
 
In the absence of added CO2, the production of succinate was too low to 
estimate fluxes within the TCA cycle. However, the increase in succinate 
production induced by CO2 enabled the characterisation of the TCA cycle 
reactions in more detail.  Approximately 97 % (18.84 out of 19.58 mM, 
Table 2.3) of the labelled succinate pool was enriched in either of the inner 
carbons (C2 or C3) (Table 2.3), reflecting the prominent contribution of the 
reductive branch of the TCA cycle. The low proportion of succinate labelled 
on either C1 or C4 (3%) indicated a small but statistically significant 
contribution of the oxidative branch of the TCA cycle (see Discussion).  
The proportions of succinate produced via the oxidative versus the 
reductive TCA cycles determined the amount of CO2 released (1%, three 
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mol per mol of succinate via oxidative TCA) and the amount incorporated 
through PEP/Pyr carboxylation reactions (ca. 17%, one mol per mol of total 
succinate). Decarboxylation of pyruvate into acetate or acetyl-CoA and of 
6-phosphogluconate (in PPP) added to the loss of carbon through CO2 
(about 7% in total) (Fig. 2.4B). In experiments where pure CO2 was 
provided, it is reasonable to assume that all of the incorporated CO2 was 
unlabelled, whereas about one third of the CO2 lost in decarboxylation 
reactions was labeled on average across the various experiments. The 
gain (carboxylation reactions) and loss of carbon (decarboxylation 
reactions) was accounted for in both the 13C and total carbon balances. 
The remaining loss of 13C of about 10-20% was attributed to channelling of 
13C-glucose to reserve materials (glycogen, trehalose, etc). The flux 
towards glycogen and trehalose was confirmed by in vivo NMR 
experiments that showed increasing resonances of glycogen and trehalose 
from the metabolism of C1-labeled glucose (data not shown). The 
difference between total and 13C balances, after accounting for 
incorporation of unlabelled CO2, was attributed to catabolism of unlabelled 
intracellular reserves that had accumulated during growth (ca. 4% without 
CO2 and 13% with 100% CO2 experiments) (Fig. 2.4A and B). Therefore, 
there is carbon exchange with internal reserves and a net channelling of 
supplied glucose to the formation of storage compounds. The equations 





Figure 2.4. Scheme representing the reactions in the metabolic model used to 
estimate the flux distribution in non-growing cells of C. glutamicum (OD600 =7.5), 
with no supply of CO2 (A); and 100% CO2 (B) at pH 7.0. To extract the minimal 
set of reactions operating under these conditions we analyzed the 13C labelling in 
end-products from anaerobic metabolism of [1-13C]glucose, [2-13C]glucose, [1,2-
13C]glucose and [U-13C]glucose. Fluxes are shown as a percentage in relation to 
the number of carbon atoms taken up as glucose. Lines with arrows represent 
respective fluxes in the central metabolism: PPP (green), EMP (black), reductive 
TCA (red), oxidative TCA (blue), oxaloacetate/malate decarboxylation into 
PEP/Pyr (grey). More precise values for fluxes are shown in Table 2.4.    
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Intracellular pools of lactate and succinate determined by in vivo 13C-
NMR  
Production of organic acids by fermentation at low pH is highly desirable to 
facilitate downstream processing and minimize waste products (Straathof 
2013). Moreover, high intracellular pools of succinic and lactic acids may 
inhibit protein activity (Carvalho et al. 2013, Reinscheid 1994a). Therefore, 
we examined the effect of CO2 on succinate production at a lower pH. 
Furthermore, at acidic pH it is possible to monitor intracellular pools of 
organic acids non-invasively by 13C-NMR (Carvalho et al. 2013). The 
species of weak organic acids in solution are in fast exchange on the NMR 
timescale, thus giving rise to a single resonance whose chemical shift is 
determined by the proportion of the protonated and non-protonated 
species, i.e., by pH. When the pH values of the intracellular and 
extracellular compartments are sufficiently different, the internal and 
external pools originate distinct resonances in the NMR spectrum. Herein 
the pH of the external solution was set at 5.7 based on the pH dependence 
of the chemical shift of succinate (C2/C3 resonance), and considering the 
neutrophilic character of C. glutamicum. A typical sequence of 13C-NMR 
spectra obtained during the metabolism of [1-13C]glucose (Fig. 2.5) shows 
intense resonances due to extracellular succinate (δ, 33.4 ppm) and 
lactate (δ, 20.6 ppm). More importantly, two small resonances appear at 
33.7 ppm and 20.7 ppm, which arise from these organic acids inside the 





Figure 2.5.  Sequences of 13C-NMR spectra acquired during glucose metabolism 
by dense cell suspensions (OD600 =100), of C. glutamicum at pH 5.7 under 100% 
CO2 atmosphere. The resonances due to intra- and extracellular succinate and 
lactate are depicted. Sucin, intracellular succinate; Sucout, extracellular succinate; 
Lacin, intracellular lactate; Lacout, extracellular lactate. A single experiment is 
depicted from two independent replicates with high reproducibility.   
 
The kinetics of glucose consumption and the build-up of intra- and 
extracellular pools under anaerobic conditions (with and without CO2) are 
shown in Fig. 2.6. A shift in the external pH from 7.0 to 5.7 did not alter the 
nature of end-products but led to a clear change in their proportions (Table 
2.2). As for pH 7.0, CO2 had a positive effect on succinate production (8.3 
 0.2 mM as compared to 3.1  0.3 mM without CO2), but lactate was the 
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major end-product at the lower pH regardless the presence of pure CO2 in 
the atmosphere. At pH 5.7, GCR was impaired and this negative effect was 
more pronounced in the absence of CO2 (Table 2.2). Intracellular succinate 
and lactate pools increased steadily during glucose metabolism, reaching 
their maximal concentrations at the onset of glucose exhaustion. In the 
absence of CO2, succinate and lactate reached intracellular levels of 17.2  
0.9 mM and 196.1  28.4 mM, respectively (Fig. 2.6A). Under CO2 the 
intracellular lactate pool decreased to 123.3  18.4 mM, while the 
intracellular succinate concentration increased to 57.1  1.7 mM. Except 
for small resonances assigned to fructose-1,6-bisphosphate, intermediate 
metabolite pools were below the detection limit of these experiments 




Figure 2.6. Time courses for consumption of glucose (20 mM), and build-up of 
intra- and extracellular pools of lactate and succinate determined from the 
sequences of spectra shown in Figure 4, in the absence of CO2 (A) and in the 
presence of 100% CO2 (B). Symbols: black diamonds, glucose; full squares, 
extracellular lactate; empty squares, intracellular lactate; full circles, extracellular 
succinate; empty circles, intracellular succinate. (C) Plot of the ratio intracellular 
succinate/extracellular succinate, and   intracellular lactate/extracellular lactate 




In this study we investigated the effect of CO2 on anaerobic organic acid 
formation by wild type C. glutamicum and found that the succinate yield 
increased 3-fold to 1 mol succinate per mole glucose in the presence of 
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CO2. This experimental yield is significantly higher than those reported in 
the literature for wild type C. glutamicum, which do not exceed 0.44 mol 
succinate per mol glucose (Inui et al. 2004, Yamamoto et al. 2011). 
Moreover, it is significant even when compared with engineered C. 
glutamicum strains that show succinate yields between 1.02 and 1.67 mol 
per mol glucose (Litsanov et al. 2012a, Okino et al. 2008a, Wieschalka et 
al. 2012b, Zhu et al. 2014). 
The increase in the succinate yield prompted us to characterize the 
underlying redistribution of carbon fluxes. Analysis of enrichment on C2 and 
C3 of lactate derived from [2-
13C]glucose showed a low proportion of flux 
through PPP in relation to glycolysis, and this split ratio was only slightly 
increased in the presence of CO2. To our knowledge, this is the first 
estimation of the contribution of PPP in C. glutamicum under oxygen 
depletion conditions. The low contribution of the PPP flux corroborates the 
view that in C. glutamicum the activity of this pathway is controlled by the 
demand for NADPH (Marx et al. 1999)), which is naturally low in non-
growing cells producing mainly organic acids. Accordingly, during the 
valine production phase of a recombinant L-valine-producing strain of C. 
glutamicum (non-growing cells, oxygen supplied), the carbon flux was fully 
directed to PPP to match the high demand for NADPH associated with the 
synthesis of this amino acid (two mol NADPH per valine produced) (Bartek 
et al. 2011).   
In the absence of added CO2, besides lactate, cells produced considerable 
amounts of DHA, which indicate the presence of a metabolic bottleneck at 
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the level of glyceraldehyde-3-phosphate dehydrogenase, most likely due to 
enzyme inhibition by a high NADH/NAD+ ratio (Even et al. 1999). 
Significantly, this redox imbalance was abolished under succinate 
producing conditions since the reductive part of the TCA cycle provides a 
sink for reducing equivalents, and hence DHA was not produced.   
Succinate production occurred mainly via PEP/Pyr carboxylation and 
reductive TCA cycle. However, the detection of 13C-labelling on the outer 
carbons of succinate (Fig. 2.3, Table 2.3), denotes the operation of the 
oxidative path and/or the glyoxylate shunt. These two pathways lead to 
identical labelling patterns on succinate, and so their individual 
contributions cannot be resolved. We assumed that the flux through the 
glyoxylate shunt is negligible under the experimental conditions used in 
this study, based on the following information: the activity of isocitrate lyase 
is absent in C. glutamicum during anaerobic glucose metabolism (Inui et al. 
2004); succinate is an effective inhibitor of isocitrate lyase (inhibition 
constant of 1.48 mM) (Reinscheid et al. 1994a). Therefore, it seems 
reasonable to neglect the glyoxylate shunt contribution in our metabolic 
model, which was designed for cells producing high levels of succinate, 
under anaerobic non-growing conditions. 
Activity of the full oxidative branch of the TCA cycle makes sense in view 
of the overall redox balance. For calculation of the redox balance, all three 
reduced cofactors (NADH, NADPH and MQH2), were considered as 
equivalent electron reducing units (Bott 2003, Genda et al. 2003). It is 
rewarding to find that the small flux through the oxidative TCA cycle (2 
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C-atoms succinate for each 100 C-atoms glucose taken up), estimated 
from the 13C-enrichment on C1/C4 of succinate, provides the balance of 
reducing power needed for succinate production. Indeed, the calculation of 
the overall redox balance would be exactly 100% with a flux of 3.5 (instead 
of 2) carbons through the oxidative TCA cycle, which is a difference within 
the uncertainty of the data. However, a large deficit in reducing capacity 
(up to 20%) would occur if the glyoxylate shunt was active and the 
oxidative branch inoperative. Low contributions of the oxidative branch to 
anaerobic succinate production have also been reported in Basfia 
succinoproducens and appear to be required for optimal production in non-
growing cells (Becker et al. 2013). The operation of the oxidative branch of 
the TCA cycle implies a cost in terms of CO2 loss, thus Zhu et al., (Zhu et 
al. 2014) constructed a C. glutamicum strain with overexpression of the 
genes involved in the glyoxylate shunt, but this strategy alone was not 
satisfactory as the yield was essentially unchanged (1.21 to 1.23 mol per 
mol glucose).  
The experiments with [1-13C]glucose and [U-13C]glucose showed that back-
flux from oxaloacetate/malate to PEP/Pyr is insignificant  under 100% CO2 
atmosphere. This was unexpected knowing that the PEP/Pyr/oxaloacetate 
node shows great flexibility in C. glutamicum cells, at least in the presence 
of oxygen (Bartek et al. 2011, Wendisch et al. 2000). There are three 
possible routes through which oxaloacetate/malate can be decarboxylated 
into PEP/Pyr: i) oxaloacetate decarboxylase, which is inhibited by 
succinate (Jetten and Sinskey 1995); ii) PEP carboxykinase which is down-
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regulated under oxygen deprivation (Inui et al. 2007); iii) and the malic 
enzyme, which is over-expressed under oxygen deprivation (Inui et al. 
2007). Therefore, it appears that the malic enzyme has very low activity in 
the decarboxylating direction, probably because of low requirement for 
NADPH. Actually, having the malic enzyme acting in the malate-forming 
direction as previously suggested (Gourdon et al. 2000), would provide a 
sink for NADPH produced in PPP, a useful feature since this bacterium 
lacks NADPH:NAD+ transhydrogenase activity (Blombach et al. 2011, 
Kabus et al. 2007). 
The difference between the recovery of 13C and total carbon (Table 2.2) 
deserves further discussion. In addition to the obvious dilution of label 
resulting from 12C incorporation from CO2 in PEP/PYR carboxylation 
reactions, one should consider the contribution of unlabelled internal 
reserves. C. glutamicum can store glycogen and maltodextrins during 
growth (Seibold et al. 2007), as well as trehalose (Wolf et al. 2003) and the 
catabolism of these components concomitantly with the metabolism of 
added labeled glucose will lead to 13C dilution, as demonstrated by the 
presence of unlabeled end-products when uniformly labeled glucose was 
provided. This phenomenon has been observed in bacteria and yeast 
which showed fast mobilization of carbohydrate storage pools (Matheron et 
al. 1998, Aboka et al. 2009). Moreover, the reverse flux from labeled 
glucose to reserves was apparent from the build-up of labeled glycogen 
and trehalose (data not shown). Therefore, our model takes into account 
that both the utilization of internal reserves and storage of labeled glucose 
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occur in the presence and absence of CO2. According to this model, 12% 
and 19% of labelled glucose was stored, and unlabelled reserves (4% and 
13% of C-atoms taken up as glucose) were channelled to catabolism. 
Lowering pH from neutral to 5.7 had a strong negative effect on the GCR. 
Furthermore, the decrease in metabolic efficiency was accompanied by 
decline in the succinate yield. As cells were grown under identical 
conditions, transcriptional or proteomic effects are unlikely to occur and the 
metabolic effects are ascribed to immediate impact of pH on the efficiency 
of glucose transporters and/or cytoplasmic enzymes. The lack of effect at 
the transcriptional level has been demonstrated in Lactococcus lactis 
under similar experimental conditions (Carvalho et al. 2013). Despite the 
poor performance of C. glutamicum at acidic pH we decided to measure 
the intracellular pools of organic acids, seeking information on eventual 
constraints at the level of organic acid export systems. The average 
number, n, of protons exported with the lactate or succinate anions was 
determined directly from the kinetics of accumulation of intra and 
extracellular organic acids (Carvalho et al. 2013). During glucose 
consumption in a CO2 atmosphere, n was maintained close to 1.4 in the 
case of lactate, and varied only slightly (between 2.7 and 2.3) in the case 
of succinate, indicating lack of inhibition of exporters by the acid 
intracellular pools, which are actually much lower than those observed in L. 
lactis (up to 0.7 M lactate). Both for lactate and succinate, the ratio 
intracellular/extracellular pools tended rapidly to about 10 during glucose 
utilization (Fig. 2.6). Succinate exporters have been identified in several C. 
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glutamicum strains but their detailed characterization is lacking (Huhn et al. 
2011, Fukui et al. 2011). We speculate that, although cultivated at neutral 
pH, the organism is well adjusted to sustain the observed production fluxes 
at pH 5.7; moreover, the ability to maintain a high concentration gradient 
across the cell membrane creates a favourable contribution to the 
energetics of the efflux processes.  
In conclusion, this study demonstrates that the supply of CO2 to wild type 
C. glutamicum caused an important redistribution of the central metabolic 
fluxes, resulting in an up to 3-fold improvement in succinate yield without 
involvement of genetic manipulation. Succinate was produced largely via 
the reductive part of the TCA cycle, but there was also a significant flux 
through the oxidative part to meet the redox balance. Under production 
conditions (no-growth, lack of oxygen), the split ratio between PPP and 
glycolysis was low (around 5%), and independent of CO2 availability 
indicating that the flux via PPP is primarily controlled by NADPH demand. 
The metabolism of glucose-grown cells of C. glutamicum seemed well 
tuned to produce succinate at high yield with straightforward manipulation 
of environmental conditions and taking advantage of cellular regulation 
mechanisms. However, further effort should be directed at improving the 
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Summary 
2,3-Butanediol is an important bulk chemical with a wide range of 
applications. In bacteria, this metabolite is synthesized from pyruvate via a 
three-step pathway involving α-acetolactate synthase, α-acetolactate 
decarboxylase and 2,3-butanediol dehydrogenase. Thus far, the best 
producers of 2,3-butanediol are pathogenic strains, hence, the 
development of more suitable organisms for industrial scale fermentation is 
needed. Herein, 2,3-butanediol production was engineered in the 
Generally Regarded As Safe (GRAS) organism Corynebacterium 
glutamicum. A two-stage fermentation process was implemented: first, 
cells were grown aerobically on acetate; in the subsequent production 
stage cells were used to convert glucose into 2,3-butanediol under non-
growing and oxygen-limiting conditions.  
A gene cluster, encoding the 2,3-butanediol biosynthetic pathway of 
Lactococcus lactis, was assembled and expressed in background strains, 
C. glutamicum ΔldhA, C. glutamicum ΔaceEΔpqoΔldhA and C. glutamicum 
ΔaceEΔpqoΔldhAΔmdh, tailored to minimize pyruvate-consuming 
reactions, i.e., to prevent carbon loss in lactic, acetic and succinic acids. 
Producer strains were characterized in terms of activity of the relevant 
enzymes in the 2,3-butanediol forming pathway, growth, and production of 
2,3-butanediol under oxygen-limited conditions. Productivity was 
maximized by manipulating the aeration rate in the production phase. The 
final strain, C. glutamicum ΔaceEΔpqoΔldhAΔmdh(pEKEx2-
als,aldB,PtufbutA), under optimized conditions produced 2,3-butanediol with 
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a 0.66 mol·mol-1 yield on glucose, an overall productivity of 0.2 g·L-1·h-1 
and a titer of 6.3 g·L-1.  
We have successfully developed C. glutamicum into an efficient cell factory 
for 2,3-butanediol production. The use of the engineered strains as a basis 
for production of acetoin, a widespread food flavour, is proposed. 
Introduction  
Concern over exhaustion of fossil fuel resources, emission of CO2 linked 
with petroleum-derived products, and accumulation of non-degradable 
synthetic polymers urged the development of environmentally friendly 
processes for production of chemicals. A solution offered by the rising field 
of white biotechnology is to produce chemical building blocks by microbial 
fermentation of sugars derived from renewable biomass (Bozell and 
Petersen 2010). 
2,3-Butanediol (2,3-BD) is an important chemical used in the production of 
plasticizers and fumigants, as an antifreeze agent, a fuel and octane 
booster, among other applications (Celińska and Grajek 2009). The range 
is still expanding and the market size is expected to reach 74 kilo tons by 
2018 (Transparency Market Research 2012). Significantly, the 2,3-BD 
derivative, 1,3-butanediene, can be used in synthetic rubber production, 
while 2-butanone (methyl ethyl ketone) is a fuel additive and solvent for 
resins and lacquers. Additionally, ester-derivatives are used in the 
pharmaceutical and cosmetics industries. The world annual market for 2,3-
BD derivatives is estimated at around $43 billion (Köpke et al. 2011).   
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2,3-BD has three stereoisomeric forms: the enantiomers (2S,3S)-2,3-BD 
and (2R,3R)-2,3-BD, and the optically inactive form (2R,3S)-2,3-BD (meso-
2,3-BD). 2,3-BD is an end-product of the metabolism of many bacteria, 
synthesized from pyruvate via a three step pathway (Fig. 3.1). The first 
reaction involves the condensation of two pyruvate molecules into α-
acetolactate, which is catalyzed by α-acetolactate synthase (ALS, EC 
2.2.1.6), the enzyme committed to pyruvate catabolism. Alternatively, as in 
Corynebacterium glutamicum, α-acetolactate can be synthesized by the 
action of acetohydroxyacid synthase (AHAS, EC 2.2.1.6, encoded by 
ilvBN), and used as precursor for the synthesis of branched chain amino 
acids (L-valine, L-leucine and L-isoleucine). In the catabolic route, α-
acetolactate is decarboxylated by α-acetolactate decarboxylase (ALDC, 
EC 4.1.1.5, encoded by aldB) to yield (R)-acetoin. In the presence of 
oxygen, α-acetolactate can undergo spontaneous decarboxylation to form 
diacetyl, which is subsequently reduced to (R)- or (S)-acetoin by diacetyl 
reductases (EC 1.1.1.303; EC 1.1.1.304). Acetoin is finally reduced to 2,3-
BD by butanediol dehydrogenases (BDH, EC 1.1.1.76; EC 1.1.1.4). In 
some cases, such as C. glutamicum or L. lactis, BDH is promiscuous and 
recognizes as substrates diacetyl as well as acetoin, thus diacetyl can be 
reduced to acetoin via this activity (Takusagawa et al. 2001, Crow 1990). 
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Figure 3.1. A scheme depicting major pyruvate consuming reactions, including the 
proposed pathway for synthesis of optically active 2,3-BD in C. glutamicum and the 
strategy for engineering meso-2,3-BD synthesis. L. lactis genes of the 2,3-BD biosynthetic 
pathway (green) were introduced into C. glutamicum. Endogenous genes of interest are 
presented in blue; the red cross marks indicate genes that were inactivated in host strains 
to prevent the production of lactic acid (ldhA) and acetic acid (aceE and pqo); suppression 
of succinic acid was attempted by deletion of mdh. Abbreviations: mdh, malate 
dehydrogenase gene; mqo, malate:quinone oxidoreductase gene; ALS, α-acetolactate 
synthase (encoded by als); ALDC, α-acetolactate decarboxylase (encoded by aldB); BDH, 
butanediol dehydrogenase (encoded by butA), AHAS, acetohydroxyacid synthase; LDH, 
lactate dehydrogenase (encoded by ldhA); PQO, pyruvate:quinone oxidoreductase 
(encoded by pqo); AlaT, alanine-glutamate transaminase; AvtA, alanine-valine 
transaminase;  AceE, E1-subunit of the pyruvate dehydrogenase complex (encoded by 
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Thus far, the best producers of 2,3-BD are pathogenic strains, such as 
Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter aerogenes, and 
Serratia marcescens (Wang et al. 2010, Jantama et al. 2015, Jung et al. 
2013, Zhang et al. 2010), hence, a considerable research effort has been 
directed to the development of more suitable organisms for industrial scale 
fermentation. Lactococcus lactis, Bacillus subtilis, Paenibacillus polymyxa, 
Saccharomyces cerevisiae and Escherichia coli have been used for this 
purpose, but the low production efficiency or complex nutritional 
requirements of the engineered strains make the overall process 
unsatisfactory (Gaspar et al. 2011, Fu et al. 2014, Häßler et al. 2012, Lian 
et al. 2014, Xu et al. 2014). Therefore, the search goes on for more 
appropriate host strains and more efficient fermentation processes. A few 
years ago, some of us engineered L. lactis for the production of 2,3-BD by 
overexpression of two endogenous genes (als, butA) (Gaspar et al. 2011); 
theoretical product yields were reached, but the fastidious nutritional 
requisites of this bacterium precludes its utilization as an industrial 
producer of bulk chemicals. 
In this work, we selected Corynebacterium glutamicum as an industrially 
established host strain and aimed to develop an efficient 2,3-BD producer. 
C. glutamicum is an important industrial microorganism, widely known for 
the million-ton scale production of L-glutamate and L-lysine (Ajinomoto 
Co., Inc. 2011). Therefore, the existing knowledge of the industrial 
fermentation of this bacterium could be exploited for the production of bulk 
chemicals, such as 2,3-BD. In addition, C. glutamicum is a facultative 
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anaerobic organism with GRAS (Generally Regarded As Safe) status, 
robust (osmotolerant, phageresistant, organic solvent tolerant), extensively 
studied with respect to metabolism and regulation, and for which a 
comprehensive toolbox for genetic manipulation has been developed 
(Wendisch et al. 2006, Eggeling and Bott 2005, Burkovski 2008). 
Considerable research effort has been invested in metabolic engineering of 
C. glutamicum, resulting in the construction of producer strains for a broad 
spectrum of compounds, such as biofuels (isobutanol), polymer precursors 
(diaminopentane, cadaverine and putrescine), sugar alcohols (xylitol) and 
organic acids (Blombach et al. 2011, Yamamoto et al. 2013, Mimitsuka et 
al. 2007, Kind et al. 2010, Schneider and Wendisch 2010, Sasaki et al. 
2010, Okino et al. 2008a, Litsanov et al. 2012a, Okino et al. 2008b). As a 
result of this research endeavour, platform strains of C. glutamicum have 
been established. More specifically, strains deficient in L-lactate 
dehydrogenase (LDH, encoded by ldhA) have been proven to be a useful 
starting point for strain development since deletion of the ldhA gene 
eliminates L-lactate formation, concomitantly increasing NADH availability 
(Okino et al. 2008a, Okino et al. 2008b). In addition, strains deficient in the 
aceE-encoded E1 subunit of the pyruvate dehydrogenase complex 
(PDHC) were also shown to be suitable hosts for the production of 
pyruvate and pyruvate-derived products, L-valine, L-lysine, 2-
ketoisovalerate, succinate and isobutanol (reviewed in (Eikmanns and 
Blombach 2014). Typically, PDHC-deficient strains are unable to grow on 
glucose as sole carbon source unless the medium is supplemented with 
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acetate or ethanol (Schreiner et al. 2005, Blombach et al. 2009). However, 
in the absence of the latter substrates, C. glutamicum aceE remains 
metabolically active and converts glucose to pyruvate, L-alanine and L-
valine under aerobic conditions (Eikmanns and Blombach 2014). 
Combined activities of pyruvate:quinone oxidoreductase, acetate kinase 
and phosphotransacetylase (Fig. 3.1) do not provide sufficient acetyl-CoA 
to replace the PDHC reaction in glucose containing medium, however, 
deletion of the respective pqo gene was shown to be beneficial for the 
production of pyruvate and its derived products L-valine and 2-
ketoisovalerate (Blombach et al. 2008, Krause et al. 2010). In this 
framework, we constructed and tested three strains as potential hosts for 
efficient 2,3-BD production. In addition to C. glutamicum ΔldhA, and C. 
glutamicum ΔaceEΔpqoΔldhA, designed to minimize lactate and acetate 
formation, a third strain, C. glutamicum ΔaceEΔpqoΔldhAΔmdh, was 
constructed with an extra deletion of the malate dehydrogenase gene to 
reduce succinate formation (Fig. 3.1). In these strains we expressed als, 
aldB, butA from L. lactis and devised a two-stage process for efficient 
production of 2,3-BD. In the first stage cells were grown aerobically on 
acetate or glucose for biomass formation; in the second stage (production 
stage), biomass was used to convert glucose into 2,3-BD under non-
growing and oxygen-limiting conditions. 
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Materials and Methods 
Bacterial strains and growth conditions 
Strains and plasmids used in this work are shown in Table 3.1. Cells were 
grown aerobically in the 2×TY medium described by Green and Sambrook 
(Green and Sambrook 2012). Medium was supplemented either with 0.5% 
(wt/vol) glucose or with 1% (wt/vol) potassium acetate. Plasmid-harbouring 
strains were selected using kanamycin (25 μg·mL-1). Gene expression was 
induced by using 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG). 
Cultivations were performed at 30C with constant agitation at 160 rpm and 
were initiated by addition of a pre-culture to an optical density at 600 nm 
(OD600) of about 0.3. Growth was monitored by measuring the OD600. 
Specific growth rates (μ) were calculated through linear regression of the 
plots of ln(OD600) versus time during the exponential growth phase. For 
growth characterization, samples (1 mL) were taken periodically and pH 
was measured. 
For the molecular biology procedures, E. coli DH5α was grown in test 
tubes containing 5 mL of 2×TY medium at 37˚C and 180 rpm. Plasmid 
selection was achieved using 50 μg kanamycin per mL. 
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Table 3.1. Bacterial strains and plasmids used in this study.  
Strains Description Ref 
E. coli DH5α Plasmid-free E. coli 
Amersham 
Biosciences 
C. glutamicum ATCC13032 Wild-type strain 
Kinoshita et 
al. 1958 
C. glutamicum ΔldhA 
ATCC13032 with deletion of lactate 




ATCC13032 with deletions of the genes for the 
E1 subunit of pyruvate dehydrogenase complex, 
the pyruvate:quinone oxidoreductase and the 
lactate dehydrogenase 
Wieschalka 
et al. 2012a 
C. glutamicum ΔaceEΔpqo 
ΔldhAΔmdh 
ATCC13032 with deletions of the genes for the 
E1 subunit of pyruvate dehydrogenase complex, 
the pyruvate:quinone oxidoreductase, lactate 




C. glutamicum ΔaceEΔpqoΔldhA harboring 
plasmid pEKEx2 
This work 
C. glutamicum ΔldhA 
(pEKEx2) 
C. glutamicum ΔldhA harboring plasmid pEKEx2 This work 
C. glutamicum ΔaceEΔpqo 
ΔldhAΔmdh (pEKEx2) 
C. glutamicum ΔaceEΔpqoΔldhAΔmdh 
harboring plasmid pEKEx2 
This work 
C. glutamicum ldhA 
(pEKEx2- als,aldB,butA) 












C. glutamicum ΔaceEΔpqoΔldhAΔmdh 
















Plasmids   
pEKEx2 
kanR from pUC4K; Ptrc, lacI, pUC18 mcs, 
induced by addition of IPTG 
Eikmanns 
et al. 1991a 
pEKEx2-als pEKEx2 with cloned als from L. lactis This study 
pEKEx2-als,aldB,butA pEKEx2-als with aldB and butA from L. lactis This work 
pEKEx2-als,aldB,PtufbutA pEKEx2-als wit aldB and Ptuf-butA from L. lactis This work 
Abbreviations: als, α-acetolactate synthase gene; aldB, α-acetolactate 
decarboxylase gene; butA, butanediol dehydrogenase gene; Ptuf, a 185 bp 
region upstream of tuf gene of C. glutamicum; kanR, kanamycin resistance; 
Ptrc, trc promoter; lacI, lac repressor gene. 
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Construction of strains and plasmids 
All primers used are listed in Table 3.2. To construct control strain C. 
glutamicum ∆ldhA, deletion of ldhA (cg3219) gene was performed 
according to (Wieschalka et al. 2012a), using the primer pairs described 
there. Deletion of the mdh (cg2613) gene in C. glutamicum 
∆aceE∆pqo∆ldhA (aceE, cg2466; pqo, cg2891) was performed as 
described in (Blombach et al. 2011). Chromosomal DNA of L. lactis 
MG1363, isolated according to (Johansen and Kibenich 1992), was used 
as template in PCR amplifications. In the first cloning step, the α-
acetolactate synthase gene (als) was amplified from L. lactis chromosome 
using primer pair als-FW and als-RE and cloned into plasmid pEKEx2. In 
the second step, genes encoding the α-acetolactate decarboxylase (aldB) 
and 2,3-butanediol dehydrogenase (butA) of L. lactis were amplified using 
primers aldB-FW, aldB-RE, butA-FW and butA-RE, ligated, and 
subsequently inserted into pEKEx2-als, giving pEKEx2-als,aldB,butA. 
Alternatively, gene butA fused with 185 bp region upstream of tuf gene 
(Ptuf) was synthesized by NZYTech (Lisbon, Portugal). Plasmid pUC57 
containing Ptuf-butA fusion was amplified in E. coli DH5α and restricted 
using BamHI and KpnI. The Ptuf-butA fragment was purified from agarose 
gel and ligated to aldB, after which joint DNA fragment was inserted into 
pEKEx2-als, yielding pEKEx2-als,aldB,PtufbutA.
 Plasmids were obtained 
and maintained in E. coli DH5α. After verification of the correctness of the 
insert by sequencing (GATC, Konstanz, Germany), plasmids were isolated 
from E. coli and electroporated into competent C. glutamicum cells using 
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the procedure described in (Liebl et al. 1989) and (Van der Rest et al. 
1999). Then, plasmids were isolated from C. glutamicum in the following 
way: 5 mL of overnight culture was centrifuged for 1 min at 16,100 × g and 
room temperature, to be re-suspended in 0.2 mL of solution A (50 mM 
glucose, 25 mM Tris-HCl, 10 mM EDTA, pH 8.0, freshly prepared). One μL 
of RNase A (10 mg·mL-1), and 15 mg·mL-1 (final concentration) lysozyme 
were added, and the lysis was performed for 1.5 h at 55C. After the initial 
lysis step, isolation was continued with comercially available kits according 
to supplier instructions (Qiagen MiniPrep or Illustra Plasmid Mini 
Preparation Kit, GE Healthcare). Isolated plasmids were used as templates 
for PCR amplification of the inserted genes. Amplified region sequence 
was confirmed to be correct by sequencing (GATC, Konstanz, Germany).  
 
Table 3.2. Primers used in this study  
Primer 
name  




















butA-RE  CGGGGTACCTTAATGAAATTGCATTCACCATC KpnI 
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Preparation of cell suspensions 
Cells grown as described above were harvested 14 h after inoculation, 
centrifuged (3,214 × g, 10 min, 4C), and washed once with 0.9 % (wt/vol) 
NaCl. The resulting cell suspension was centrifuged (3,214 × g, 10 min, 
4C) and the pellet was re-suspended in a minimal CGXII basal solution at 
pH 7.0, that contained per liter: 1 g KH2PO4, 1 g K2HPO4, 21 g MOPS (3-
[N-morpholino] propanesulfonic acid), 0.25 g MgSO4·7 H2O, 10 mg 
CaCl2·2 H2O (Eikmanns et al. 1991b). Nitrogen sources (urea and 
(NH4)2SO4) were omitted, in order to minimize the biosynthesis of amino 
acids during the production phase. 
Two-stage fermentations processes 
C. glutamicum strains were grown and cell suspensions prepared as 
described above. For the second fermentation stage (production phase), 
50 mL of cell suspension (OD600 of 15 - 20) were placed in an 80-mL 
fermenter (mini-fermenter), kept at 30C with a water bath and mixed with 
a magnetic stirrer at 200 rpm. Aeration was performed by sparging sterile 
air at a rate of 5, 10 or 20 mL·min-1. The oxygen electrode 
(InPro® 6100/320/T/N, Mettler Toledo), was used to attempt monitoring 
dissolved oxygen during the production stage. The electrode 
was calibrated to 0% and 100% after equilibration with pure argon and air, 
respectively.  Glucose was provided to a final concentration of 2% (wt/vol) 
and samples were collected over a period of 30 h. For the first round 
evaluation of the performance of the several constructs, 25 mL of 
concentrated cell suspension (OD600 of between 20 and 30) were placed in 
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50 mL closed falcon tubes kept at 30C in a rotary shaker (180 rpm). 
Glucose was provided to a final concentration of 2% (wt/vol) and the 
fermentation was allowed to proceed for 48 h. Samples (1 mL) were 
centrifuged for 5 minutes at room temperature and 16,100 × g; 
supernatants were then separated and kept at -20C until further analysis. 
End-products of metabolism were quantified by using 1H-NMR.  
Enzymatic activities 
C. glutamicum strains were grown as described above and cell 
suspensions prepared in 50 mM PIPES at pH 7.0. Crude cell extracts were 
prepared by using glass beads (<106 μm) in a MiniBeadbeater-8 cell 
disrupter (Biospec Products) in 3 cycles of 1 min, with breaks of 3 min 
during which the extracts were kept on ice. After disruption, extracts were 
centrifuged at 16,100 × g for 20 min at 4°C. All enzyme activities were 
assayed at 30°C in a Beckman Coulter DU 800 spectrophotometer in 50 
mM PIPES (pH 7.0). One unit of enzyme activity corresponds to 1 μmol of 
substrate/product converted/formed per minute under the experimental 
conditions applied. The protein concentration was determined using Pierce 
BCA Protein Assay Kit (Thermo Scientific). Specific activity was expressed 
as units (μmol min-1) per milligram of protein [U · (mg of protein)-1]. α-
Acetolactate synthase activity was determined as described by 
(Hugenholtz and Starrenburg 1992). The reaction was stopped by the 
addition of 100 μL of 6N H2SO4, and acetoin was quantified colorimetrically 
at 525 nm as described by Westerfeld (Westerfeld 1945). Butanediol 
dehydrogenases were assayed as described by Stormer (Stormer 1975), 
Production of 2,3-butanediol with C. glutamicum 
 98 
in a modified reaction mixture containing 50 mM buffer, 0.2 mM NADH and 
2.5 mM racemic acetoin. 
NMR spectroscopy  
All 1H-NMR spectra were acquired on a Bruker AVANCE II+ 400 MHz 
spectrometer (Bruker BioSpin GmbH) at 27º C, using a BBO-F probe head. 
Pre-saturation of the residual water signal was applied. Acquisition 
parameters: flip angle of 90º; 32K acquisition data points; repetition delay 
of 31.5 s. Formate was used as a concentration standard.  
Chemicals and reagents 
For the molecular biology purposes, RNase A and Pwo polymerase were 
purchased from Roche Life Science; lysozyme (Fluka) was purchased from 
Sigma-Aldrich, while all other enzymes were from New England Biolabs. 
Acetoin used in enzymatic assays was from Sigma-Aldrich. All other 
chemicals were commercially available reagent-grade (Sigma-Aldrich or 
Merck Sharp & Dohme). 
Results 
Design of a synthetic pathway for 2,3-BD and functional analysis  
The first step in engineering C. glutamicum for the synthesis of 2,3-BD was 
to construct an artificial operon comprising als, aldB, and butA that form 
the 2,3-BD biosynthetic pathway of L. lactis. The three genes were cloned 
into pEKEx2 expression vector under control of the isopropyl β-D-1-
thiogalactopyranoside (IPTG)-inducible Ptac promoter (Fig. 3.2), and 
transformed into the three selected background strains C. glutamicum 
ΔldhA, ΔaceEΔpqoΔldhA and ΔaceEΔpqoΔldhAΔmdh (Table 3.1).  
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Figure 3.2. Plasmid maps of pEKEx2-als,aldB,butA and of pEKEx2-als,aldB, 
PtufbutA.
  Abbreviations: mcs, multiple cloning site; rbs, ribosomal binding site; 
term, transcriptional terminator; als, acetolactate synthase; aldB, acetolactate 
decarboxylase; butA, butanediol dehydrogenase; aph, aminoglycoside resistance 
determinant; Orf-1, open reading frame 1; lacI – Lac repressor.  
 
To evaluate whether the target enzymes were functionally produced, 
specific activities were determined in cell extracts (Table 3.3). Induced 
expression of als and aldB genes in C. glutamicum ΔldhA(pEKEx2-
als,aldB,butA) led to 61- and 15-fold increase in ALS/ALDC activity when 
compared to control C. glutamicum Δldh(pEKEx2) grown on glucose and 
acetate, respectively; this corresponded to an increase from 0.024 ± 0.003 
to 1.47 ± 0.42 U·(mg of protein)-1 in glucose grown cells, and from 0.037 ± 
0.002 to 0.54 ± 0.09 U·(mg of protein)-1 in acetate grown cells. For C. 





































Production of 2,3-butanediol with C. glutamicum 
 100 
activity was increased 17-fold (0.034 ± 0.001 compared to 0.58 ± 0.12 
U·(mg of protein)-1), and for ΔaceEΔpqoΔldhAΔmdh(pEKEx2-
als,aldB,butA) the activity was 8-fold higher (0.055 ± 0.019 compared to 
0.43 ± 0.04 U·(mg of protein)-1). The activity of BDH in strain 
ΔldhA(pEKEx2-als,aldB,butA) doubled in glucose grown cells, and, 
unexpectedly, decreased 2-fold (from 0.2 to 0.1 U·(mg of protein)-1) in 
acetate-grown cells, when compared to the control strain cultivated under 
the same conditions. Acetate grown C. glutamicum 
ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,butA) and 
ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,butA) showed 3- and 8-fold 
increase in BDH activity, compared to the control strain. Maximal specific 
activity values of 0.97 ± 0.19 U·(mg of protein)-1) were obtained. In an 
attempt to increase BDH activity further we cloned the constitutive Ptuf 
promoter (Litsanov et al. 2012a, Fukui et al. 2011) in front of butA, yielding 
pEKEx2-alsaldBPtufbutA (Fig. 3.2). However, this increased BDH activity 
only slightly (Table 3.3). 
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Table 3.3. Overexpression and specific activities of enzymes for the synthesis of 
2,3-butanediol as determined in crude cell extracts. Cells were grown for 14 h in 
2×TY medium supplemented with acetate, unless stated otherwise. Values shown 

























0.02  0.00 0.66  0.03 - - 
ΔldhA 
(pEKEx2-als,aldB,butA)* 
1.47  0.42 1.18  0.26 61 2 
ΔldhA 
(pEKEx2) 
0.04  0.00 0.20  0.03 - - 
ΔldhA 
(pEKEx2-als,aldB,butA) 
0.54  0.09 0.10  0.03 15 - 
     
ΔaceEΔpqoΔldhA 
(pEKEx2) 
0.03  0.01 0.24  0.04 - - 
ΔaceEΔpqoΔldhA 
(pEKEx2-als,aldB,butA) 
0.58  0.12 0.67  0.01 17 3 
ΔaceEΔpqoΔldhA 
(pEKEx2-als,aldB,PtufbutA) 
1.42  0.24 0.53  0.17 31 2 
     
ΔaceEΔpqoΔldhAΔmdh 
(pEKEx2) 
0.06  0.02 0.11  0.04 - - 
ΔaceEΔpqoΔldhAΔmdh 
(pEKEx2-als,aldB,butA) 
0.43  0.04 0.97  0.19 8 8 
ΔaceEΔpqoΔldhAΔmdh 
(pEKEx2-als,aldB,PtufbutA) 
0.47  0.14 1.21  0.01 9 10 
Abbreviations: *, cells grown on glucose; ALS, α-acetolactate synthase; ALDC, α-
acetolactate decarboxylase; BDH, butanediol dehydrogenase. 
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Growth profiles of engineered strains 
First, we characterized growth and biomass formation of the engineered 
strains in shake-flasks in 2×TY medium containing glucose or acetate (Fig. 
3.3 and Table 3.4). The ΔaceE strains (PDHC-deficient) are unable to 
grow on glucose as sole carbon source, therefore, they were grown 
aerobically on acetate alone. Strains C. glutamicum Δldh(pEKEx2) 
and ΔldhA(pEKEx2-als,aldB,butA) were grown on glucose and also on 
acetate for comparison purposes. While the control strain C. 
glutamicum Δldh(pEKEx2) had similar specific growth rates when 
grown on glucose or acetate (0.52  0.02 and 0.51  0.05 h-1, 
respectively), ΔldhA(pEKEx2-als,aldB,butA) displayed a lower growth 
rate on acetate (0.46  0.01 versus 0.58  0.01 h-1). The pH profiles 
were also dependent on the substrate used for growth as glucose-
grown cells presented a sharper decrease in pH at the onset of 
stationary phase (Fig. 3.3). The biomass formation was fairly similar 
for C. glutamicum Δldh(pEKEx2) and producer strain ΔldhA(pEKEx2-
als,aldB,butA) regardless of the substrate used for growth (maximal 
OD600 values in the range 21 to 24).  
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Figure 3.3. Growth curves and pH profiles of the 2,3-BD producer and parental 
strains, grown in 2×TY medium for 30 h at 160 rpm and 30 °C. The pH profiles 
for each set of producer and control strains are identical. The ΔaceE strains 
were unable to grow on glucose as sole carbon source, thus they were grown 
only on acetate. For comparison, C. glutamicum Δldh(pEKEx2) and 
ΔldhA(pEKEx2-als,aldB,butA) were grown on glucose (A) or acetate (B). 
Remaining panels show C. glutamicum ΔaceEΔpqoΔldhA derived strains (C) and 
C. glutamicum ΔaceEΔpqoΔldhAΔmdh derived strains (D) grown on acetate. 
Legend: blue, pH; green, control strains; orange, strains with pEKEx2-
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The C. glutamicum ΔaceEΔpqoΔldhA-derived producers showed growth 
and pH profiles identical to those of the control strain 
ΔaceEΔpqoΔldhA(pEKEx2). The specific growth rate of C. glutamicum 
ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,butA) was higher as compared 
to the control strain ΔaceEΔpqoΔldhAΔmdh(pEKEx2) (0.55  0.04 vs 0.46 
 0.01 h-1); on the other hand, the growth rate of 
ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,PtufbutA) was comparable to that 
of the control strain (0.44  0.01 vs 0.46  0.01 h-1). For all 
ΔaceEΔpqoΔldhA- and ΔaceEΔpqoΔldhAΔmdh-derived strains, the initial 
and final pH values were 7.1 and 9.2, respectively, and maximal OD600 
values were in the range 15 to 19. In summary, cell growth was not 
impaired by the expression of heterologous genes (Table 3.4), reflecting 
the robustness of these platform strains.  
Characterization of 2,3-BD production under low-oxygen conditions 
The production of reduced compounds, such as 2,3-BD, is expected to be 
maximal under oxygen limiting conditions. Having this in mind, we devised 
a strategy for the production of 2,3-BD in which aerobically grown cells are 
collected, washed, re-suspended in minimal medium and provided with 
glucose under oxygen limiting conditions. Oxygen concentration was not 
measured, but the observed formation of organic acids indicated restricted 
oxygen availability (Fig. 3.4). 
In a first attempt to reduce pyruvate consuming reactions leading to end-
products other than 2,3-BD, we used as background C. glutamicum ΔldhA.   
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Table 3.4. Growth parameters of producer strains as compared to the control 
strains. Cultures were grown in 2×TY medium supplemented with 1% (wt/vol) 
potassium acetate, unless stated otherwise. Values shown are means  SD of 
three independent experiments 







ΔldhA (pEKEx2)*  0.52 ± 0.02  22.0 ± 0.3  
ΔldhA (pEKEx2-als,aldB,butA)*  0.58 ± 0.01  20.7 ± 0.8  
ΔldhA (pEKEx2)  0.51 ± 0.05  20.8 ±1.5  
ΔldhA (pEKEx2-als,aldB,butA)  0.46 ± 0.01  23.7 ± 2.7  
   
ΔaceEΔpqoΔldhA (pEKEx2)  0.46 ± 0.04  15.0 ± 0.2  
ΔaceEΔpqoΔldhA (pEKEx2-




butA)  0.46 ± 0.01  18.7 ± 0.5  
   
ΔaceEΔpqoΔldhAΔmdh (pEKEx2)  0.46 ± 0.01  19.4 ± 1.9  
ΔaceEΔpqoΔldhAΔmdh (pEKEx2-




butA) 0.44 ± 0.01  17.5 ± 0.8  
*Strain was grown on 0.5% (wt/vol) glucose. All other strains are grown on 
acetate. For experimental details see Materials and methods.  
 
During the production phase, glucose-grown cells produced 2,3-BD  
with a yield of 0.05 mol per mol of glucose (Tables 3.5 and S3.1); the yield 
was even lower for cells grown on acetate (0.02 mol per mol of glucose). 
The glucose consumption rate (GCR) was low, i.e., 2.5  0.4 
nmolmin-1mg CDW-1. For comparison purposes, the GCR of the wild type 
strain (grown on acetate) was determined in a similar experimental set-up 
to give 24.6  0.5 nmolmin-1mg CDW-1. Actually, this value agrees 
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perfectly with 25 nmolmin-1mg CDW-1, the GCR reported earlier for wild 
type C. glutamicum with a different experimental set-up (Chapter 2). 
Importantly, the introduction of the lactoccocal pathway had a 
positive effect on GCR in glucose grown C. glutamicum 
ΔldhA(pEKEx2-als,aldB,butA) (4.4  0.4 nmolmin-1mg CDW-1 compared to 
2.5  0.4 nmolmin-1mg CDW-1 in the control strain), and no effect on 
acetate grown cells (3.4  0.4 compared to 3.0  0.2 nmolmin-1mg CDW-1 
in the control strain). 2,3-BD produced by the engineered strain 
ΔldhA(pEKEx2-als,aldB,butA) grown on glucose and acetate was, 
respectively, 34 ± 3 mM (yield of 0.34  0.04 mol per mol glucose, a 7-fold 
increase compared to the control strain), and 19.5 ± 0.7 mM (0.27  0.06 
mol per mol glucose;  11-fold increase). Other major products of 
metabolism were acetate, succinate, and glycerol at respective 
concentrations of 29 ± 2, 22 ± 2, 10 ± 1 mM in cells grown on acetate, and 
25 ± 6, 20 ± 1, 19 ± 6 mM in glucose grown cells  (Fig. 3.4, Table S3.1).  
The inactivation of the PDHC and PQO in the producer strain 
ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,butA) had a drastic effect on 2,3-BD 
yield that increased from 0.27  0.06 in ΔldhA(pEKEx2-als,aldB,butA), to 
0.66  0.05 mol per mol, reflecting primarily the reduction of acetate 
formation (from 29 mM to below 0.5 mM). Moreover, the GCR increased 
about 1.6-fold and there was a 7-fold increase in overall productivity. 
Glycerol and succinate were the major side-products (12  1 and 8  1 
mM, respectively) (Fig. 3.4).  
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Table 3.5. Glucose (Glc) consumption rate (GCR), molar yield and productivity of 
2,3-butanediol (2,3-BD), and carbon recovery (CR) by the control and engineered 
C. glutamicum strains. In the first phase, cells were grown aerobically on 1% 
(wt/vol) potassium acetate except for the strains indicated with an asterisk for 
which 0.5% (wt/vol) glucose was used instead. Second phase fermentations were 
carried out for 48 h, using 25 mL of cell suspension in closed 50-mL falcon flasks 
with glucose as substrate. The cardinal symbol indicates that optically active 2,3-
BD was produced; remaining strains produced meso-form of 2,3-BD. Values are 
averages of at least three independent experiments. A single NMR spectrum was 





















ΔldhA (pEKEx2)* 2.5  0.4 0.05  0.00
#
 0.12  0.01 81  3 
ΔldhA (pEKEx2- 
als,aldB,butA)* 
4.4  0.4 0.34  0.04 1.28  0.09 79  9 
ΔldhA(pEKEx2) 3.0  0.2 0.02  0.01
#
 0.06  0.03 77  1 
ΔldhA (pEKEx2- 
als,aldB,butA) 
3.4  0.4 0.27  0.06 0.53  0.13 82  3 
     
ΔaceEΔpqoΔldhA(pEKEx2)  1.6  0.3 0.22  0.01
#
 0.30  0.00 87  1 
ΔaceEΔpqoΔldhA 
(pEKEx2-als,aldB,butA) 
5.4  0.7 0.66  0.05 3.55  0.58 84  7 
ΔaceEΔpqoΔldhA 
(pEKEx2-als,aldB,PtufbutA) 
6.1  0.1 0.61  0.06 3.13  0.22 87  3 
     
ΔaceEΔpqoΔldhAΔmdh 
(pEKEx2) 
1.6  0.3 0.34  0.05
#
 0.53  0.00 91  6 
ΔaceEΔpqoΔldhAΔmdh 
(pEKEx2-als,aldB,butA) 
6.0  0.3 0.64  0.09 4.34  0.16 90  4 
ΔaceEΔpqoΔldhAΔmdh 
(pEKEx2-als,aldB,PtufbutA) 
6.5  0.5 0.64  0.10 4.25  0.41 91  7 
 
 
Further engineering aimed at succinate reduction (MDH inactivation by 
deletion of the cg2613-encoded activity), left both yield and GCR 
essentially unchanged while productivity was slightly improved in C. 
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glutamicum ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,butA) (4.3 ± 0.2 
compared to 3.6 ± 0.6 nmolmin-1mg CDW-1). Strains in which the 
lactococcal butA gene was placed under the control of Ptuf promoter 
showed similar behavior to those which had this gene under Ptac control in 
terms of all production parameters (Table 3.5, Fig. 3.4). In summary, C. 
glutamicum ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,butA), 
ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,butA) and 
ΔaceEΔpqoΔldhAΔmdh (pEKEx2-als,aldB,PtufbutA) showed the highest 
yield of about 0.65 mol 2,3-BD per mol of glucose with the latter two 
strains exhibiting the highest productivities of about 4.3 nmol 2,3-BD 
per min and mg CDW (Table 3.5). All control strains produced optically 
active 2,3-BD, while only the meso-form was found as end-product of the 
producer strains (Fig. 3.4; Table S3.1).   
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Figure 3.4. End-products of glucose metabolism in 2,3-BD producers and control 
strains under oxygen limiting conditions: 25 mL of cell suspension in stoppered 
50-mL flasks incubated with 2% (wt/vol) glucose for 48 h at 180 rpm and 30⁰C. 
Control strains produced optically active 2,3-BD (most likely (2S,3S)-2,3-BD), 
while the engineered strains produced meso-2,3-BD. For simplicity, a single color 
is used to represent any form of 2,3-BD. Lactate dehydrogenase negative strains 
(A) grown on glucose (left) and acetate (right); triple deletion mutants C. 
glutamicum ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,butA), C. glutamicum 
ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,PtufbutA) (B) and quadruple deletion mutants 
C. glutamicum ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,butA) and C. 
glutamicum ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,PtufbutA) (C). Legend: ■, 
2,3-BD; ■, acetoin; ■, acetolactate; ■, succinate; ■, acetate; ■, pyruvate; ■, α-
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It is important to note that pH was not controlled during the production 
phase. All fermentations started at pH 7.0, but the final pH value varied as 
mutants exhibited different acidifying properties due to their differential 
ability to produce organic acids. At the end of 48 h-fermentation, pH was 
between 5.1 and 5.3 for ldhA-negative strains. As expected, reduction of 
succinate and acetate, and accumulation of neutral compounds led to 
higher final pH values: 6.6, 6.4, 5.7 and 6.6 for C. glutamicum 
ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,butA), ΔaceEΔpqoΔldhAΔmdh 
(pEKEx2-als,aldB,butA), ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,PtufbutA) 
and ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,PtufbutA), respectively. 
Earlier work has shown that a decrease in pH results in considerably lower 
GCR in resting cells of wild-type C. glutamicum (Chapter 2).  
Optimization of 2,3-BD production by manipulation of oxygen supply  
Engineered strains of C. glutamicum converted up to two thirds of glucose 
into 2,3-BD (Table 3.5), however the consumption rate of glucose was not 
satisfactory when compared to other C. glutamicum strains, such as those 
manipulated for the production of isobutanol and succinate (Blombach et 
al. 2011, Litsanov et al. 2012). The accumulation of reduced compounds, 
such as succinate and glycerol, hinted that the low GCR in the engineered 
strains could result from a high NADH:NAD+ ratio, as previously proposed 
(Tsuge et al. 2015). Oxygen can be an alternative acceptor of electrons 
from NADH, via the electron transfer chain, hence we performed 
fermentations under different controlled oxygen supply conditions 
(sparging rates of 5, 10 or 20 mL air min-1) in the mini-fermenter as 
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described in Methods, to determine the conditions that would support 
maximal yield, GCR and productivity (Tables 3.6 and S3.2, Fig. 3.5). 
Strains C. glutamicum ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,PtufbutA) and 
ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,PtufbutA) were selected for 
this optimization step as they showed particularly high ALS/ALDC 
and BDH activity, respectively.  
 
Table 3.6. Glucose (Glc) consumption rate (GCR), molar yield and productivity of 
2,3-butanediol (2,3-BD), and carbon recovery (CR) achieved with C. glutamicum 
ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,PtufbutA) and C. glutamicum 
ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,PtufbutA) strains under different 
aeration conditions. Cells were grown aerobically on 1% (wt/vol) potassium 
acetate. The second, production phase was performed in a 80-mL fermenter at 
30C for 30 h with glucose as substrate. The cell suspension was sparged with air 
at the flow rates indicated. Meso-2,3-BD was by far the major stereoisomer. At the 
optimal aeration rate (10 mLmin-1), there was 95% of the meso-form. Values are 
averages of three independent experiments; a single NMR spectrum was 


























5 7.2  0.6 0.44  0.04 3.4  0.3 89  6 
10 15.8  1.7 0.57  0.03 8.1  0.4 91  4 
20 14.7  1.1 0.36  0.06 5.0  0.9 83  10 




5 11.1  1.0 0.52  0.03 5.5  0.7 85  2 
10 21.1  0.8 0.66  0.01 10.9  1.8 90  8 
20 22.8  1.6 0.46  0.02 8.0  0.7 78  7 
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Cell suspensions of C. glutamicum ΔaceEΔpqoΔldhA(pEKEx2-
als,aldB,PtufbutA) and ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,PtufbutA)
 
under constant air flow of 5 mL·min-1 showed an increased GCR (7.2  0.6 
and 11.1  1.0 nmolmin-1mg CDW-1 in mini-fermenter for the two 
respective strains (Table 3.6), compared to 6.1  0.1 and 6.5  0.5 
nmolmin-1mg CDW-1 in flasks (Table 3.5)); the productivity in mini-
fermenter was 3.4  0.3 and 5.5  0.7 nmolmin-1mg CDW-1 compared to 
3.1  0.2 and 4.3  0.4  nmolmin-1mg CDW-1 in flasks, but the yield was 
higher for fermentations in closed flasks (Tables 3.5 and 3.6). Upon 
doubling of the air flow to 10 mL·min-1, GCR and the productivity of C. 
glutamicum ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,PtufbutA) and 
ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,PtufbutA) increased two-fold; 
both strains produced 2,3-BD at highest yields (0.57 ± 0.03 and 0.66 ± 
0.01 mol 2,3-BD per mol glucose). Interestingly, further increase in the flow 
rate to 20 mL·min-1 resulted in significantly lower yields and productivities 
(Table 3.6).  
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Figure 3.5. Effect of aeration rate on end-products of glucose metabolism in the 
triple deletion mutant C. glutamicum ΔaceEΔpqoΔldhA(pEKEx2-
als,aldB,PtufbutA)
 (A) and the quadruple deletion mutant 
ΔaceEΔpqoΔldhAΔmdhA (pEKEx2-als,aldB,PtufbutA) (B).  Fifty mL of cell 
suspension in 80-mL fermenter incubated with 2% (wt/vol) glucose for 30 h at 
30⁰C. The air flow was 5, 10 or 20 mL/min. Legend: ■, 2,3-BD; ■, acetoin; ■, 
acetolactate; ■, succinate; ■, acetate; ■, pyruvate; ■, α-ketoisovalerate; ■, α-
ketoglutarate; ■, DHA; ■, glycerol; ■, ethanol; ■, L-alanine. 
 
Ethanol was produced by both strains in experiments using 5 mL·min-1 air, 
and glycerol was absent only in the experiment using 20 mL·min-1 air with 
the ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,PtufbutA) strain. Other side 
products in these experiments were acetoin, succinate, dihydroxyacetone 
(DHA), pyruvate, acetate, L-alanine, α-acetolactate, α-ketoglutarate, and 
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showed a clear dependence on oxygen availability, increasing about 3- 
and 5-fold when the air flow was increased from 5 to 10 mL·min-1 and from 
5 to 20 mL·min-1, respectively. Dissolved oxygen was not controlled, but 
we confirmed that the oxygen concentration was below the detection limit 
of the oxygen electrode even at the highest aeration rate. The time course 
for glucose consumption and end-product formation is illustrated in Figure 
3.6 for the best producer strain. In summary, under an air flow of 10 
mL·min-1 C. glutamicum ΔaceEΔpqoΔldhAΔmdh(pEKEx2-
als,aldB,PtufbutA) produced 70 ± 8 mM 2,3-BD with a yield of 0.66 mol 
per mol of glucose and productivity of 11 nmolmin-1mg CDW-1, which 
represent a notable improvement (Fig. 3.7). 
  




Figure 3.6. Fermentation profile of the best 2,3-BD producer strain C. glutamicum 
aceEpqoldhAmdh(pEKEx2-als,aldB,PtufbutA) as a function of time.  Fifty mL 
of cell suspension in 80-mL fermenter incubated with 2% (wt/vol) glucose for 30 h 
at 30⁰C. The air flow was 10 mL·min-1. Error bars are shown as standard deviation 
of three independent replicates. Legend: ●, biomass as OD600; ○, pH value; ▲, 




The wild-type C. glutamicum produces vestigial amounts of 2,3-BD 
(Dickschat et al. 2010). Accordingly, low levels of 2,3-BD were also found 
in the end-products of glucose metabolism by the control strain C. 
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glutamicum was the favored candidate for 2,3-BD production given its high 
performance as an industrial organism and its GRAS status. Moreover, we 
verified that 2,3-BD has low toxicity to C. glutamicum as cell growth was 
not affected by 2% 2,3-BD (data not shown). 2,3-BD producing bacteria, 
such as Klebsiella spp., synthesize this diol from pyruvate in a sequence of 
three reactions catalyzed by α-acetolactate synthase, α-acetolactate 
decarboxylase and butanediol dehydrogenase. In this work, we 
constructed an artificial operon with the three relevant genes of L. lactis 
and introduced this heterologous pathway into C. glutamicum (Fig. 3.2).  
C. glutamicum is able to synthesize α-acetolactate from pyruvate via the 
action of the anabolic enzyme, AHAS; however, this enzyme is highly 
inhibited by the branched chain amino acids derived from α-acetolactate 
(Elisáková et al. 2005). Therefore, our engineering strategy endowed the 
host strain with a heterologous ALS, i.e., the catabolic enzyme from L. 
lactis, which is not susceptible to amino acid inhibition (Snoep et al. 1992). 
The enhanced activity of ALS should also be beneficial for directing the flux 
towards 2,3-BD.  
The second step in the biosynthetic pathway, decarboxylation of α-
acetolactate into (R)-acetoin, is carried out by α-acetolactate 
decarboxylase. A homologue of this enzyme is not predicted in the 
genome of C. glutamicum, and indeed the ALS/ALDC activity was low in 
cell extracts of all control strains (Table 3.3). The third step, reduction of 
acetoin, is performed by BDH, and a relatively high activity (0.2-0.3 
U·(mg protein)-1) was detected in the control strains (Table 3.3). 
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Actually, this is not surprising given that C. glutamicum possesses 
(2S,3S)-BDH, which is claimed to be absolutely stereospecific for 
(S)-acetoin (Takusagawa et al. 2001). Like all known ALDCs, the 
enzyme from L. lactis produces exclusively (R)-acetoin (Marlow et al. 
2013), thus a BDH with suitable stereospecific properties needed to 
be included.  
1H-NMR can distinguish the optically active from the meso-form of 
2,3-BD (Fig. 4.5). Control strains produced only optically active 2,3-
BD (Table 3.5), most likely derived from diacetyl formed via 
spontaneous decarboxylation of α-acetolactate in the presence of 
oxygen. Diacetyl is then converted to 2,3-(2S,3S)-BD in two 
reduction reactions catalyzed by the endogenous BDH (Fig. 3.1). In 
contrast to the control strains, meso-2,3-BD was by far the main 
form synthesized by the producer strains, the optically act ive form 
(around 5% of total 2,3-BD), being detected only in fermentations 
performed at the highest aeration rates, in agreement with the 
oxygen dependence of the spontaneous decarboxylation of α -
acetolactate. Given that C. glutamicum lacks α-acetolactate 
decarboxylase, the presence of BDH in this bacterium is rather puzzling. 
Moreover, according to a recent study, C. glutamicum BDH is a 
promiscuous enzyme that besides acetoin recognizes DHA as substrate, 
though with a low affinity (30 mM or higher DHA concentration needed for 
activity) (Jojima et al. 2015). Further work should be directed to clarify the 
physiological role of BDH in C. glutamicum.  
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The L. lactis genes (als, aldB, butA) were functionally expressed in the 
three host strains. The combined activity ALS/ALDC was in the range 0.4 - 
1.4 U·(mg of protein)-1 for producer strains grown on acetate, 
corresponding to overexpression levels of 8 to 31-fold. Opportunely, the 
heterologous activities are comparable to those of glycolytic enzymes 
measured in crude extracts of C. glutamicum (Yamamoto et al. 2012). 
Overexpression of butA (encoding BDH activity) was similarly successful, 
yielding final BDH activity up to 1.2 U·(mg of protein)-1, which confirms 
the suitability of using the lactococcal genes for 2,3-BD production in 
C. glutamicum.        
The introduction of the assembled pathway in C. glutamicum ΔldhA 
enabled efficient redirection of the flux from pyruvate into 2,3-BD. 
However, the yield was relatively low (0.3 mol per mol glucose) and the 
two major products were succinate and acetate. Hence, the next 
engineering step had the objective of suppressing acetate pathways; this 
proved to be crucial in the by-product elimination strategy, as the 2,3-BD 
yield doubled in the ΔaceEΔpqoΔldhA-derived producer strains (Table 
3.5; Fig. 3.7). Additional inactivation of mdh did not improve the yield 
significantly, but there was a slight increase in productivity (Table 3.5).  
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Figure 3.7. A summary of the stepwise systematic approach used to engineering 
C. glutamicum for the production of 2,3-BD. The values reflect the impact of the 
several steps on yield and productivity. Blue boxes refer to strain optimization 
steps, while the yellow box indicates the process optimization step. Abbreviations: 
2,3-BD, 2,3-butanediol; Glc, glucose. 
 
Curiously, the strains derived from C. glutamicum 
ΔaceEΔpqoΔldhAΔmdh produced substantial amounts of succinate 
despite the intended suppression of succinate formation via the reductive 
branch of the TCA cycle. The genome of C. glutamicum includes mdhB 
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this second activity may contribute to succinate formation. On the other 
hand, involvement of the glyoxylate shunt and/or the oxidative branch of 
the TCA cycle cannot be ruled out.  
Glycerol was the second major side-product detected in C. glutamicum 
ΔaceEΔpqoΔldhA- and ΔaceEΔpqoΔldhAΔmdh-derived strains. Two 
pathways have been proposed for the synthesis of this polyol in C. 
glutamicum (Jojima et al. 2015, Lindner et al. 2012). Jojima and coworkers 
(Jojima et al. 2015) proposed that under oxygen-deprivation conditions 
glycerol is formed through reduction of DHA by the activity of endogenous 
BDH. On the other hand, DHA is a product of dihydroxyacetone-phosphate 
(DHAP) dephosphorylation via the respective phosphatase (Jojima et al. 
2012). Therefore, endogenous BDH and DHAP phosphatase are obvious 
targets for inactivation in further attempts to minimize side products. In this 
way, the electrons that are used for glycerol formation could be directed to 
acetoin reduction. The elimination of BDH would also be advantageous for 
the stereochemical purity of the desired end-product, since the small 
contamination with the optically active form would vanish, though at the 
expense of some carbon loss in the form of diacetyl.   
Under production conditions (oxygen limitation), it is anticipated that the 
BDH activity plays an important role in satisfying the redox balance via 
cofactor recycling. Further enhancement of BDH activity was attempted by 
including an additional promoter, but the BDH activity remained unchanged 
(Tables 3.3 and 3.5). However, a high BDH activity would not fix the redox 
imbalance since the synthesis of 2,3-BD results in net production of 1 mol 
Production of 2,3-butanediol with C. glutamicum 
 121 
NADH per mol of glucose consumed, and an additional sink for the 
reducing power becomes mandatory. Accordingly, providing controlled 
amounts of oxygen significantly improved GCR and 2,3-BD productivity. 
Manipulation of oxygen availability had no clear impact on 2,3-BD 
yield, but was crucial to increase GCR, which reached maximal 
values of approx. 21 nmol·min -1·mg CDW -1, comparable to those of C. 
glutamicum strains engineered for isobutanol production (Blombach et al. 
2011). This optimization step was more effective for C. glutamicum 
ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,PtufbutA) than for 
ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,PtufbutA) (Table 3.6). The reason 
could be related with the different BDH activity in these two strains (Table 
3.3). The stronger activity in C. glutamicum 
ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,PtufbutA) would pull the flux 
towards 2,3-BD more efficiently, with concomitant benefit on the rate of 
NAD+ regeneration, and hence on the GCR. Further increase in the air 
supply (from 10 to 20 mL·min-1) had a negative impact on 2,3-BD yield, 
which is in conformity with the equivalent accumulation of acetoin. This 
shift in end-products towards compounds less reduced than 2,3-BD 
indicates that the competition of oxygen as an electron sink became 
excessive.  
Thus far, Klebsiella spp., E. aerogenes and S. marcescens are the top 
producers of 2,3-BD (reviewed in (Ji et al. 2011)), however, the 
pathogenicity of these strains is regarded as a disadvantage and hinders 
large-scale production. The best non-pathogenic producer is Paenibacillus 
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polymyxa (72 g·L-1 and about 2 g·L-1·h-1), which grows in complex medium 
and has the drawback of producing exopolysaccharides that increase the 
viscosity of the fermentation broth (Häßler et al. 2012). Engineered S. 
cerevisiae has a 0.29 g·L-1·h-1 productivity and a yield of 0.70 mol 2,3-BD 
per mol glucose, while engineered E. coli produces 1.19 g·L-1·h-1 with a 
yield of 0.82 mol·mol-1 (Lian et al. 2014, Xu et al. 2014). The theoretical 
maximal yield of 2,3-BD from glucose is 1 mol per mol (0.5 g per g), and it 
was almost reached with pathogenic (Klebsiella spp.), and non-pathogenic 
producers (Bacillus spp.) (see General discussion). Compared with these 
non-native producers, the best C. glutamicum 2,3-BD producer, 
ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,PtufbutA), has a productivity close 
to the lower limit (10.9 nmol·min-1·mg CDW-1 corresponding to 0.21 g·L-1·h-
1), and a good yield (0.66 mol 2,3-BD per mol glucose). Our work used cell 
suspensions at a relatively low OD600 (20 - 30, corresponding to about 5 g 
CDW·L-1), but C. glutamicum can easily be grown to much higher cell 
density, allowing for higher 2,3-BD productivity during the production 
phase. For example, the utilization of a high density bioreactor (50 g 
CDW·L-1), as in (Okino et al. 2008a), would lead to one order of magnitude 
greater productivity (around 2 g·L-1·h-1), which compares well with that of 
the non-pathogenic natural producer (Häßler et al. 2012). Further increase 
in GCR of engineered C. glutamicum strains might be possible with a more 
fine manipulation of the oxygen supply conditions. 
While this manuscript was in a late stage of preparation, a study was 
published by Yang et al. (Yang et al. 2015) with the same purpose as ours, 
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albeit using different engineering strategies, host strains and production 
process. The 2,3-BD yield obtained was lower than that presented here 
(0.47 vs 0.66 mol per mol glucose), but a more extended comparison is 
hampered by the very different production processes used in the two 
studies.  
By using a systematic approach C. glutamicum was successfully 
engineered for the production of 2,3-BD (Fig. 3.7). Organic acid production 
was strongly reduced or eliminated and adequate activities of the 2,3-BD 
biosynthetic pathway were achieved. By means of genetic engineering and 
manipulation of production conditions, productivity and yield were 
optimized. Characterization of production provided insight into metabolic 
features of producer strains, and indicated directions for further rounds of 
strain improvement. Future work should aim at increasing 2,3-BD yield by 
eliminating the side-products DHA and glycerol. By using the full potential 
of C. glutamicum, improvement of productivity and titer is also feasible. 
Additionally, we propose that the optimized construct, under adequate 
aeration conditions, can be used as a GRAS-platform for production of 
acetoin, another valuable chemical widespread in the food industry as 
flavor enhancer. Alternatively, straightforward developments, e.g., 
omission of the butA gene in the artificial operon and disruption of 
endogenous BDH, are expected to yield efficient acetoin producers. 
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Table S3.1. End-products of glucose metabolism and residual glucose measured in supernatants of 
cell suspensions of parent and producer strains incubated under oxygen limiting conditions (closed 
falcon tubes) for 48 h. All concentrations are in mM. Results are shown as means ± SD of three 
independent experiments. 
*, cells grown on glucose; ** detected only in one experiment. Abbreviations: 2,3-BD, 2,3-butanediol; 
Acn, acetoin; DA, diacetyl; Succ, succinate; Ac, acetate; Pyr, pyruvate; α-KIV, α-ketoisovalerate; DHA, 
dihydroxyacetone; Gly, glycerol; Isobut, isobutanol; α-KG, α-ketoglutarate; Ala, L-alanine. 
Strain  Glc  2,3-BD  Acn  DA  Succ  Ac  Pyr  α-KIV  DHA  Gly  Eth  Isobut  Ala  
ΔldhA (pEKEx2)*  55±2  2.1±0.4  0.7±0.1  0.5±0.0  17.3±0.1  26±2  0.0  0.0  1.5±0.1  8±1  0.0  0.0  0.8±0.4  
ΔldhA(pEKEx2- 
als,aldB,butA)*  
14±5  34±3  0.6±0.1  0.0  20±1  25±6  0.0  0.0  8±3  19±6  1.6±0.2  0.0  1.2±0.1  
ΔldhA(pEKEx2)  39±11  3.0±0.3  1.1±0.3  0.0  20±1  35.5±0.3  0.0  0.0  1±0.1  16±2  0.0  0.0  1.4±0.2  
ΔldhA(pEKEx2- 
als,aldB,butA)  
44±11  20±1  0.4±0.1  0.0  22±2  29±2  0.0  0.0  3.4±0.6  10±1  1.0±0.3  0.0  1.3±0.3  
ΔaceEΔpqoΔldhA  
(pEKEx2) 










0.0  66±12  10±2  0.0  26.2±0.4  0.2±0.1  0.0  0.0  1.0±0.6  11.8±0.3  1.3±0.2  0.0  2.2±0.4  
ΔaceEΔpqoΔldhA 
Δmdh(pEKEx2)  










0.0  73±7  2.0±1.5  0,0  8.8±0.4  0.2±0.1  0.0  0.0  0.4±0.1  22±3  0.9±0.1  0.0  1.6±0.2  
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Table S3.2. End-products of glucose metabolism and residual glucose measured in supernatants of 
cell suspensions of producer strains incubated under different aeration conditions for 30 h. All 
concentrations are in mM, air is in mL·min-1. Results are shown as means ± SD of three independent 
experiments.  
Strain  Air Glc 
2,3-
BD  

























2.2±0.1  0.0  
2.0± 
0.3  





















20  0.0  36±7  25±6  0.0  1.0**  
0.5± 
0.2  
5±3  6±1  2.5±0.4  
0.2± 
0.2  































0.0  10±1  17±3  0.0  0.0  
1.1± 
0.3  



















0.0  0.0 
0.8± 
0.2  
*, cells grown on glucose; ** detected only in one experiment. Abbreviations: 2,3-BD, 2,3-butanediol; 
Acn, acetoin; DA, diacetyl; Succ, succinate; Ac, acetate; Pyr, pyruvate; α-KIV, α-ketoisovalerate; DHA, 
dihydroxyacetone; Gly, glycerol; Isobut, isobutanol; α-KG, α-ketoglutarate; Ala, L-alanine. 
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Stereospecificity of Corynebacterium glutamicum 
2,3-butanediol dehydrogenase and implications for 
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The stereochemistry of 2,3-butanediol (2,3-BD) synthesis in microbial 
fermentations is industrially relevant as it determines the range of 
applications of this bio-based product. In this work, Corynebacterium 
glutamicum was engineered for the production of 2,3-BD using the 
following strategy: the activities of α-acetolactate synthase and 
decarboxylase were introduced by heterologous expression of the 
Lactococcus lactis genes encoding these two activities; additionally, the 
endogenous 2,3-butanediol dehydrogenase (BDH) was overproduced. The 
engineered strain produced meso-2,3-BD, suggesting that (R)-acetoin is a 
substrate for the endogenous 2,3-BDH. This observation challenged the 
reported absolute stereospecificity of C. glutamicum BDH for (S)-acetoin 
(Takusagawa et al. 2001. Biosc. Biotechnol. Biochem. 65:1876-8). 
Therefore, we decided to investigate the stereospecific properties of this 
enzyme to explain the apparent contradiction. The BDH of C. glutamicum 
(encoded by gene butA) was produced in E. coli and purified. Activity 
assays monitored online by 1H-NMR using as substrates racemic acetoin 
and excess of NADH showed an initial, fast and complete reduction of (S)-
acetoin to (2S,3S)-2,3-BD, followed by a slow (~20-fold lower apparent 
rate) conversion of (R)-acetoin into meso-2,3-BD. In experiments with 
limitation of NADH the initial behavior was similar but the subsequent slow 
synthesis of meso-2,3-BD proceeded at the expense of the (2S,3S)-2,3-BD 
pool, until equilibrium between the two forms was reached. Kinetic 
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parameters (Vmax and Km) for R/S-acetoin, meso-2,3-BD and (2S,3S)-BD 
were determined by specrophotometric assays. Our results show that C. 
glutamicum BDH is not absolutely specific for (S)-acetoin though this is by 
far the preferred substrate.   
 
Introduction  
2,3-Butanediol (2,3-BD) is an important chemical building block with 
multiple applications (Celińska and Grajek 2009). This C4-diol is a product 
of the metabolism of bacteria, such as Klebsiella pneumoniae, Klebsiella 
oxytoca, Enterobacter aerogenes, Enterobacter cloacae, Paenibacillus 
polymyxa, Serratia marcescens, and Lactococcus lactis (Höhn-Bentz and 
Radler 1978, Chen et al. 2014, Park et al. 2013, Stormer 1975, Jung et al. 
2012, Wang et al. 2012, Häßler et al. 2012, Zhang et al. 2010, Gaspar et 
al. 2011). The 2,3-BD biosynthetic pathway consists of three steps, with α-
acetolactate and acetoin (or diacetyl), as intermediate metabolites (Fig. 
4.1). In the first step, two pyruvate molecules are joined by the α-
acetolactate synthase (ALS) into α-acetolactate, which is subsequently 
decarboxylated by the α-acetolactate decarboxylase (ALDC) to yield (R)-
acetoin. In the presence of oxygen, α-acetolactate can undergo 
spontaneous decarboxylation to form diacetyl, which is reduced to (R)- or 
(S)-acetoin by diacetyl reductases. Acetoin is finally reduced to 2,3-BD by 
2,3-butanediol dehydrogenase (BDH). Some BDHs, such as those of 
Corynebacterium glutamicum or L. lactis, recognize as substrates diacetyl 
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as well as acetoin, hence diacetyl can be reduced to acetoin via this 
activity (Crow 1990, Takusagawa et al. 2001).  
 
Figure 4.1. Scheme illustrating the pathways for the synthesis of 2,3-butanediol in 
bacteria. The strategy used in this work for engineering 2,3-BD synthesis in C. 
glutamicum is also depicted. Endogenous genes and enzymes are indicated in 
blue, while exogenous genes/enzymes are indicated in green. The first two genes 
of the 2,3-butanediol biosynthetic pathway were introduced from L. lactis; the third 
gene was butACg encoding the endogenous butanediol dehydrogenase of C. 
glutamicum. Abbreviations: ALS, α-acetolactate synthase (encoded by als); 
ALDC, α-acetolactate decarboxylase (encoded by aldB); BDH, butanediol 
dehydrogenase (encoded by butACg), AHAS, acetohydroxyacid synthase.  
 
The acetoin molecule contains a single chiral carbon and can exist as 
(R)-acetoin or (S)-acetoin). The molecule of 2,3-BD possesses two chiral 
centers resulting in three stereoisomers: (2R,3R)-2,3-BD (or D-2,3-
butanediol), (2S,3S)-2,3-BD (or L-2,3-butanediol), and the optically inactive 
(2R,3S)-2,3-BD also designated meso-2,3-BD (Fig. 4.2). In most cases, 
bacteria produce a mixture of 2,3-BD stereoisomers, which is generally 










































properties or to a single enzyme that can recognize both stereoforms of 
acetoin (see Chen et al. 2014). 
The stereochemical purity of 2,3-BD is not a primary concern if it is used as 
a bulk chemical; however, optically active forms are specially important 
reagents to provide chiral groups for synthesis of pharmaceuticals and 
other high value chemicals (Qi et al. 2014). In particular, (2R,3R)-
butanediol is used as an antifreeze agent and solvent due to its low 
freezing point (Gao et al. 2013). Therefore, the production of pure 
stereoisomers of 2,3-BD is highly desirable for many applications; to this 
end, it is important to study the stereospecific properties of BDHs and the 
respective catalytic mechanisms (Ji et al. 2011). The number of fully 
characterized BDHs is very small, probably because of the high cost and 
limited availability of the pure enantiomers of acetoin. To our knowledge, 
the stereospecificity of BDH with respect to (R)- and (S)-acetoin has been 
studied only with the enzymes of  C. glutamicum, K. pneumonia and K. 
terrigena (Takusagawa et al. 2001).     
 
 
Figure 4.2.  Skeletal formulas of the three stereoforms of 2,3-butanediol: optically 
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BDHs belong to the NAD(P)-dependent alcohol dehydrogenase family, 
generally divided into three large groups: i) Fe-dependent alcohol 
dehydrogenases, which belong to the smallest and the least studied group; 
ii) Zn-dependent alcohol dehydrogenases, also designated the medium-
chain dehydrogenase/reductase (MDR) family; and iii) the short-chain 
dehydrogenase/reductase (SDR) family that includes metal-ion-
independent enzymes.  
The BDHs of K. pneumoniae, S. marescens, and E. cloacae belong to the 
SDR family; these enzymes introduce the new hydroxyl group in the (S)-
configuration, thus reducing (R)-acetoin to meso-2,3-BD and (S)-acetoin to 
(2S,3S)-2,3-BD (Table 4.1). C. glutamicum (formerly Brevibacterium 
saccharolyticum C-1012), and Rhodococcus erythropolis possess BDHs 
that belong to the SDR family, with claimed absolute specificity for (S)-
acetoin and (2S,3S)-2,3-BD (Z Wang et al. 2014, Takusagawa et al. 2001). 
On the other hand, the BDHs of Bacillus subtilis, P. polymyxa and 
Saccharomyces cerevisiae belong to the MDR family, and generally 
catalyze the introduction of a hydroxyl group in the (R)-configuration; they 
use (R)-acetoin and (S)-acetoin to produce (2R,3R)-2,3-BD and meso-2,3-
BD, respectively (Table 4.1).  
K. pneumoniae, which is considered a model organism for studying the 
mechanism of 2,3-BD stereoisomer formation, produces a high proportion 
of meso-2,3-BD and minor amounts of (2S,3S)-2,3-BD (Chen et al. 2014). 
The BDH enzyme is designated meso-BDH when the meso-form of 2,3-BD 
is preponderant. However, under certain conditions, such as growth on 
Chapter 4 
 134 
glycerol, (2R,3R)-2,3-BD appears as end-product of K. pneumoniae 
fermentation: proportions of 90:9:1 (meso-2,3-BD : (2R,3R)-2,3-BD : 
(2S,3S)-2,3-BD) are typically found. Formation of the third stereoisomer is 
attributed to a secondary activity of glycerol dehydrogenase (Y. Wang et al. 
2014). Enzyme promiscuity with regard to substrate utilization was also 
observed in C. glutamicum BDH, which besides reducing acetoin to 2,3-BD 
can also reduce dihydroxyacetone (DHA) to glycerol (Jojima et al. 2015).  
 
Previously we engineered C. glutamicum to produce 2,3-BD by 
transforming it with the complete 2,3-BD-forming pathway from L. lactis 
(Chapter 3). As expected, under anaerobic conditions, the meso-form was 
the only stereoform of 2,3-BD that was detected. On the other hand, we 
were intrigued by the formation of meso-2,3-BD in a strain engineered to 
overexpress the endogenous C. glutamicum BDH along with ALS and 
ALDC from L. lactis (this work). This observation is difficult to explain, 
having in mind the stringent stereospecificity reported for C. glutamicum 
BDH (Takusagawa et al. 2001) and the information that (R)-acetoin is the 
sole product of L. lactis ALDC. Thus, we set out to investigate the origin of 
this paradox. The recombinant BDH of C. glutamicum was purified and 
assays were performed to determine the stereospecificity of the enzyme in 
relation to the substrates (R)-acetoin and (S)-acetoin. We showed that C. 
glutamicum BDH is not absolutely specific for (S)-acetoin, and uses (R)-
acetoin at a rate approx. 20-fold lower than that of the preferred substrate.   
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Abbreviations: SDR, short-chain dehydrogenase/reductase; MDR, medium-chain 
dehydrogenase/reductase; ND, not determined; the relative activities of pure 




Materials and Methods 
Bacterial strains and growth conditions 
Strains and plasmids used in this work are shown in Table 4.2. C. 
glutamicum cultures were grown aerobically in the 2×TY medium described 
by Sambrook and Green (Sambrook and Green 2012). Medium was 
supplemented either with 0.5% (wt/vol) potassium acetate or with 0.5% 
(wt/vol) potassium acetate plus 2% (wt/vol) glucose. Plasmid-harboring 
strains were selected using kanamycin (25 μg·mL-1); gene expression was 
induced by using 0.5 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG). 
Cultivations were performed in shake flasks (50 mL of culture in 500 mL 
flasks), at 30C with constant agitation at 160 rpm. Cultures were initiated 
by addition of a pre-culture to an optical density at 600 nm (OD600) of about 
0.3. Growth was monitored by measuring the OD600. Specific growth rates 
(μ) were calculated through linear regression of the plots of ln(OD600) 
versus time during the exponential growth phase. For growth 
characterization, samples (1 mL) were taken periodically and analyzed by 
High Performance Liquid Chromatography (HPLC). 
For the molecular biology procedures, Escherichia coli DH5α was grown in 
test tubes containing 5 mL of 2×TY medium at 37˚C and 180 rpm. Plasmid 
selection was achieved using 50 μg kanamycin·mL-1. For the protein 
production, Escherichia coli BL21(DE3) (200 mL) was grown in LB medium 
supplemented with 100 μg ampicillin·mL-1 at 37˚C and 180 rpm. Protein 
production was induced using 1 mM IPTG at an OD600 of 0.7; cells were 
collected 5 h after induction.  
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Construction of strains and plasmids 
All primers used are listed in Table 4.3. Chromosomal DNA of L. lactis 
MG1363 or C. glutamicum ATCC13032, isolated according to Johansen 
and Kibenich 1992 and as described in Chapter 3, respectively, were used 
as templates in PCR amplifications. To obtain the expression vector of the 
2,3-BD synthetic pathway, gene butACg (cg2958) was amplified from 
chromosomal DNA of C. glutamicum using primers RESTR-SOE7-FW 
and SOE7-RE and ligated to L. lactis aldB amplified by using aldB-FW and 
RESTR-SOE1-RE. Then, the aldB-butACg fragment was inserted in 
pEKEx2-als (Chapter 3), generating pEKEx2-als,aldB,butACg (Table 4.2). 
After confirmation of the correctness of the insert by sequencing (StabVida, 
Lisbon), plasmids were isolated from E. coli DH5α and electroporated into 
C. glutamicum strains using the procedure described in Liebl et al. 1989 
and van der Rest et al. 1999.  
To obtain the expression vector for recombinant protein production, gene 
butACg was amplified from the genomic DNA of C. glutamicum using primer 
pair butA-His-FW and butA-His-RE, and inserted into pET19b. Plasmid 






Table 4.2. Bacterial strains and plasmids used in this study.  
Strain Description Reference 
E. coli DH5α 




E. coli BL21(DE3) 







et al. 1958 
E. coli pET19b-butA
Cg
 E. coli BL21(DE3) carrying pET19b-butA
Cg
 This work 
C. glutamicum 
ΔaceEΔpqoΔldhA 
ATCC13032 with deletions of the genes 
encoding the E1 subunit of pyruvate 
dehydrogenase complex, the 
pyruvate:quinone oxidoreductase and the 
lactate dehydrogenase  
Wieschalka 
et al. 2012 
C. glutamicum 
ΔaceEΔpqoΔldhAΔmdh 
ATCC13032 with deletions of the genes 
encoding the E1 subunit of pyruvate 
dehydrogenase complex, pyruvate:quinone 






C. glutamicum ΔaceEΔpqoΔldhA harboring 





C. glutamicum ΔaceEΔpqoΔldhAΔmdh 




























, T7lac, N-terminal Histidine-tag with the 




 pET19b with cloned butA
Cg




from pUC4K; Ptrc, lacI, pUC18 mcs, 
induced by addition of IPTG 
Eikmanns 
et al. 1994 




pEKEx2-als with cloned aldB (L. lactis) and 
butA from C. glutamicum 
This work 
Abbreviations: als, α-acetolactate synthase gene; aldB, α-acetolactate 
decarboxylase gene; butACg, butanediol dehydrogenase gene of C. glutamicum; 
kanR, kanamycin resistance; ampR, amplicillin resistance; Ptrc, trc promoter; T7, 
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T7 RNA polymerase promoter sequence; lac, lac operator sequence; lacI, 
lac repressor gene. 
 
Table 4.3. Primers used in this study 
Primer name  5' - 3' sequence  Restriction 
site  
butA-His-FW  GGAATTCCATATGATGAGCAAAGTTG  NdeI  
butA-His-RE  CGCGGATCCCTAGTTGTAGAGC  BamHI  
aldB-FW*  ACGCGTCGACTTTAAAAGGAGCCTCATATGTC
AGAAATCACACAAC  SalI  
RESTR-SOE1-




AAAGTTGCAATG  XhoI  
SOE7-RE  CGGGGTACCCCGCTAGTTGTAGAGCATGCC  KpnI  
*see Table 3.2. 
Preparation of cell suspensions  
Cells grown as above were harvested 16 h after inoculation at OD600 of 16 
– 20 for C. glutamicum ΔaceEΔpqoΔldhA derived strains, and at 
OD600 of 13 – 15 for C. glutamicum ΔaceEΔpqoΔldhAΔmdh derived 
strains, centrifuged (9,924 × g, 10 min, 4C), and washed once with an 
appropriate buffer (PIPES - piperazine-N,N′-bis(2-ethanesulfonic acid), 10 
mM at pH 7.0). The resulting cell suspension was centrifuged (11,325 × g, 
10 min, 4C) and the pellet re-suspended in 50 mM PIPES buffer at pH 
7.0. 
Two-stage fermentations using 2,3-BD producing strains 
C. glutamicum strains were grown and cell suspensions prepared as 
described above. The second fermentation step was initiated by placing 50 
mL of concentrated cell suspension (OD600 of 30 - 40) in a 50 mL shake 
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flask or by placing 50 mL of cell suspension (OD600 of 15 - 20) into an 80-
mL fermenter (mini-fermenter). Shake flasks were kept in a rotary shaker 
at 30C and 160 rpm; temperature in the mini-fermenter was kept at 30C 
using a water bath and stirring was done using a magnetic stirrer. The gas 
atmosphere in the mini-fermenter was established by sparging sterile air at 
a rate of 5, 10 or 15 mL·min-1. The cell suspension was provided with 
glucose to a final concentration of 2% (wt/vol) and samples were collected 
over a period of 72 h in the case of shake flask experiments, and after 53 h 
in the case of mini-fermenter experiments. Samples (1 mL) were 
centrifuged for 5 minutes at room temperature and 16,100 × g; 
supernatants were kept at -20C until further analysis. Products of 
metabolism were quantified by using 1H-NMR on a Bruker Avance400 
(Bruker BioSpin GmbH). 
Enzymatic activities in cell extracts 
For the enzymatic assays, C. glutamicum strains were grown as described 
above and cell suspensions prepared in 50 mM PIPES at pH 7.0. Crude 
cell extracts were prepared by using glass beads (<106 μm) in a 
MiniBeadbeater-8 cell disrupter (Biospec Products) in 3 cycles of 1 min, 
with breaks of 3 min during which the extracts were kept on ice. After 
disruption, extracts were centrifuged at 16,100 × g for 20 min at 4°C. All 
enzyme activities were assayed at 30°C in a Beckman Coulter DU 800 
spectrophotometer. One unit of enzyme activity is the amount of enzyme 
catalyzing the conversion of 1 μmol of substrate per minute under the 
experimental conditions used. The protein concentration was determined 
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using Pierce BCA Protein Assay Kit (Thermo Scientific). Specific activity 
was expressed as units (μmol · min-1) per milligram of protein (U · mg of 
protein-1). Acetolactate synthase activity was determined as described by 
Hugenholtz and Starrenburg (Hugenholtz and Starrenburg 1992). The 
reaction was stopped by the addition of 100 μl of 6N H2SO4, and acetoin 
was quantified colorimetrically at 525 nm as described by Westerfeld 
(Westerfeld 1945). Butanediol dehydrogenase was assayed as described 
by Stormer (Stormer 1975), in a modified reaction mixture containing 50 
mM PIPES at pH 7.0, 0.2 mM NADH and 2.5 mM of racemic acetoin. The 
kinetics of oxidation of different forms of 2,3-BD was studied in 50 mM 
CAPS buffer (N-cyclohexyl-3-aminopropanesulfonic acid) at pH 10.5, using 
5 mM 2,3-BD and 0.2 mM NAD+. 
Protein purification 
Cells of E. coli pET19bbutACg grown as described above, were collected, 
centrifuged (9,924 × g, 10 min, 4C), and washed once with an appropriate 
buffer (Tris-HCl, 2-amino-2-hydroxymethyl-propane-1,3-diol hydrochloride), 
10 mM at pH 7.5. The resulting cell pellet was re-suspended in 2 mL of 50 
mM Tris-HCl at pH 7.5; the cell suspension was passed through a French 
press 3 times (120 MPa), and centrifuged (12,857 × g, 20 min, 4C). The 
supernatant was applied to 5 mL-HisTrap HP column (GE Healthcare Life 
Sciences) and eluted according to the instruction of the manufacturer. The 
most pure fraction (see Fig. 4.3), was dialysed against 50 mM PIPES pH 
7.0 and concentrated using an Amicon concentrator. The purified protein 




Figure 4.3. SDS-PAGE gel of different fractions eluted from the His-Trap column 
used for purification of recombinant C. glutamicum butanediol dehydrogenase. 
Fraction 3 (F3) was used for determination of kinetic parameters by 
spectrophotometric assays and for monitoring reaction kinetics by NMR. 
Abbreviations: M, marker; F2, fraction 2.  
 
Kinetic parameters of the recombinant BDH 
Kinetic parameters of the purified recombinant BDH were determined using 
R/S-acetoin (0.105, 0.206, 0.412, 0.618, 0,824, 1.648, 4.11, 8.22, 16.44 
and 41.1 mM), meso-2,3-BD (0.491, 0.982, 2.455, 4.91, 7.37, 9.82, and 
19.64 mM), and (2S,3S)-2,3-BD (0.030, 0.054, 0.109, 0.217, 0.435, 0.870, 
2.174, 4.348, 6.522, 8.696 mM) as substrates. Acetoin reduction reactions 
were performed in the presence of 0.2 mM NADH in buffer PIPES (50 mM 
at pH 7.0), and the oxidation of each form of 2,3-BD was followed in the 
presence of 0.2 mM NAD+ in 50 mM CAPS buffer at pH 10.5. The kinetics 
of NADH reduction or NAD+ was determined from absorbance 
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computer-aided direct fit to the Michaelis-Menten equation. All reactions 
followed Michaelis-Menten-type kinetics. 
Kinetics of R/S-acetoin reduction monitored by NMR spectroscopy 
The time courses for acetoin reduction, NADH oxidation, and production of 
2,3-BD were followed online by 1H-NMR. The reaction was studied using 
either excess or limitation of NADH with respect to racemic acetoin. 
Reaction mixtures contained either 21 mM R/S-acetoin and 9 mM NADH or 
9 mM R/S-acetoin and 21 mM NADH in 40 mM PIPES at pH 7.0. Two μL 
of NaN3 (4%, wt/vol) were added to the mixture to prevent microbial 
contamination. A lock signal was provided by addition of 60 μL of D2O. The 
total volume was 550 μL. The reaction was started by addition of 1.5 μg of 
pure recombinant C. glutamicum BDH at time zero, and carried out at 
30°C. 
The time courses for substrate utilization and product build-up were 
studied by sequential acquisition of 1H-NMR spectra on a Bruker AVANCE 
II+ 500 MHz spectrometer (Bruker BioSpin GmbH), using a QXI-Z H 
C/N/P-D (5 mm) probe head. Acquisition parameters: flip angle of 60º; 32K 
acquisition data points; repetition delay of 1.5 s, number of scans, 4. Pre-
saturation of the residual water signal was applied. For quantification, 10 
μL of 50 mM DSS was used as internal standard. Fully relaxed spectra 
were acquired (flip angle of 60º; 32K acquisition data points; repetition 
delay of 60 s, number of scans, 4), to determine correction factors that 




NMR quantification of fermentation products in non-growing cells  
1H-NMR spectra were acquired on a Bruker AVANCE II+ 400 MHz 
spectrometer at 27ºC, using a BBO-F probe head. Pre-saturation of the 
residual water signal was applied. Acquisition parameters: flip angle of 90º; 
32K acquisition data points; repetition delay of 61.5 s. Formate was used 
as an internal concentration standard.  
Quantification of products during growth by HPLC  
End-products of metabolism in growing cultures were quantified by HPLC 
using an apparatus equipped with a refractive index detector (Shodex RI-
101, Showa Denko K. K., Japan) and an HPX-87H anion exchange column 
(Bio-Rad Laboratories Inc., California, USA) at 60ºC, with 5 mM H2SO4 as 
the elution fluid and a flow rate of 0.5 mL·min-1. 
Chemicals and reagents 
For molecular biology purposes, RNAse A and Pwo polymerase were 
purchased from Roche Life Science; lysozyme (Fluka) was purchased from 
Sigma-Aldrich, while all other enzymes were from New England Biolabs. 
Acetoin (≥98%), meso-2,3-BD (99%) and (2S,3S)-2,3-BD (97%, 99% 
optical purity) used in enzymatic assays were purchased from Sigma-
Aldrich. All other chemicals were commercially available reagent-grade 
(Sigma-Aldrich or Merck Sharp & Dohme). 
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Results 
Functional analysis of engineered activities 
Artificial operon comprising three genes encoding the 2,3-BD biosynthetic 
pathway (als, aldB, and butACg) was assembled in the pEKEx2 expression 
vector and transformed into the two selected background strains, C. 
glutamicum ΔaceEΔpqoΔldhA and ΔaceEΔpqoΔldhAΔmdh (Table 
4.2). To evaluate whether the target enzymes were functionally produced, 
specific activities were determined in cell extracts (Table 4.4). Induced 
expression of als and aldB genes in C. glutamicum 
ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,butACg) led to 45-fold increase in 
ALS/ALDC activity when compared to control C. glutamicum 
ΔaceEΔpqoΔldhA(pEKEx2), while the increase was 20-fold for 
ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,butACg) compared to 
ΔaceEΔpqoΔldhAΔmdh(pEKEx2). ALS/ALDC activity in crude extracts of 
the two engineered strains reached values of 1.2 - 1.4 U·(mg of protein)-1. 
BDH activity doubled in strain ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,butACg)  
and increased 7-fold in ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,butACg) 









Table 4.4. Overexpression and specific activities of enzymes for the synthesis of 
2,3-butanediol as determined in crude cell extracts. Cells were grown for 14 h in 
2×TY medium supplemented with acetate and glucose. BDH activity was 
measured with R/S-acetoin as substrate. Values are averages  SD of at least 






























1.35  0.05 0.81  0.08 45 2 
     
ΔaceEΔpqoΔldhAΔmdh 
(pEKEx2) 
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Growth characterization  
The two host strains C. glutamicum ΔaceEΔpqoΔldhA and C. glutamicum 
ΔaceEΔpqoΔldhAΔmdh require acetate for growth, since all the pathways 
for acetate formation from glucose have been abolished. When grown on 
2% (wt/vol) glucose plus 0.5% (wt/vol) acetate, both strains showed a 
growth profile different from wild-type C. glutamicum, in accordance with 
previous reports (Eikmanns and Blombach 2014). The deletion strains 
used primarily acetate for growth, while glucose was consumed mainly 
once acetate was exhausted; moreover, the OD600 did not change 
significantly after acetate depletion, indicating that glucose was converted 
preferentially into products other than biomass (Fig. 4.4). Growth 
parameters, such as specific growth rate () and maximal OD (ODmax) are 
presented in Table 4.5. All cultures grew relatively fast with  values of 
about 0.5 h-1, with the growth rate of the producer strains being slightly 
lower than that of the control strains. ODmax values showed very small 
variation, being slightly higher in the producer strains as compared to 
control strains (OD600 of about 26 – 28 for the producer strains and 22 – 23 




Figure 4.4. Growth curves, substrate consumption and acetoin production by the 
2,3-BD producers and control strains, grown in 2×TY medium for 31 h at 160 rpm 
and 30 °C. The ΔaceE strains were unable to grow on glucose as sole carbon 
source, thus they were grown on a mixture of acetate (0.5% wt/vol) and glucose 
(2% wt/vol). Panels refer to strains derived from either C. glutamicum 
ΔaceEΔpqoΔldhA (A and B) or C. glutamicum ΔaceEΔpqoΔldhAΔmdh (C and D). 
Legend: ♦, control strains; ♦, strains with pEKEx2-als,aldB,butACg; ■, acetoin; ▲, 
acetate; ♦, glucose.  
 
Growing cultures of control strains accumulated mostly pyruvate and 
dihydroxyacetone (DHA) (data not shown), while acetoin was a minor 
product (5 mM) (Table 4.5). The two producer strains accumulated about 
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consumed all acetate after 31 h, but about 33 mM glucose remained in the 
culture; the producer strains consumed all glucose, but 5 mM acetate 
remained in the culture supernatants.  
 
Table 4.5. Growth parameters of producer strains, as compared to the control 
strains, and acetoin, glucose and acetate concentrations in supernatant solutions 
collected 31 h after the inoculation. Values shown are means  SD of at least 
three independent experiments. 
Strain 
Specific 


















0.51  0.12 28.8  2.0 52.2  5.5 0.0 
     
ΔaceEΔpqoΔldhAΔmdh 
(pEKEx2) 






0.48  0.02 26.0  1.7 45.2  4.4 0.0 
 
Characterization of 2,3-BD production under oxygen-limiting 
conditions 
C. glutamicum was grown in the presence of oxygen, while the production 
of 2,3-BD is expected to be maximal under oxygen limiting conditions. 
Having this in mind, we have employed a two-stage fermentation strategy 
for the production of 2,3-BD in which aerobically grown cells are collected, 
washed, re-suspended in appropriate buffer and used under oxygen 
deprivation conditions in the subsequent production step. The results of the 
Chapter 4 
 150 
two-stage fermentations with C. glutamicum ΔaceEΔpqoΔldhA(pEKEx2-
als,aldB,butACg), ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,butACg) and 
their respective control strains, are shown in the Tables 4.6 and 4.7. 
When the second fermentation stage was performed in shake flasks, the 
two control strains C. glutamicum ΔaceEΔpqoΔldhA(pEKEx2) and 
ΔaceEΔpqoΔldhAΔmdh(pEKEx2) consumed glucose at a slow rate (1.8  
0.1 and 1.4  0.0 nmolmin-1mg CDW-1); 20 -  28 % of glucose was used 
for the synthesis of 2,3-BD, which was produced in the optically active form 
(Fig. 4.5C). Introduction of 2,3-BD biosynthetic pathway increased GCR in 
both producer strains to 4.2 nmolmin-1mg CDW-1, and more importantly, 
meso-2,3-BD was the main form produced in shake flask fermentations 
(Fig. 4.5B), with a yield of 0.62  0.04 and 0.70  0.02 mol per mol glucose 
for ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,butACg) and 
ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,butACg), respectively. Optically 
active 2,3-BD was below the detection limit (0.1 mM). Glycerol was by far 
the major side product in both strains (25  9 mM and 20  6 mM for  
ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,butACg) and 
ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,butACg), respectively), followed 
by acetoin (17  6 mM and 4  3 mM for  ΔaceEΔpqoΔldhA(pEKEx2-
als,aldB,butACg) and ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,butACg), 
respectively). 
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Figure 4.5. 1H-NMR spectra of fermentation products of C. glutamicum 
ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,butACg) under aeration of 10 mL·min-1 (A), in 
shake flasks (B), or the control strain C. glutamicum ΔaceEΔpqoΔldhA(pEKEx2) 
in shake flasks (C). Legend: meso-2,3-BD, meso-2,3-butanediol; (2S,3S)/(2R,3R)-
2,3-BD, optically active 2,3-butanediol; Gly, glycerol. Resonances of residual 
glucose are labeled with an asterisk. 
 
Performing the production step in the mini-fermenter, with the strain 
ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,butACg) under controlled aeration 
(sparging air at 5, 10 or 15 mL·min-1), led to increased GCR and decreased 
yield of 2,3-BD. The optimal performance was achieved under an air flow 
rate of 10 mL·min-1 (GCR of 11.6  0.6 nmolmin-1mg CDW-1 and yield of 

















The major form of 2,3-BD was meso-2,3-BD, and the ratio meso-2,3-BD : 
optically active 2,3-BD was 95:5 (Fig. 4.5A). The main side-products were 
glycerol (28  9 mM), ethanol (11  6 mM) and acetoin (7  3 mM). Further 
attempts to optimize production parameters by manipulating growth 
conditions (growing cells only in acetate) did not influence the 2,3-BD 
production significantly (Tables 4.6 and 4.7). 
  
Table 4.6. Glucose consumption rate and molar yield of 2,3-BD achieved in the second stage of 
fermentation under oxygen limited conditions by the control and producer C. glutamicum strains. Unless 
otherwise stated, cells were grown on a mixture of 2% (wt/vol) glucose and 0.5% (wt/vol) potassium 
acetate and the second stage was performed in glass shake flasks for 72 h or in the mini-fermenter for 






























NA 4.2  0.3 0.62  0.04 0.93  0.06 96  10 















15 10.4  1.9 0.39  0.3 3.81  0.76 77  8 










10 11.2  3.2 0.58  0.16 5.8  0.8 73  5 
      





NA 4.2  0.2 0.70  0.02 1.13  0.04 94  5 
Abbreviations: GCR, glucose consumption rate; Glc, glucose; 2,3-BD, 2,3-butanediol; CR, carbon 
recovery; NA, not applicable, designates experiments performed in shake flasks. * Strain was grown on 
0.5% (wt/vol) potassium acetate and no glucose. For experimental details see Materials and Methods. 
The values are averages of three independent experiments. 
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Table 4.7. End-products of glucose metabolism and residual glucose in fermentations of control and producer 
strains incubated under oxygen limiting conditions. All concentrations are mM. *Strain grown on 0.5% (wt/vol) 
potassium acetate and no glucose; **metabolite detected in a single experiment. NA, not applicable, indicates 
experiments performed in shake flasks. Abbreviations: 2,3-BD, 2,3-butanediol; Acn, acetoin; DA, diacetyl; Succ, 
succinate; Ac, acetate; Pyr, pyruvate; α-KIV, α-ketoisovalerate; DHA, dihydroxyacetone; Gly, glycerol; Isobut, 
isobutanol; α-KG, α-ketoglutarate; Ala, L-alanine. 
Strain  Air Glc  
2,3-
BD  




ΔaceEΔpqoΔ ldhA   
(pEKEx2)  
NA 42±8  17±2  7.6±0.4  13.2**  5±2  0.0 6±4  11±6  1.0±0.3  2.7**  0.0  0.0  0.0  1±1  





NA 0.0  67±4  17±6  0.0  2±1  0.0  0.0  0.0  3±3  25±9  4±2  0.0  0.0  1.4±0.2  





5  27±14  40±6  3.1±0.7  2±1  0.8±0.3  2±1  1±1  0.0  4±1  18±5  1.8±0.2  5±3  2±1  0.0  





10  0.0  65±14  7±3  1.4±0.3  0.6±0.3  0.4±0.4  0.0  0.0  9±2  28±9  1.5±0.4  11±6  4±1  0.0  





15  0.7±0.0  43±14  25±8  4±1  8.8±0.4  0.2±0.2  1.7±0.3  0.0  6±2  6±5  1.5±0.6  2.5±2.2  3±2  0.0  





NA  0.0  75±1  8±7  0.6±0.1  2.7±0.4  0.0  0.3±0.0  0.0  2.0±0.5  8±5  0.5±0.1  0.0  0.0  1.3±0.6  





10  0.0 62±11  1.0±0.2  0.0  7.6±0.5  0.2±0.1  1.1±0.6  0.9±0.1  1.2±1.1  12±1  4±2  0.0  0.0  1.8±0.6  
ΔaceEΔpqoΔ ldhA 
Δmdh (pEKEx2)  






NA 0.0  83±2  4±3  0.7±0.2  3±2  0.0  0.7**  0.0  0.0  20±6  2.7±0.5  0.0  0.0  1.4±0.2  
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Stereospecificity of the recombinant BDH of C. glutamicum 
Interestingly, meso-2,3-BD was the major form produced in fermentations 
using a producer that over-expressed ALS/ALDC of L. lactis, and BDH of 
C. glutamicum. Decarboxylation of α-acetolactate yields (R)-acetoin, thus 
the production of meso-2,3-BD indicates that the BDH of C. glutamicum 
can use (R)-acetoin in contrast with earlier studies reporting absolute 
stereospecificity for (S)-acetoin (Marlow et al. 2013, Takusagawa 2001). 
Therefore, we decided to produce the recombinant BDH and clarify this 
inconsistency. The pure enantiomers of acetoin are not available 
commercially, but this drawback was overcome by using NMR that can 
distinguish between meso-2,3-BD and optically active 2,3-BD (Fig. 4.5 and 
4.6). meso-2,3-BD is necessarily formed from (R)-acetoin, because the C. 
glutamicum BDH belongs to the SDR family, introducing the hydroxyl-
group to yield an S-stereocenter (Table 4.1). Moreover, the utilization of 
(S)-acetoin by this BDH will produce optically active (2S,3S)-2,3-BD. In this 
way, NMR provides indirect information on the utilization of individual 
enantiomers of acetoin present in the racemic mixture provided as 
substrate. In other words, it is able to “separate” the enantiomers in the 
racemic mixture.   
The time courses for product formation are especially informative in assays 
using an excess of NADH, i.e., 21 mM NADH : 9 mM R/S-acetoin (Fig. 
4.7). The trace for acetoin utilization showed two phases: an initial rapid 
consumption (77.4 ± 4.0 μmol·min-1·mg protein-1) matched the rate of 




formation of meso-2,3-BD proceeded at a rate about 20-fold lower 
(maximal value of 3.7 ± 0.5 μmol·min-1·mg protein-1). Significantly, the level 
of optically active 2,3-BD leveled-off at the time half of the initial amount of 
acetoin was consumed. The production of meso-2,3-BD continued slowly 
until acetoin was exhausted and the two forms of 2,3-BD reached equal 
concentrations.  
In the experiments with deficit of NADH versus acetoin, i.e., 9 mM NADH: 
21 mM R/S-acetoin (Fig. 4.8), initially acetoin was consumed rapidly at a 
maximal rate of 92.7 ± 6.2 μmol·min-1·mg protein-1, and optically active 2,3-
BD was produced at a comparable rate (74.2 ± 0.6 μmol·min-1·mg protein-
1). After about 10 minutes of reaction, meso-2,3-BD was detected and 
increased slowly (maximal rate 2.5 ± 0.2 μmol·min-1·mg protein-1). 
Interestingly, after depletion of the reducing agent, NADH, the build-up of 
meso-2,3-BD was concomitant with an equivalent decrease in optically 
active 2,3-BD, this trend proceeding until the two stereoforms reached 
approximately equal concentrations. The incubation was prolonged up to 7 
days. At equilibrium, the molar ratio, optically active 2,3-BD: meso-2,3-BD 
was 1.25 ± 0.3. 
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Figure 4.6. Sections of 1H-NMR spectra of 2,3-butanediol forms, meso-2,3-BD 
and (2S,3S)-2,3-BD: pure compounds used as standards (A); and produced from 
R/S-acetoin by the purified recombinant butanediol dehydrogenase of C. 
glutamicum at 30°C (B). The mixture contained 9 mM NADH and 21 mM racemic 
acetoin in 40 mM PIPES buffer, pH 7.0. The reaction was started at time zero by 
addition of 1.5 μg of pure protein. Legend: X, methylene group of ethanol, a 
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Figure 4.7. Time course of R/S-acetoin consumption, NADH consumption, and 
2,3-butanediol formation by the butanediol dehydrogenase of C. glutamicum. 
Reaction mixture consisting of 9 mM acetoin and 21 mM NADH in 40 mM PIPES 
buffer (pH 7.0), was incubated with recombinant butanediol dehydrogenase at 
30°C. The reaction kinetics was followed in real time by 1H-NMR. Symbols: ■, 
acetoin; ▲, total 2,3-butanediol, ♦, NADH; ●, optically active 2,3-butanediol; ♦, 
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Figure 4.8. Time course of R/S-acetoin and NADH consumption, and 2,3-
butanediol formation by butanediol dehydrogenase of C. glutamicum. The 
reaction mixture, consisting of 21 mM acetoin and 9 mM NADH in 40 mM PIPES 
buffer (pH 7.0), was incubated with recombinant butanediol dehydrogenase at 
30°C. The reaction kinetics was followed in real time by 1H-NMR. Symbols: ■, 
acetoin; ▲, total 2,3-butanediol, ♦, NADH; ●, optically active (2S,3S)-2,3-
butanediol. This is a representative data set from three replicates. 
 
 
Table 4.8. Kinetic properties of C. glutamicum butanediol dehydrogenase 




Reaction rate  






Reaction rate  






S-Acetoin  77.4 ± 4.0 92.7 ± 6.2 
(2S,3S)-2,3-BD   70.2 ± 15.2 74.2 ± 0.6 


























Kinetic parameters of the recombinant BDH of C. glutamicum: 
spectrophotometric assays  
To determine the kinetic parameters Vmax and Km for the substrates 
commercially available, the oxidation (or reduction) of NADH was 
monitored spectrophotometrically (Table 4.9). Under the experimental 
conditions used in this work (50 mM PIPES buffer at pH 7.0 and 30°C), Km 
for R/S-acetoin was 0.10 ± 0.03 mM, and Vmax was 112 ± 15 μmol·min
-1 
·mg protein-1. Interestingly, a slight inhibition of the enzyme by acetoin was 
observed, for which an inhibition constant of 11.0 ± 0.4 mM was calculated. 
The Km values for (2S,3S)-2,3-BD and meso-2,3-BD determined in 50 mM 
CAPS buffer at pH 10.5, were 0.052 ± 0.005 mM and 2.01 ± 0.40 mM, 
respectively, while the respective Vmax values were 22 ± 1 and 4.1 ± 0.3 
μmol·min-1·mg protein-1. 
 
Table 4.9. Kinetic properties of C. glutamicum butanediol dehydrogenase 
determined by spectrophotometry. Values are averages  SD of at least three 




















(S)-Acetoin**  112  15 0.10  0.03 ND 11.0  0.4 
(2S,3S)-2,3-BD  22  1 0.052  0.005 187.5 ND 
meso-2,3-BD  4.1  0.3 2.01  0.40 0.9 ND 
(S)-Acetoin* ND 0.44 ND ND 
*from (Takusagawa et al. 2001); ND, not determined; **, Racemic acetoin was provided 
but (S)-acetoin is the major isomer utilized in this time scale. 
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As the recombinant C. glutamicum BDH carries an N-terminal histidine tag 
with 10 residues and this could affect in some way the structure and 
stereoselectivity properties of the protein, we decided to compare the 
stereoselectivity of the purified enzyme with that of the BDH activity 
overproduced in the 2,3-BD-producer strain (Table 4.10). The results show 
that the enzyme prefers by far (2S,3S)-2,3-BD  and the pattern is not 
significantly affected by heterologous expression of the His-tagged protein 
in E. coli.   
 
Table 4.10. Stereoselective oxidation of the three stereoisomers of 2,3-BD by C. 
glutamicum BDH. Activity measurements were carried out with preparations of the 
purified recombinant protein and also with crude cell extracts of the 2,3-BD producer 
and control strains. Relative activities appear in parentheses. Assays were 
performed at 30°C and pH 10.5, in CAPS buffer (50 mM) containing 0.2 mM NAD+ 







C. glutamicum ΔaceEΔpqoΔldhAΔmdh 
(2S,3S)-2,3-BD  (100) 0.233 ± 0.019 
(2R,3R)-2,3-BD  (3) 0.008 ± 0.002 
meso-2,3-BD   (1) 0.003 ± 0.000 
 
  




(2S,3S)-2,3-BD  (100) 0.452 ± 0.017 
(2R,3R)-2,3-BD  (3) 0.012 ± 0.002 
meso-2,3-BD  (1) 0.005 ± 0.001 
 
  
Purified C. glutamicum BDH 
(2S,3S)-2,3-BD  (100) 74.3 ± 17.2 
(2R,3R)-2,3-BD  (1.6) 1.154 ± 0.007 






In an early study Takusagawa et al (2001) over-produced the BDH of C. 
glutamicum in E. coli and characterized the kinetic parameters of the 
enzyme with different substrate stereoisomers, both for the oxidation and 
the reduction reactions (Takusagawa et al. 2001). The authors found no 
significant activity with (R)-acetoin, (2R,3R)-BD or meso-2,3-BD, but the 
enzyme catalyzed the reduction of (S)-acetoin as well as the oxidation of 
(2S,3S)-BD. The absolute stereoselectivity of BDH for (S)-acetoin was put 
in doubt by recent results with C. glutamicum hosts engineered for the 
production of 2,3-BD (this work, and Yang et al. 2015). These authors 
showed that the best production was obtained with a strain overproducing 
ALS/ALDC from K. pneumoniae, but without an exogenous BDH. 
Therefore, the endogenous BDH of C. glutamicum must be responsible for 
the reduction of enzymatically produced (R)-acetoin.  
In our work, the endogenous BDH was overproduced along with ALS and 
ALDC of L. lactis. Under limited oxygen conditions (shake flaks), this 
engineered strain produced 2,3-BD in the meso-form, which was 
necessarily derived from (R)-acetoin. On the other hand, optically active 
2,3-BD, certainly (2S,3S)-2,3-BD, was the sole stereoform detected in the 
fermentation products of the control strain. Indeed, as C. glutamicum lacks 
ALDC activity, the synthesis of 2,3-BD in the control strain should proceed 
via spontaneous decarboxylation of  α-acetolactate; the resulting product, 
diacetyl, is reduced to (S)-acetoin by C. glutamicum BDH, as this SDR 
enzyme typically introduces a stereocenter in the S-configuration. 
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Likewise, subsequent reduction of (S)-acetoin yields (2S,3S)-2,3-BD (Fig. 
4.1). This description also agrees with the observed production of (2S,3S)-
2,3-BD from diacetyl in E. coli engineered to express C. glutamicum BDH 
(Ui et al. 2004).   
 In summary, work from us and others shows that C. glutamicum BDH 
uses (R)-acetoin to some extent in vivo. This has been fully corroborated 
by our in vitro studies with the recombinant enzyme. The assays monitored 
by online NMR clearly showed that (R)-acetoin was used, though at an 
apparent rate approx. 20 times lower than (S)-acetoin (Table 4.8). As for 
the reverse catalysis (oxidation), the specificity constant (kcat/Km) for meso-
2,3-BD is about two-orders of magnitude lower than for (2S,3S)-2,3-BD, 
but still clearly measurable (Table 4.9). Even so, these values should be 
regarded with caution since the pH used for the assay, 10.5, is far from the 
physiological range. More reliable parameters will be obtained directly with 
(R)-acetoin, when this compound becomes available (on-demand 
synthesis, Enamine, Ukraine).   
The discrepancy between our results and those of Takusagawa et al 
(2001), with the recombinant C. glutamicum BDH, is difficult to explain. We 
used a His-tagged protein, while they used an untagged protein; one could 
argue that the presence of the His-tag might affect the enzyme 
stereospecificity. This was proven untrue, by comparing the BDH activity in 
cell extracts of the engineered strain and in preparations of the pure 
enzyme (Table 4.10). So, perhaps those authors overlooked the low 
activities obtained with (R)-acetoin, meso-2,3-BD and (2R,3R)-2,3-BD. 
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Still, this minor activity towards (R)-acetoin is responsible for a reasonable 
2,3-BD productivity of C. glutamicum ΔaceEΔpqoΔldhA(pEKEx2-
als,aldB,butACg) when compared with that of the strain optimally 
engineered with the full biosynthetic pathway from L. lactis, 
(ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,PtufbutA), which contains a BDH 
specific for (R)-acetoin (Gaspar et al. 2011, also see Chapter 3). The 2,3-
BD productivity values for these strains, at an aeration rate of 10 mLmin-1, 
are 5.8  0.8 (Table 4.6) and 8.1  0.4 nmolmin-1mg CDW-1 (Table 3.6, 
Chapter 3). Moreover, the corresponding GCR values are also surprisingly 
similar, i.e., 11.2  3.2 nmolmin-1 mg CDW-1 and 15.8  1.7 nmolmin-1mg 
CDW-1. Furthermore, strain ΔaceEΔpqoΔldhA (pEKEx2-
als,aldB,butACg) has a BDH activity of about 40 nmolmin-1mg protein-1 
with respect to (R)-acetoin (one twentieth of the total activity, Tables 4.4 
and 4.10), which is much lower than 0.53  0.17 µmol·min-1mg protein-1 
present in strain ΔaceEΔpqoΔldhA(pEKEx2-als,aldB,PtufbutA) (see 
Table 3.3, chapter 3), yet GCR and productivity are not substantially 
different. This indicates that the metabolic bottleneck for 2,3-BD production 
does not reside at the level of C. glutamicum BDH, despite its relatively low 
activity for the less preferred substrate, (R)-acetoin). In conclusion, the 
main handicap of the producer strains is the low GCR, and the underlying 
reason is unrelated with the level of BDH activity. 
A mixture of 2,3-BD-forms is produced by many natural producers (Chen et 
al. 2014, Haßler et al. 2011, Qi et al. 2014). Before the genomic era this 
was ascribed to the existence of acetoin racemase (Voloch et al. 1983). 
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However, it is now generally accepted that this multi-form production is due 
to the presence of more than one BDH activity. This multiplicity of BDHs 
has been shown for B. subtilis, Bacillus licheniformis, L. lactis, R. 
erythropolis, and several other bacteria (Zhang et al. 2013, Qi et al. 2014, 
Crow 1990, Z Wang et al. 2014, Yu et al. 2015). Several homologs of Zn-
dependent alcohol dehydrogenase are predicted in the genome of C. 
glutamicum, thus it is surprising that the BDH activity with (2R,3R)-2,3-BD 
was very low in crude cell extracts of producer and control strains (2-3% of 
the activity with (2S,3S)-2,3-BD). Moreover, this result is comparable to 
what was found with the purified BDH of C. glutamicum (Table 4.10). 
Therefore, it seems that the butA-encoded enzyme is the only BDH 
expressed under these conditions. It is also interesting to note that the 
activity for (2R,3R)-2,3-BD is higher than for meso-2,3-BD, so it will be 
pertinent to determine the kinetic parameters of the enzyme for (2R,3R)-
2,3-BD. Definite proof about the presence or other BDHs implies the 
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Anaerobic succinate production in Corynebacterium 
glutamicum 
Confronted with the exhaustion of petroleum resources and the negative 
environmental impact associated with the use of fossil fuels, fermentative 
production of bulk chemicals from renewable biomass is becoming an 
appealing alternative to traditional petrochemical processes. More 
specifically, the bio-based production of succinate and 2,3-butanediol (2,3-
BD), have received substantial attention lately, as they are good examples 
of how science and technology cooperate to overcome the limitations of 
microbial production and move towards an industrial setting. 
In this work, we describe our contribution to metabolic engineering of the 
industrial bacterium C. glutamicum for the production of the two bulk 
chemicals, succinate and 2,3-BD. The first part of the work focuses on the 
characterization of anaerobic succinate production by the wild-type 
organism. 
C. glutamicum is well known for the industrial production of amino acids 
under aerobic conditions, hence this aspect of metabolism has been 
extensively studied using various approaches. In particular, the metabolic 
fluxes of L-lysine and L-glutamate producer strains were characterized in 
detail (Vallino and Sephanopulos 1993, Kiefer et al. 2004, Uy et al. 2004, 
Wittman and Heinzle 2001, Marx et al. 1997, Shirai et al. 2007, Dominguez 
et al. 1998). In contrast, at the beginning of this thesis work, knowledge on 
the fluxes operating under anaerobic conditions was very limited, thus we 
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deemed it important to take a systems biology approach and study 
anaerobic glucose metabolism in this bacterium.  
Our first attempt involved the use of in vivo 13C-NMR, which is a powerful 
technique for measurements of intracellular metabolites. The non-invasive 
character of this methodology is highly advantageous, but the intrinsic low 
sensitivity of the NMR technique restricts the range of applications (Neves 
et al. 1999, Neves et al. 2002a, Carvalho et al. 2013). In cell suspensions 
of C. glutamicum we were able to detect and quantify fructose 1,6-
bisphosphate (FBP), glycogen (data not shown), and succinic and lactic 
acids (Fig. 2.5). The low intracellular pools of other metabolites precluded 
their detection in vivo. On the other hand, the experimental set-up 
developed in our lab for in vivo NMR requires the establishment of a 
defined gas atmosphere, and this requisite led us to discover a prominent 
increase in succinate production upon changing the gas atmosphere from 
argon to CO2 (Fig. 2.2).   
Lactate and dihydroxyacetone (DHA) were the two major end-products of 
glucose metabolism when CO2 was not supplied. While lactate is a 
common product of C. glutamicum anaerobic metabolism (Inui et al. 2004, 
Dominguez et al. 1993), the accumulation of DHA is rarely reported. It was 
observed in a lysine-producing strain, and the authors speculated the 
existence of a glycolytic bottleneck at the level of glyceraldehyde 3-
phosphate dehydrogenase (GAPDH), an enzyme inhibited by a high 
NADH/NAD+ ratio (Dominguez et al. 1998, Kiefer et al. 2004). In our 
hands, under high CO2 conditions and production of a reduced compound 
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such as succinate, DHA was abolished, most probably due to a decreased 
NADH/NAD+ ratio. 
Upon switching the atmosphere to pure CO2, succinate yield increased to 
almost 1 mol per mol glucose, with lactate and acetate as major side-
products (Table 2.2). As succinate production yields net 1 mol NAD+ per 
mol succinate, the main focus of engineering strategies has been to 
increase NADH availability. Eliminating lactate production is a common first 
step to redirect carbon and electrons towards succinate (Okino et al. 2008, 
Litsanov et al. 2012a). To satisfy the redox balance, carbon is theoretically 
distributed between succinate (-2 NADH) and acetate production (+4 
NADH per mol glucose) in a ratio succinate:acetate of 2:1. Further 
reduction of acetate, a source of ATP and NADH, may impair anaerobic 
growth, as observed in E. coli (Stols and Donnelly 1997, Vemuri et al. 
2002). More importantly, other sources of NADH to support succinate 
production have to be found. Litsanov et al. (2012) observed that, once 
acetate and lactate production were abolished, the maximal yield of 
succinate was 1 mol per mol glucose, meaning that succinate formation 
was constrained by insufficient reducing power (Litsanov et al. 2012a). In 
the same study, the authors tested formate oxidation as a source of CO2 
and electrons for succinate production in a C. glutamicum strain 
engineered with formate dehydrogenase; the anaerobic metabolism of 
glucose in the presence of formate and bicarbonate yielded 1.67 mol 
succinate per mol glucose (Litsanov et al. 2012a).  
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The model for anaerobic metabolism developed in this thesis showed that 
the flux via the Pentose Phosphate Pathway was low (~5% of the total 
glycolytic flux), in the presence or absence of CO2. Similarly, a low PPP 
flux was found under succinate producing conditions in Actinobacillus 
succinogenes (1 - 4%) and Basfia succiniciproducens (7 - 8%) (McKinlay 
et al. 2007, McKinlay and Vielle 2008, Becker et al. 2013). Interestingly, in 
Escherichia coli AFP111, the fraction of carbon going through PPP 
changed from 4 to 17% when the atmosphere was switched from 3% to 
50% CO2, and succinate production increased accordingly. This E. coli 
strain responded to an increase in NADH consumption with an increase in 
NADPH production, since it has a transhydrogenase activity, which 
enables interconversion of these two reduced co-factors (Lu et al. 2009). 
C. glutamicum is known to respond to high NADPH demand by increasing 
the flux via PPP, but does not possess a functional transhydrogenase 
(Marx et al. 1999, Bartek et al. 2011, Blombach et al. 2011, Kabus et al. 
2007). However, the existence of a transhydrogenase-like cycle, consisting 
of pyruvate carboxylase and/or PEP carboxylase, malate dehydrogenase, 
and malic enzyme, has been described. This cycle was proposed to be 
responsible for at least part of the NADPH supply in the isobutanol 
producing C. glutamicum strain (Blombach et al. 2011).  
There were attempts to increase the PPP flux in a succinate producer 
strain by overproducing the first two enzymes of the PPP, which are 
insensitive to feedback inhibition by their reaction products, however this 
had only a slight positive effect on the GCR and succinate yield (Wiechalka 
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2012). PPP is a relevant source of reducing power, but due to the absence 
of transydrogenase and consequent lack of efficient interconversion 
between NADH and NADPH, employing this pathway to generate the 
reducing equivalents needed for anaerobic succinate production did not 
meet expectations.  
By analyzing the 13C-label in succinate derived from [2-13C]glucose 
metabolism, we concluded that succinate production occurred mainly via 
PEP/Pyr carboxylation and the reductive tricarboxylic acid (TCA) cycle, 
with a small contribution of the oxidative branch, which was responsible for 
provision of NADH necessary for closing the redox balance. Similarly low 
activity of the oxidative TCA branch was observed in B. succiniciproducens 
(Becker et al. 2013). In our metabolic model, we assume that the flux 
through the glyoxylate shunt is negligible since the activity of isocitrate 
lyase is absent in C. glutamicum during anaerobic glucose metabolism 
(Inui et al. 2004), and because succinate is an effective inhibitor of 
isocitrate lyase (Ki of 1.48 mM) (Reinscheid et al. 1994a). Accordingly, Zhu 
et al. (2013) constructed a C. glutamicum strain with overexpression of the 
genes involved in the glyoxylate shunt, but this strategy alone turned out 
unsatisfactory as the yield was essentially unchanged (Zhu et al. 2014). 
Also, overproduction of isocitrate lyase and malate synthase has a minor 
positive effect in aerobic succinate production (Litsanov et al. 2012b). 
In E. coli, strain AFP111, the flux via the glyoxylate shunt contributes about 
6 – 8 % for succinate production (Lu et al. 2009), but in strain SBS990MG 
(pHL413), optimal succinate yields (1.6 – 1.7 mol per mol glucose) were 
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obtained when about one third of oxaloacetate was directed to the 
glyoxylate shunt (Sánchez et al. 2006). In fact, it is important to consider 
the glyoxylate shunt since it uses less NADH than the reductive branch of 
TCA for succinate formation (Hong et al. 2003). A combination of the 
glyoxylate shunt and the reductive TCA requires 1.25 mol NADH, 
compared to 2 mol NADH per mol succinate when only the reductive TCA 
branch is used. Moreover, the maximal succinate yield achievable in the 
absence of external electron donors (1.65 mol per mol glucose) is only 
possible with the contribution of the glyoxylate shunt (Hong et al. 2003). 
Top succinate producers, yeast and E. coli, use the glyoxylate shunt in 
combination with the reductive TCA branch (Sánchez et al. 2006, van den 
Tweel 2010).  
Possible engineering of the glyoxylate shunt for succinate production in C. 
glutamicum should consider the following information: i) in glucose grown 
cells, transcription of the isocitrate lyase and malate synthase genes is 
repressed (Gertsmeir et al. 2004); and ii) isocitrate lyase activity is inhibited 
by several metabolites (3-phosphoglycerate, 6-phosphogluconate, PEP, 
fructose-1,6-bisphosphate, succinate, and glyoxylate, with Ki values  
between 0.5 and 1.5 mM) (Reinscheid et al. 1994a). Perhaps over-
producing an isocitrate lyase with more suitable properties could be a 
useful strategy to take advantage of the glyoxylate shunt.  
The experiments with [1-13C]glucose and [U-13C]glucose showed that back-
flux from oxaloacetate/malate to PEP/Pyr was insignificant under 100% 
CO2 atmosphere. This was unexpected knowing that the 
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PEP/Pyr/oxaloacetate node shows great flexibility in C. glutamicum, at 
least in the presence of oxygen (Bartek et al. 2011, Wendisch et al. 2000). 
However, having this reaction practically unidirectional was beneficial for 
succinate production. Pyruvate and PEP carboxylase overproduction 
enhanced the succinate yield (Okino et al. 2008a, Litsanov et al. 2012a, 
Sánchez et al. 2006). According to Lu et al. (2009) the activity of the 
carboxylating enzymes limits CO2 utilization at high CO2 concentrations, 
and this could explain the beneficial effect of overexpressing pyruvate and 
PEP carboxylase genes (Okino et al. 2008a, Litsanov et al. 2012a, 
Litsanov et al. 2012b, Sánchez et al. 2006).  
In conclusion, our efforts to study succinate production resulted in high 
succinate yields in the wild-type strain without genetic manipulation. This 
strain produced 1 mol succinate per mol glucose, which is significant even 
when compared with the highest yield obtained thus far (1.7 mol per mol 
glucose). The model of anaerobic glucose metabolism provided useful 
hints for strain development. Forcing flux via PPP or glyoxylate shunt could 
be useful approaches to further improve the succinate yield. 
 
Engineering 2,3-butanediol production in C. glutamicum 
We transformed C. glutamicum into a cell factory for the production of 2,3-
BD. Herein, we compare our engineering strategies and strain 
performance with those of other microbial producers; special attention was 
directed to the stereochemistry of 2,3-BD formation.  
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Because under oxygen limiting conditions C. glutamicum produces organic 
acids (lactic, acetic and succinic), host strains with minimized accumulation 
of these organic acids were selected. Actually, elimination of reduced side-
products is a common strategy employed to create efficient 2,3-BD 
producers. A few examples: lactate elimination in Klebsiella pneumoniae 
and Enterobacter aerogenes; lactate, acetate and ethanol elimination in 
Klebsiella oxytoca; acetate, glycerol, and ethanol elimination in S. 
cerevisiae (Kim et al. 2014, Jung et al. 2012, Lian et al. 2014, Ng et al. 
2012, Jantama et al. 2015). Our strategy was successful, as the best 
producer strain under optimized conditions accumulated only traces of 
acetate (0.1 mM), and succinate and lactate were below this level (Table 
S3.2). In particular, elimination of acetate had a crucial impact on the yield 
of 2,3-BD (Fig 3.7). 
Acetate formation by the 2,3-BD producer strains is curious, as all known 
acetate-forming pathways were inactivated (Tables S3.2 and 4.7). The 
results of 13C-tracer experiments using a similar strain showed that acetate 
was derived from glucose (Appendix I). A possible candidate for acetate 
synthesis is the α-ketoglutarate dehydrogenase complex, whose catalytic 
subunit shows a low activity with pyruvate (Hoffelder et al. 2010). 
 
C. glutamicum host strains were transformed with the 2,3-BD biosynthetic 
pathway from L. lactis that consists of three genes: als, encoding α-
acetolactate synthase (ALS); aldB, encoding α-acetolactate decarboxylase; 
and butA, encoding butanediol dehydrogenase (BDH). Typical ALS/ALDC 
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activities in crude cell extracts were 0.5 U·mg protein-1 (about 0.25 U·mg 
CDW-1) and, for BDH, 1 U·mg protein-1 (about 0.5 U·mg CDW-1). These 
values are one order of magnitude higher than the productivity of 2,3-BD 
(0.011 μmol·min-1·mg CDW-1, Table 3.3), hence these activities should be 
sufficient to support the cellular fluxes. And indeed, in the best producer 
strain, 98% of pyruvate was directed towards the 2,3-BD pathway and 
transformed into acetoin and 2,3-BD (Table S3.2). We conclude that the 
activity of ALS and ALDC were not limiting for the 2,3-BD production. 
Most of the carbon that was not processed to pyruvate (24% of the total 
glucose provided), was converted into DHA and glycerol (Table S3.2). 
DHA accumulation was also observed in L-lysine producer, suggesting that 
DHA elimination could be a goal common to metabolic engineering 
strategies of C. glutamicum (Kiefer et al. 2004). Dihydroxyacetone 
phosphate phosphatase and BDH, responsible for DHA and glycerol 
formation, respectively, are apparent engineering targets (Jojima et al. 
2012). Another useful strategy to prevent loss of carbon in the over-flow 
metabolites from glycolysis was applied in the anaerobic L-alanine 
production; it consisted of over-producing the glycolytic enzymes, GAPDH, 
pyruvate kinase, phosphofructokinase and glucose-6-phosphate 
isomerase. This strategy led to a decreased concentration of metabolites 
upstream of GAPDH and a 5-fold increase in the GCR. Therefore, this 
could also be a useful strategy to further improve productivity of 2,3-BD in 
C. glutamicum (Yamamoto et al. 2012). 
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Despite high BDH activity in crude cell extracts, the accumulation of 
acetoin was observed in all 2,3-BD producer strains, both with BDH of L. 
lactis and of C. glutamicum (Tables S3.2 and 4.7). Acetoin accumulation 
was higher in strains with the overproduction of endogenous BDH, 
probably reflecting the lower preference for (R)-acetoin of the enzyme. As 
expected, the acetoin accumulation increased with oxygen availability. 
The strain with overproduction of the endogenous BDH accumulated much 
higher levels of glycerol than the strain with the lactococcal enzyme. BDH 
of C. glutamicum, active in all strains, can use DHA and produce glycerol, 
although with a very low affinity (Jojima et al. 2015). If the same enzyme is 
involved in both reactions, then concomitant accumulation of acetoin and 
glycerol are contradictory and difficult to explain. It is likely that under our 
experimental conditions the endogenous BDH is not the only enzyme 
responsible for glycerol formation. On the other hand, the slow reaction 
rate of (R)-acetoin reduction by BDH of C. glutamicum, and consequent 
slow NADH oxidation, could lead to inhibition of GAPDH, accumulation of 
DHA and glycerol.  
 
Under strict anaerobic conditions, the theoretical yield is 0.67 mol 2,3-BD 
per mol glucose. Addition of oxygen as an electron acceptor increases the 
theoretical yield to one mol of 2,3-BD per one mol of glucose (0.5 g per g). 
In our experiments, the most important step towards increasing productivity 
was the optimization of oxygen availability. This confirmed that excess 
NADH influenced negatively the GCR and the productivity. Under optimal 
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air supply (10 mL·min-1), the productivity increased over two-fold (10.9 
nmol·min-1·mg CDW-1, Fig. 3.7) compared to the fermentation in shake 
flasks (4.3 nmol·min-1·mg CDW-1). Elimination of DHA and glycerol, as well 
as the fine tuning of oxygen supply should help to further increase the yield 
of 2,3-BD.  
The introduction of an NADH oxidase, as done in PDHC-negative 2,3-BD 
producing yeast, could be considered (Kim et al. 2015). However, as 
NADH oxidase has very high affinity for NADH (Km of 25 μM in L. lactis), 
compared with BDH (Km of 100 μM), it would be difficult to optimize 2,3-BD 
production. This strategy has proven very useful when acetoin is the 
desired end-product (Neves et al. 2002b, Sun et al. 2012, Ji et al. 2013, 
Bao et al. 2014).  
Thus far, the best producers of 2,3-BD are pathogenic organisms, such as 
K. pneumoniae, K. oxytoca, E. aerogenes and Serratia marcescens (Table 
5.1). Typical productivities are in the range 1 – 4 g·L-1·h-1, and titers of 100 
– 150 g·L-1, reaching almost theoretical yields of 2,3-BD from glucose. 
However, the potential pathogenicity of these organisms is still a major 
obstacle for large-scale production. One of the best non-pathogenic 
alternatives is Paenibacillus polymyxa (2 g·L-1·h-1 and 72 g·L-1), however 
this bacterium produces exopolysaccharides, which drains carbon and 
increases the viscosity of the fermentation broth; only upon temperature 
increase was the formation of exopolysaccharides decreased, but not 
completely (Häßler et al. 2012). Significant progress was made towards 
developing production processes for Bacillus amyloliquefaciens and 
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Bacillus licheniformis, which form 2,3-BD at a specific productivity of 1 – 2 
g·L-1·h-1 and titer of 74 – 100 g·L-1, reaching almost theoretical yields (T 
Yang et al. 2015, Li et al. 2014).  
The two common industrial hosts, E. coli and S. cerevisiae, fall behind the 
natural producers in terms of production parameters; however, advance 
was achieved over the years, especially through engineering E. coli, which 
produces up to 74 g·L-1 with a productivity of 1.2 g·L-1·h-1 and a yield that is 
82% of the theoretical one. Yeast, on the other hand, produces 100 g·L-1 in 
about 300 h of fermentation, with a yield of 0.35 g·g-1, which is in the range 
of productivities and yields of the best C. glutamicum producer, C. 
glutamicum ΔaceEΔpqoΔldhAΔmdh(pEKEx2-als,aldB,PtufbutA), that 
formed 2,3-BD with a yield of 0.33 g·g-1 and a productivity of 0.21 g·L-1·h-1 
(this work). The GCR reached by this strain (21 nmol·min-1·mg CDW-1, 
corresponding to 1.3 mmol·h-1·g CDW-1) is good, when compared to a 
similar strain that produced isobutanol under oxygen-limiting conditions 
(1.1 mmol·h-1·g CDW-1) and twice lower than that of the succinate producer 
(2.6 mmol·h-1·g CDW-1) developed in the lab of Michael Bott (Blombach et 
al. 2011, Litsanov et al. 2012). 
Our strains were grown on acetate due to auxotrophy caused by the 
pyruvate dehydrogenase complex (PDHC) inactivation. Growth on glucose 
is known to increase the level of glycolytic enzymes in C. glutamicum 
(Muffler et al. 2002). Instead of full inactivation of PDHC it would be useful 
to manipulate this activity to levels that would allow for growth on glucose, 
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as this strategy showed beneficial impact on the production of L-lysine, L-
valine, α-ketoisovalerate by C. glutamicum (Buchholz et al. 2013). Glucose 
also supports growth to higher optical densities, which is desirable to reach 
enhanced volumetric productivity.  
Interestingly, under growth conditions, strains that over-expressed 
endogenous BDH produced up to 52 mM acetoin from glucose, which is 
about 4.6 g·L-1 in 31 h (0.23 g·g-1) (Table 4.5). This is a reasonable yield of 
acetoin if we take into account that optimization was not carried out. 
Therefore, C. glutamicum appears like a promising platform for production 
of this food additive because of its GRAS status. Omission of the butA 
gene in the 2,3-BD biosynthetic operon and disruption of endogenous BDH 
are expected to yield efficient acetoin producers. So far, B. subtilis is the 
most studied producer of acetoin, reaching yields of 0.36 g·g-1 and a titer of 
54 g·L-1 in 144 h (Zhang et al. 2013).  
 
Fig 5.1. Acetoin and tetramethylpyrazine molecules. 
 
Another potential application of the strains constructed in this work is the 
production of tetramethylpyrazine (TMP), a derivative of acetoin (Fig. 5.1). 




traces of TMP were detected in the fermentation headspace of wild-type 
strain; and ii) considerable amounts of TMP were produced by a mutant 
strain that accumulated α-acetolactate; upon cooling, TMP formed crystals 
in the fermentation broth (Dickschat et al. 2010, Demain et al. 1967). TMP 
is a biologically active alkaloid that has a potent effect on 
neurovascularization and is prescribed as a complementary treatment for 
glaucoma (N Yu et al. 2014, Gong et al. 2014). The mechanism of TMP 
synthesis is not fully understood, but spontaneous formation from acetoin 
and ammonium salts has been proposed. Cultures of B. subtilis produce 
up to 7.5 g·L-1 TMP (Huang et al. 1996, Zhu et al. 2010).  
Table 5.1. Summary of the best 2,3-butanediol (2,3-BD) producers.  
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Stereochemistry of 2,3-butanediol biosynthesis 
Most microorganisms produce mixtures of 2,3-BD isomers with variable 
proportions. This is a consequence of i) existence of BDHs with different 
stereochemical properties; and/or ii) existence of more than one BDH in a 
particular organism. As for some applications it is essential to have the 
enantiopure 2,3-BD, the stereochemical properties of BDHs should be 
investigated (Gao et al. 2013, Qi et al. 2014, Ji et al. 2011). Available data 
on BDHs are summarized in Table 4.1; in addition, the nature of the 2,3-
BD stereoforms found as fermentation products is shown in Table 5.2.  
The focus of this part of our work was to study the stereochemical 
properties of C. glutamicum BDH. Takusagawa et al. (2001) characterized 
the kinetic parameters of this enzyme and showed that it catalyzed the 
reduction of (S)-acetoin as well as the oxidation of (2S,3S)-BD and had no 
significant activity with (R)-acetoin, (2R,3R)-BD or meso-2,3-BD 
(Takusagawa et al. 2001). However, when this BDH was overproduced in 
C. glutamicum together with ALS and ALDC of L. lactis, meso-2,3-BD was 
observed as a major end-product of glucose metabolism under limited 
oxygen conditions (this work). As this SDR enzyme typically introduces a 
chiral center in the S-configuration, the meso-form detected was 
necessarily derived from (R)-acetoin. While our work was in progress, an 
article appeared in the literature reporting 2,3-BD production by C. 
glutamicum using ALS and ALDC from K. pneumoniae, but without a 
heterologous BDH (Yang et al. 2015). Therefore, an endogenous BDH of 




produced (R)-acetoin. It is important to point out that known ALDC 
enzymes specifically decarboxylate α-acetolacteate into (R)-acetoin 
(Marlow et al. 2013).  
The assays with pure preparations of the recombinant BDH of C. 
glutamicum showed that (R)-acetoin (present in the racemic mixture), was 
reduced into meso-2,3-BD, though at an apparent rate 20 times lower than 
(S)-acetoin (Table 4.8). This work will be complemented with the 
determination of the kinetic parameters with (R)-acetoin, as soon as this 
compound becomes available (on-demand synthesis, Enamine, Ukraine).   
Studying the properties of BDHs suggested some guidelines for the 
construction of better producers. SDRs typically introduce a new hydroxyl 
group in S-configuration and form meso-2,3-BD from enzymatically 
produced (R)-acetoin, or (2S,3S)-2,3-BD from (S)-acetoin formed by 
spontaneous decarboxylation of α-acetolactate in the presence of oxygen. 
This means that strains that employ SDRs for 2,3-BD production will 
always form a mixture of meso- and (2S,3S)-2,3-BD in the presence of 
oxygen; (2S,3S)-2,3-BD will be the minor product under oxygen limiting 
conditions as the substrate (S)-acetoin is less efficiently accumulated. 
Relevant examples are E. coli engineered with the pathway from E. 
cloacae, or K. pneumoniae with native pathway, both using SDRs (Tables 
4.1 and 5.2). This also means that under aerated conditions, it will not be 
possible to produce pure meso-2,3-BD by C. glutamicum with a pathway 
that contains the lactococcal butA gene, which encodes an SDR. Our data 
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(Appendix II) corroborates this conclusion as it shows that this enzyme 
produced a mixture of meso- and (2S,3S)-2,3-BD. Table 5.2 shows that, 
when enantiopure 2,3-BD is desired, a more suitable strategy is to employ 
MDRs that introduce the new hydroxyl group in an R-configuration; 
consequently, the only product that can be formed from diacetyl and (R)-
acetoin is (2R,3R)-2,3-BD. This strategy was implemented in S. cerevisiae 
overproducing BDH from B. subtilis, and led to production of enantiopure 
(2R,3R)-2,3-BD (Table 5.2).  
Curiously, butB-encoded BDH (BDHB) of L. lactis, an MDR-type enzyme, 
produced traces of meso-2,3-BD, rather than (2R,3R)-2,3-BD upon 
incubation with racemic acetoin. Similarly, Nielsen et al. found that E. coli 
that overexpressed lactococcal butB formed meso-2,3-BD (Nielsen et al. 
2010). It seems that this enzyme is different from other MDRs, thus it 
would be interesting to further optimize the production of BDHB and 




Table 5.2. 2,3-Butanediol forms produced by different bacteria. The relative 
proportion of each 2,3-BD form is given in parenthesis. 
Organism Pathway used 
Fermentation 
conditions 




pathway from E. 
cloacae 
Fed-batch; pH 7; 
400 rpm and 
aeration rate 1.5 
vvm 
meso-2,3-BD (95.5) 




     
S. cerevisiae JL0432 
Endogeneous 
BDH and ALS; 
ALDC from B. 
subtilis 












Fed-batch; pH 6 






     




Fed-batch; pH 6; 
stirring 300 rpm 
and aeration rate 
1.67 vvm 





     




Fed-batch;  pH 6; 
stirring 800 rpm 













pathway from L. 
lactis MG1363 
Batch; pH 7 and 














pathway from L. 
lactis MG1363 

















BDH, ALS and 
ALDC from L. 
lactis MG1363 









Abbreviations: ALS, α-acetolactate synthase; ALDC, α-acetolactate 
decarboxylase; BDH, 2,3-butanediol dehydrogenase; vvm, gas volume flow per 





Finally, the physiological role of the 2,3-BD pathway and the function of 
BDH in C. glutamicum are interesting questions which deserve some 
discussion. In L. lactis IL1403, ALS was found to be upregulated under low 
pH conditions and the 2,3-BD pathway was speculated to be involved in 
preventing intracellular acidification by redirecting carbon to neutral 
compounds rather than to organic acids (Zuljan et al. 2014). This pathway 
was also proposed to be part of the response to low pH in the pathogens 
S. marcescens MG1 and Serratia plymuthica RVH1 (Van Houdt et al. 
2006). Furthermore, the acquisition of heterologous ALS and ALDC 
improved growth of E. coli due to lesser extent of external acidification 
(Vivijs et al. 2014). Over-expression of the 2,3-BD-forming lactococcal 
pathway in C. glutamicum caused cells to grow slightly better on acetate, 
compared to control strains, and also to survive better during the stationary 
phase (Fig. 3.3). This puzzling result is not associated with a response to 
low pH, since the pH of the culture medium was higher than 7.0 in both 
cases.  
Interestingly, it was recently shown that bacterial volatiles such as 2,3-BD 
and acetoin produced by E. aerogenes increase maize resistance to 
pathogens and herbivores (DˈAlessandro et al. 2014). Similarly, in 
Arabidopsis seedlings exposed to bacterial volatiles from B. subtilis GB03 
and B. amyloliquefaciens IN937a, disease severity by the bacterial 
pathogen Erwinia carotovora was significantly reduced compared with 
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seedlings not exposed to bacterial volatiles (Song and Ryu 2013). 
Furthermore, the same study revealed that (2R,3R)-2,3-BD promoted 
growth, while the application of the racemic mixture was found to induce 
systemic resistance to pathogenesis (Song and Ryu 2013).  
The occurrence of BDH in C. glutamicum is peculiar, since C. glutamicum 
does not possess any ALDC activity, and the production of 2,3-BD by the 
wild-type and LDH-negative strain is rather inefficient (Table 3.5, Dickschat 
et al. 2010). Furthermore, it was found that butA expression is upregulated 
in nitrogen limitation (Silberbach et al. 2005). A study aimed at identifying 
proteins affected by high salt stress, also found upregulation of butA 
(Franzel et al. 2010). In an attempt to establish a comprehensive 
transcriptome map of C. glutamicum, Pfeifer-Sancar et al. (2013) detected 
three transcripts of the butA gene, differing in the 5ˈ-untranslated region, 
which indicates that this gene is under complex transcriptional control 
(Pfeifer-Sancar et al. 2013). Furthermore, our measurements show high 
BDH activity in crude cell extracts (Table 3.3). Having in mind that C. 
glutamicum is a soil-born bacterium that lacks ALDC, a key-enzyme for the 
biosynthesis of 2,3-BD, a major role in acidification prevention can be ruled 
out. It is tempting to speculate that 2,3-BD could play a role in interaction 






Major achievements of this thesis work: 
 The in vivo NMR methodology was successfully applied to C. 
glutamicum for the first time. 
 Intracellular and extracellular pools of organic acids (lactic and 
succinic) were measured non-invasively. To the best of our 
knowledge, this is the most reliable methodology to measure 
organic acid gradients across intact cells. 
 The first metabolic model of the anaerobic glucose metabolism in 
the wild-type C. glutamicum was constructed. 
 First demonstration of C. glutamicum as a host for industrial 
production of 2,3-BD was accomplished (proof of concept).  
 The use of C. glutamicum 2,3-BD producers as a GRAS platform for 
the development of new producer strains of acetoin was proposed.  
 The ability of BDH from C. glutamicum to use (R)-acetoin and 
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Corynebacterium glutamicum is a well known industrial organism and a 
promising host for succinate production. The metabolism of C. glutamicum 
strains manipulated with an aim to increase succinate formation was 
studied using the in vivo 13C-NMR and 13C-tracer studies. Results showed 
that the elimination of lactate production caused a 20% increase in 
succinate production. Additional overproduction of pyruvate carboxylase 
increased the yield by an additional 15%. Acetate elimination did not 
further improve the yield. Analysis of pathways operating under succinate 
production conditions revealed low pentose phosphate pathway (6%), and 
succinate being produced mainly via the reductive route of the tricarboxylic 
acid cycle. These studies confirmed the suitability of the chosen 
approaches for studying the anaerobic succinate production. 
 
Introduction 
Corynebacterium glutamicum is an industrial organism used for high-scale 
production of L-amino acids (Shimizu and Hirasava 2007, Becker and 
Wittmann 2012). It is known that under oxygen limiting conditions (oxygen 
deprivation), this organism produces organic acids: lactic, acetic and 
succinic acid. In the wild-type C. glutamicum, succinate is a minor product 
of glucose metabolism. Addition of bicarbonate was shown to increase 
succinate production (Okino et al. 2005, Dominguez et al. 1993, Inui et al. 
2004). As succinate is an important bulk chemical, several engineering 
strategies were applied to C. glutamicum with a goal of transforming it into 
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a host for succinate production. In one approach, lactate production was 
eliminated to enhance pyruvate and NADH availability for succinate 
formation; in addition, pyruvate carboxylase was overproduced to direct 
pyruvate into oxaloacetate (Okino et al. 2008a). As a result of this strategy, 
1.4 mol succinate per mol glucose was produced, with acetate as the 
major side-product (0.3 mol per mol glucose). In another study, this 
strategy was upgraded by eliminating acetate production, overproducing 
glyceraldehyde 3-phosphate dehydrogenase, and importantly, introducing 
formate dehydrogenase to assure the CO2 and NADH supply for succinate 
production (Litsanov et al. 2012a). A high yield of succinate (1.67 mol per 
mol glucose) was achieved in fermentations by this strain, using formate, 
bicarbonate and glucose as substrates.  
The success of engineering strategies depends on thorough knowledge of 
the bacterial metabolism, including the information on carbon flux 
distribution in the network of metabolic pathways (Kiefer et al. 2004, Bartek 
et al. 2011). Our group applied the in vivo 13C Nuclear Magnetic 
Resonance (NMR) methodology and its non-invasive characteristics to 
study different aspects of metabolism in non growing bacterial cells (Neves 
et al. 1999, Neves et al. 2002a, Carvalho et al. 2013). Using differentially 
labelled glucose isotopomers for the 13C-tracer studies is particularly useful 
in discovering and quantifying pathways that are active in the cell 
(Schrader et al. 1993, Klapa et al. 1999). We set out to apply these two 
methodologies and characterize the metabolism of C. glutamicum strains 
manipulated for the production of succinate under anaerobic conditions in 
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the presence of CO2, with a goal of obtaining indications for further 
improving succinate production. 
Materials and methods 
Strains and growth conditions  
C. glutamicum strains used in this work are listed in the Table A1.1. All 
strains were grown over-night in 2L-baffled shake flasks at 30ºC and 140 
RPM in modified CGXII with 4% glucose (w/v), as described in Chapter 2. 
C. glutamicum acepqoC-T ilvNldhAalaTavtA (ELB-PO1) was 
grown with 3% glucose (w/v), 1% potassium-acetate (w/v) and 20 mM L-
alanine. Cultures (200 mL), were inoculated at an initial OD600 of 0.5. 
Precultures (25 mL), were grown for 10 h in 250mL-baffled flasks under 
identical conditions. 
Preparation of cell suspensions 
For anaerobic in vivo NMR experiments, different volumes of cultures in 
the stationary phase of growth were collected (ELB-P01: OD600 20, 275 
mL; other strains OD600 ~35, 175 mL), centrifuged (7500 rpm, 10 min, 4ºC), 
and washed twice (buffer: 10 mM PIPES, pH 7.0). Cells were then re-
suspended in 50 mM PIPES buffer (pH 7.0); antifoaming agent (approx. 
15-20 µl), D2O (6% v/v) was added and the final volume adjusted to 50 mL.  
For experiments with diluted cell suspensions, 15 mL of cultures in the 
stationary phase of growth (ELB-P01: OD600 20) were collected, and the 
same procedure as described above, applied. Cells were then re-
suspended in 50 mM PIPES buffer (pH 7.0); antifoaming agent (approx. 
15-20 µl), D2O (6% v/v) was added and the final volume adjusted to 30 mL.  
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Table A1.1. Bacterial strains used in this study.  
Strains Description Reference 
C. glutamicum ΔldhA 
C. glutamicum carrying deletion of the lactate 
dehydrogenase 
This work 




C. glutamicum ΔldhA with the over-expression of 
pyruvate carboxylase gene from C. glutamicum 
DM1727 
Litsanov et al. 
2012a 
ELB-PO1 
C. glutamicum with deletions of the genes coding 
for the E1 subunit of pyruvate dehydrogenase 
complex, the pyruvate:quinone oxidoreductase, 
lactate dehydrogenase, alanine-glutamate 
transaminase and alanine-valine transaminase; 
also carries truncated version of regulatory subunit 
of the acetohydroxyacid synthase 
Wieschalka 





additional deletions of the pyruvate:quinone 
oxidoreductase, phosphotransacetylase - acetate 
kinase and acetyl coenzyme A (CoA):CoA 
transferase 
Litsanov et al. 
2012a 
Abbreviations: ldhA, lactate dehydrogenase gene; pyc, pyruvate carboxylase. 
In vivo 13C-NMR experiments  
Experiments were performed using the on-line system described by Neves 
et al. 1999. Essentially, experiments were performed as described in 
Chapter 2. Resting cells were kept at a constant temperature of 30ºC, and 
under anaerobic conditions achieved by bubbling pure CO2. Glucose 
specifically labeled on carbon 1 (20 mM) was added to the cell suspension 
at time-point zero. The time course of glucose consumption, product 
formation, and changes in the pools of other metabolites was monitored in 
vivo. To calculate rates of substrate consumption, cell dry-weight was 
measured. Experiments were performed once. The typical variation in the 
in vivo NMR experiments is ± 10% (Chapter 2). 
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Analysis of metabolic fluxes in non-growing cells 
Resting cells suspended in 50 mM PIPES, were kept at a constant 
temperature of 30ºC, and under 100% CO2 atmosphere. The pH value was 
controlled at 7.0. Glucose, specifically labeled on carbon 2 (50 mM), was 
added to the cell suspension at time-point zero. Samples were withdrawn 
from the metabolizing suspension, centrifuged, and supernatants were 
analyzed by 13C-NMR and HPLC, as described in Chapter 2. To calculate 
rates of substrate consumption, cell dry-weight was measured.   
Results and discussion 
Anaerobic glucose metabolism of the succinate producing strains 
measured by the in vivo 13C-NMR  
We used the in vivo 13C-NMR methodology to estimate the effect of genetic 
manipulations on the production of succinate by various C. glutamicum 
strains under optimal succinate producing conditions (100% CO2). The first 
step in metabolic engineering for succinate production was elimination of 
lactate by deleting the lactate dehydrogenase gene (Okino et al. 2008a). 
This step abolished the accumulation of lactate and the major products of 
anaerobic metabolism from the metabolism of 20 mM [1-13C]glucose under 
100% CO2 conditions were succinate (24.1 mM, 1.20 mol per mol glucose) 
and acetate (7.4 mM, 0.37 mol per mol glucose) (Table A1.2). Further 
steps in engineering comprised the over-expression of pyruvate 
carboxylase gene from C. glutamicum DM1727 to enhance the flux from 
pyruvate towards the reductive TCA cycle; resulting strain C. glutamicum 
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∆ldh(pAN6-pycP485S) produced 27.0 mM succinate (1.35 mol succinate per 
mol glucose); major side product was acetate (0.45 mol per mol glucose).  
To eliminate the acetate production, strain CQPAL was constructed with 
additional deletions of the pyruvate:quinone oxidoreductase, 
phosphotransacetylase, acetate kinase and acetyl coenzyme A (CoA):CoA 
transferase genes in C. glutamicum ∆ldh(pAN6-pycP485S). CQPAL 
produced 25.7 mM succinate (1.28 mol succinate per mol glucose). 
Acetate production was decreased from 9.0 mM in ∆ldh(pAN6-pycP485S to 
about 1.0 mM in CQPAL. The 13C-concentrations of the major and minor 
products of anaerobic glucose metabolism by these strains are shown in 
Table A1.3. 
Another approach in creating a succinate producer was applied in strain 
ELB-PO1: similarly to the previous strains, lactate dehydrogenase gene 
was deleted; acetate was abolished by eliminating pyruvate:quinone 
oxidoreductase gene and aceE, enconding the catalytic subunit of the 
PDHC. Additionally, to prevent loss of carbon in amino acids, genes 
encoding alanine-glutamate transaminase and alanine-valine transaminase 
were inactivated; a truncated version of ilvN gene was used, which 
resulted in production of acetohydroxyacid synthase with higher Km and 
lower vmax for pyruvate. Under fully saturated CO2 conditions, strain ELB-
PO1 produced 12.8 mM succinate, 0.5 mM lactate, and 0.2 mM acetate. 
Other products of the metabolism of this strain were pyruvate (11.3 mM), 
acetoin, α-ketoisovalerate and L-valine (Table A1.3). 
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Table A1.2. Products of anaerobic glucose metabolism of various C. 
glutamicum strains. The initial concentration of glucose was 20 and 50 mM 
for the experiments with dense and diluted cell suspensions, respectively. 
In dense cell suspensions (OD600 =100), end-products and glucose were 
determined online by in vivo NMR, while in diluted cell suspensions 
(OD600 =7.5), they were measured by 
13C-NMR off-line in the sample 
supernatants. The pH of the cell suspensions was maintained at 7.0, and 

























OD600 = 100      
Δldh 0.0 1.20 0.37 28.8 90 
Δldh(pAN6-pyc
P485S
) 0.0 1.35 0.45 34.7 100 
CQPAL 0.0 1.28 0.05 25.5 90 
ELB-PO1 0.02 0.64 0.0 18.2 74 
      
OD600 = 7.5      
ELB-PO1 0.05 0.83 0.08 18.2 76 
aProduct yields were calculated assuming that [1-13C]glucose was processed via 
the EMP pathway thus producing a labelled and an unlabelled pyruvate molecule 
as follows: lactate yield = [3-13C]lactate×2/[1-13C]glucose; acetate yield = [2-
13C]acetate×2/[1-13C]glucose; succinate yield = ([2,3-13C]succinate×2 + [1,4-
13C]succinate)/ [1-13C]glucose; b  13C balance is the percentage of carbon in 
metabolized 13C-glucose that is recovered in the fermentation products. 




Table A1.3. 13C-labelling in the end-products derived from anaerobic 
metabolism of [1-13C]glucose. Concentrations were determined by 13C-
NMR and corrected for natural abundance (1.1%). Values come from 










Lactate C3 n.d. n.d. 0.05 0.24 
     
Acetate C2 3.40 4.20 0.40 0.10 
Acetate C1 0.62 0.64 n.d. n.d. 
     
Succ C2, C3 11.50 13.03 12.28 6.22 
Succ C1, C4 1.06 0.99 1.13 0.39 
Succ C1-C2 n.d. n.d. n.d. 0.10 
     
Pyruvate C3 0.18 0.19 0.52 5.10 
Pyruvate C3 enol 0.10 n.d. 0.37 0.31 
     
α-KG C2 n.d. n.d. 0.1 n.d. 
α-KG C4 n.d. n.d. 0.12 n.d. 
     
Glycerol C1, C3 n.d. n.d. 0.21 n.d. 
     
Glu C4 0.27 0.24 0.61 n.d. 
Glu C2 0.36 0.21 0.55 n.d. 
     
Alanine C3 0.28 0.20 0.75 0.28 
Glycogen 0.28 0.22 0.14 0.36 
Acetoin  n.d. n.d. n.d. 0.24 
α-KIV  n.d. n.d. n.d. 0.31 
L-Valine  n.d. n.d. n.d. 0.20 





Analysis of pathways operating under anaerobic conditions in ELB-
PO1  
Strain ELB-PO1 is an efficient pyruvate producer under aerobic conditions 
(Wieschalka 2012). When atmosphere is switched to pure CO2, this strain 
produced mainly succinate and pyruvate (Table A1.3, Fig. A1.1). We 
analyzed end-products from the metabolism of [2-13C]glucose with an aim 























Figure A1.1. Time course of glucose consumption and product accumulation 
during the metabolism of 50 mM [2-13C]glucose in non-growing cell suspensions 
of C. glutamicum ELB-PO1 (OD600 = 7.5). The experiments were carried out at 30 
ºC, with pH controlled at 7.0 and bubbling 100% CO2. Symbols: open diamonds, 
glucose; open circles, succinate; open squares, pyruvate; black triangles, acetate. 
Data shown is from a single experiment. 
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From the labelling in C2 and C3 of lactate or pyruvate the distribution of 
carbon flux between EMP and PPP can be calculated (Schrader et al. 
1993, Klapa et al. 1999). The PPP in ELB-PO1 was low, with approx. 6% 
of glucose processed through this pathway.  
The proportion between labelling in C2,C3 and C1,C4 of succinate is a 
measurement of the activity of the reductive TCA vs. the oxidative TCA 
route. In strain ELB-PO1, 3.5% of succinate was formed via the oxidative 
branch and/or the glyoxylate shunt, and the remaining via C3-carboxylation 
and reductive TCA. To produce succinate in the oxidative TCA route, some 
acetyl-CoA must be present. 13C-labelled acetate was detected in both 
experiments with ELB-PO1 (dense and diluted cell suspensions). The 
labelling pattern indicates that it originated from 13C-labelled glucose. This 
is a curious result, having in mind that ELB-PO1 has all acetate pathways 





Table A1.3. 13C-labelling in the end-products derived from anaerobic 
metabolism of [2-13C]glucose. Concentrations were determined by 13C-
NMR and corrected for natural abundance (1.1%). n.d., not detected. 




Lactate C3 n.d. 
Lactate C2 1.0 
Lactate C1 n.d. 
  
Succinate C2,3 19.5 
Succinate C1,4 0.7 
Succinate C1-2 n.d. 
  
Acetate C2 n.d. 
Acetate C1 1.6 
  
Pyruvate C3 0.5 
Pyruvate C2 13.1 
Pyruvate C1 0.07 
  
Alanine C2 0.3 
Glycerol C2 0.2 
DHA C2 0.4 
 
Conclusions 
In this work, the five strains designed for anaerobic succinate production 
from glucose were studied using in vivo 13C-NMR and specifically labeled 
13C-glucose. The results indicate that the elimination of lactate production 
and overproduction of pyruvate carboxylase are two important steps in 
succinate production. In vivo 13C-NMR and 13C tracer studies are useful 
methodology for studying the anaerobic succinate production.  
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Bacteria usually produce more than one 2,3-butanediol isomer as a result 
of different stereospecificities of the butanediol dehydrogenases or the 
existence of more than one butanediol dehydrogenase in a particular 
microorganism. The stereochemistry of 2,3-butanediol production is 
studied due to the commercial interest in producing pure stereoforms of 
this chemical. Lactococcus lactis possesses two butanediol 
dehydrogenase activities, which we have set out to purify and characterize. 
The production of recombinant proteins in Escherichia coli was poor, and t 
low activities of the two enzymes were detected in spectrophotometric 
measurements. Nonetheless, upon prolonged incubation of the two 
butanediol dehydrogenases with the racemic acetoin, 2,3-butanediol was 
synthesized. The first enzyme (coded by butA) produced mainly meso-2,3-
butanediol (97%) and minor amounts of optically active form, confirming 
the in vivo data obtained by overproducing this enzyme in 
Corynebacterium glutamicum. The second butanediol dehydrogenase 
(coded by butB) produced minor amounts of the meso-2,3-butanediol, 
which made it difficult to draw firm conclusions about the nature of this 
enzyme. 
Introduction 
The NAD(P)-dependent alcohol dehydrogenases comprise a 
heterogeneous protein superfamily that catalyze the reversible oxidation of 
alcohols to aldehydes or ketones and can be grouped in at least three 
enzyme families: i) Zn-dependent medium-chain dehydrogenases/ 
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reductases (MDR); ii) short-chain dehydrogenases/ reductases (SDR); and 
iii) Fe-activated alcohol dehydrogenases. Butanediol dehydrogenases 
(BDHs), a subgroup of this protein superfamily, are of particular interest 
since they are involved in the production of 2,3-butanediol (2,3-BD), which 
is a desirable bulk chemical. Several BDHs have been characterized so far 
(Table 4.1, Chapter 4). The BDHs of Klebsiella pneumoniae, Serratia 
marescens, and Enterobacter cloacae fall into to the SDR family; these 
enzymes introduce the new hydroxyl group in the (S)-configuration, thus 
reducing (R)-acetoin to meso-2,3-BD and (S)-acetoin to (2S,3S)-2,3-BD. 
Corynebacterium glutamicum possesses a BDH that belongs to the SDR 
family, but this enzyme prefers (S)-acetoin and (2S,3S)-2,3-BD over (R)-
acetoin and meso-2,3-BD (Takusagawa et al. 2001). The third group 
comprises the BDHs of Bacillus subtilis, Paenibacillus polymyxa and 
Saccharomyces cerevisiae that belong to the MDR family, and generally 
catalyze the introduction of a hydroxyl group in the (R)-configuration; they 
use (R)-acetoin and (S)-acetoin to produce (2R,3R)-2,3-BD and meso-2,3-
BD, respectively.  
Lactococcus lactis is a natural producer of 2,3-BD, a compound which is 
assumed to be a part of the strategy to prevent over-acidification of the cell 
interior (Zuljan et al. 2014). Detailed characterization is available for the 
first two enzymes of the 2,3-BD biosynthetic pathway, α-acetolactate 
synthase (ALS) and α-acetolactate decarboxylase (ALDC) (Marlow et al. 
2013, Goupil-Feuillerat et al. 1997, Snoep et al. 1992). However, the 
knowledge on the BDHs of L. lactis is limited. Partially pure preparations of 
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the two BDHs from L. lactis subsp. lactis D10 and more specifically, their 
stereochemical properties were studied (Crow 1991). Both enzymes 
showed activity with acetoin and diacetyl; when incubated with any of 
these two substrates, enzyme 1 always produced meso-2,3-BD, and 
enzyme 2 produced a mixture of meso- and optically active form. However, 
the respective genes were not assigned in this work. 
Bioinformatic analysis indicates that these two activities could be coded by 
butA (llmg_1641) and butB (llmg_1642). Even so, some confusion exists in 
the literature on the properties of these two enzymes. In one study, butB-
encoded activity (BDHB) was used in the 2,3-BD production by E. coli; as 
the resulting strain produced meso-2,3-BD, the authors concluded that 
BDHB was responsible for the meso-BDH activity in L. lactis (Nielsen et al. 
2010). In another study, successfully overproduced BDHA (butA-encoded) 
caused meso-2,3-BD production in L. lactis (Gaspar et al. 2012). To clarify 
stereospecific properties of the two BDHs, the genes coding for butA and 
butB of L. lactis subsp. cremoris MG1363 were expressed int E. coli and 
the respective recombinant proteins were purified and characterized. 
 
Materials and methods 
Bacterial strains and growth conditions 
Strains and plasmids used in this work are shown in Table A2.1. For the 
protein production, E. coli cultures (400 mL), harboring the gene of interest 
were grown in LB medium supplemented with 100 μg ampicillin per mL at 
180 rpm. E. coli pET-19bbutALl and E. coli pET-19b were grown always at 
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37°C to OD600 of 1.5, at which point protein production was induced using 
1 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG). Cells were collected 1 
h after the induction. E. coli pET-19bbutBLl was grown for 3 h at 37°C 
(OD600 of 0.8), after which IPTG was added (1 mM) and protein production 
was continued for 16 h at 20°C.  
Construction of strains and plasmids 
All primers used are listed in the Table A2.1. Chromosomal DNA of L. 
lactis MG1363, isolated according to Johansen and Kibenich (1992), was 
used as template in PCR amplifications. To obtain expression vectors the 
two butanediol dehydrogenases, genes butALl and butBLl were amplified 
from chromosomal DNA of L. lactis using primers butALL-FW/butALL-RE 
and butBLL-FW/butBLL-RE and ligated into pET-19b. Plasmid was 
obtained and maintained in E. coli BL21(DE3). Sequencing confirmation of 
the correctness of the insert was performed at StabVida (Lisbon).  
Protein purification 
Cells of E. coli pET19bbutALl and E. coli pET19bbutALl grown as described 
above, were collected, centrifuged (9,924 × g, 10 min, 4C), and washed 
once with an appropriate buffer (Tris-HCl, 2-Amino-2-hydroxymethyl-
propane-1,3-diol hydrochloride), 10 mM at pH 7.5. The resulting cell pellet 
was re-suspended in 4 mL of 50 mM Tris-HCl at pH 7.5; cell suspension 
was passed through a French press 3 times (120 MPa), and centrifuged 
(12,857 × g, 20 min, 4C). The supernatant was applied to 5 mL-HisTrap 
HP column (GE Healthcare Life Sciences) and eluted according to the 
instruction of the manufacturer. Active fractions were then dialysed against 
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50 mM PIPES pH 7.0, concentrated using Amicon concentrator, and kept 
at 4C. 
Table 1. Bacterial strains, plasmids and primers used in this study.  
Strains Description Reference 
E. coli 
BL21(DE3) 
Plasmid-free E.coli for protein expression Stratagene 





E. coli BL21(DE3) carrying pET-19bbutA
Ll





E. coli BL21(DE3) carrying pET-19bbutB
Ll
 This work 




, T7lac, N-terminal Histidine-tag with the 




 pET-19b carrying butA gene of L. lactis This work 
pET-19bbutB
Ll




butALL-FW GGAATTCCATATGATGTCTAAAGTTGC NdeI 
butALL-RE CGCGGATCCTTAATGAAATTGC BamHI 
butBLL-FW GGAATTCCATATGATGGCTTGGTG NdeI 
butBLL-RE CGCGGATCCTATAGACCTTTTCC BamHI 
Abbreviations: butALl, butanediol dehydrogenase A (BDHA) gene; butBLl, 
butanediol dehydrogenase B (BDHB) gene; ampR, amplicillin resistance; T7, T7 
RNA polymerase promoter sequence; lac, lac operator sequence. 
Enzymatic assays 
BDH enzyme activities were assayed at 30°C in a Beckman Coulter DU 
800 spectrophotometer in 50 mM MES (pH 6.2), 0.2 mM NADH and 2.5 
mM acetoin (Stormer, 1975). One unit of enzyme activity is the amount of 
enzyme catalyzing the conversion of 1 μmol of substrate per minute under 
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the experimental conditions used. The protein concentration was 
determined using Pierce BCA Protein Assay Kit (Thermo Scientific). 
Specific activity was expressed as units (μmol·min-1) per milligram of 
protein (U·mg of protein-1). To measure the 2,3-BD isomer formation, a 
reaction mixture containing 9 mM (racemic) R/S-acetoin and 21 mM NADH 
in MES buffer (40 mM) at pH 6.2 was incubated with approximately 7.8 μg 
of protein for 24 h at 30°C. 
NMR spectroscopy 
1H-NMR spectra were acquired on Bruker AVANCE II+ 800 MHz 
spectrometer (Bruker BioSpin GmbH) at 30ºC, using a TXI-Z H/C/N/-D 
probe head. Acquisition parameters: flip angle of 60º; 32K acquisition data 
points; repetition delay of 1.5 s, number of spectra 16.  
Results and discussion 
Despite huge efforts to optimize protein production, the expression levels 
of the two proteins remained low. This is obvious when active fractions of 
the two proteins are compared with control coming from E. coli strain 
carrying the empty vector (Fig. A2.1). However, the measurements in the 
spectrophotometer showed that the two fractions had BDH activity (approx 
10 and 4.5 U·mg of protein-1 for BDHA and BDHB, respectively). Thus, we 
proceeded to test the 2,3-BD production upon incubation of these enzymes 





Figure A2.1 SDS-PAGE gel of different fractions eluted from the His-Trap 
column used for the purification of recombinant L. lactis butanediol 
dehydrogenases. The molecular masses calculated from the deduced amino acid 
sequences of BDHA and BDHB are 27 and 34.5 kDa, respectively. Active 
fractions were used for stereospecificity determinations and spectrophotometric 
activity measurements. Abbreviations: FT, flow-through fraction; M, marker; 
CTRL, proteins from the control strains; BDHA, proteins eluted in the attempted 
purification of BDHA; BDHB, proteins eluted in the attempted elution of BDHB. 
Proteins from E. coli culture harboring the empty plasmid (the control 
culture), that were bound to the His-Trap column showed no measurable 
BDH activity in the spectrophotometric measurements, and 2,3-BD 
production in the NMR assay was not detected. BDHA (coded by 
llmg_1641) produced a mixture of meso-2,3-BD (97%) and optically active 
2,3-BD (3%) after 24 h of incubation. BDHB (coded by llmg_1642) activity 
was extremely low, and a minor amount of meso-2,3-BD was detected 
after 24 h of incubation. This is in agreement with the results obtained in 
previous stereochemistry studies (Crow 1992). By amino acid similarity 
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analysis and size, BDHA belongs to the SDR family of alcohol 
dehydrogenases, and BDHB is a Zn2+-dependent MDR. It is likely that 
BDHA introduces a hydroxyl group in an (S)-conformation, and prefers (R)-
form of acetoin over the (S)-form. It is curious that BDHB produced meso-
2,3-BD, since it is an MDR-type of enzyme, although this is in agreement 
with the results of previous in vitro and in vivo studies that involved BDHB 
(Crow 1992, Nielsen et al. 2010). Since very low amounts of 2,3-BD were 
produced, these results have to be taken with care.  
 
Figure A2.2 1H-NMR spectra of 2,3-BD produced in the enzymatic reaction 
using control proteins (A), BDHA (B), and BDHB (C). Reaction mixture containing 
9 mM (racemic) R/S-acetoin and 21 mM NADH in MES buffer (40 mM) at pH 6.2 
was incubated with approximately 15 μg of protein for 24 h at 30°C. Legend: 
meso-2,3-BD, meso-2,3-butanediol; (2S,3S)-2,3-BD, optically active (2S,3S)-2,3-




In this work, we attempt to purify and characterize two BDHs from L. lactis. 
One of the enzymes (coded by butA gene), identified as a SDR, produced 
mainly meso-2,3-BD and low amounts of the optically active form. From 
this result, and from a very high similarity between this enzyme and BDH of 
K. pneumoniae (65%), we concluded that the enzyme has preference for 
reducing (R)-form of acetoin into meso-2,3-BD. Further studies are 
necessary to confirm these results and shed more light on the 
stereochemical properties of the two BDHs from L. lactis.  
 
References 
Snoep JL, Teixeira de Mattos MJ, Starrenburg MJ, Hugenholtz J. 1992. Isolation, 
characterization, and physiological role of the pyruvate dehydrogenase complex and 
alpha-acetolactate synthase of Lactococcus lactis subsp. lactis bv. diacetylactis. J. 
Bacteriol. 174(14): 4838–41. 
Goupil-Feuillerat N, Cocaign-Bousquet M, Godon, JJ, Ehrlich SD, Renault P. 1997. Dual 
role of alpha-acetolactate decarboxylase in Lactococcus lactis subsp. lactis. J. 
Bacteriol. 179(20):6285–93. 
